
<html lang="en"     class="pb-page"  data-request-id="7ab6db57-93df-4445-801d-dd4bd945932e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2010.53.issue-20;page:string:Article/Chapter View;article:article:10.1021/jm100607r;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Tetrahydropyridothieno[2,3-d]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency" /></meta><meta name="dc.Creator" content="Chia-Hsien  Wu" /></meta><meta name="dc.Creator" content="Mohane Selvaraj  Coumar" /></meta><meta name="dc.Creator" content="Chang-Ying  Chu" /></meta><meta name="dc.Creator" content="Wen-Hsing  Lin" /></meta><meta name="dc.Creator" content="Yi-Rong  Chen" /></meta><meta name="dc.Creator" content="Chiung-Tong  Chen" /></meta><meta name="dc.Creator" content="Hui-Yi  Shiao" /></meta><meta name="dc.Creator" content="Shaik  Rafi" /></meta><meta name="dc.Creator" content="Sing-Yi  Wang" /></meta><meta name="dc.Creator" content="Hui  Hsu" /></meta><meta name="dc.Creator" content="Chun-Hwa  Chen" /></meta><meta name="dc.Creator" content="Chun-Yu  Chang" /></meta><meta name="dc.Creator" content="Teng-Yuan  Chang" /></meta><meta name="dc.Creator" content="Tzu-Wen  Lien" /></meta><meta name="dc.Creator" content="Ming-Yu  Fang" /></meta><meta name="dc.Creator" content="Kai-Chia  Yeh" /></meta><meta name="dc.Creator" content="Ching-Ping  Chen" /></meta><meta name="dc.Creator" content="Teng-Kuang  Yeh" /></meta><meta name="dc.Creator" content="Su-Huei  Hsieh" /></meta><meta name="dc.Creator" content="John T.-A.  Hsu" /></meta><meta name="dc.Creator" content="Chun-Chen  Liao" /></meta><meta name="dc.Creator" content="Yu-Sheng  Chao" /></meta><meta name="dc.Creator" content="Hsing-Pang  Hsieh" /></meta><meta name="dc.Description" content="HTS hit 7 was modified through hybrid design strategy to introduce a chiral side chain followed by introduction of Michael acceptor group to obtain potent EGFR kinase inhibitors 11 and 19. Both 11 ..." /></meta><meta name="Description" content="HTS hit 7 was modified through hybrid design strategy to introduce a chiral side chain followed by introduction of Michael acceptor group to obtain potent EGFR kinase inhibitors 11 and 19. Both 11 ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 23, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100607r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100607r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100607r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100607r" /></link>
        
    
    

<title>Design and Synthesis of Tetrahydropyridothieno[2,3-d]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100607r" /></meta><meta property="og:title" content="Design and Synthesis of Tetrahydropyridothieno[2,3-d]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0010.jpeg" /></meta><meta property="og:description" content="HTS hit 7 was modified through hybrid design strategy to introduce a chiral side chain followed by introduction of Michael acceptor group to obtain potent EGFR kinase inhibitors 11 and 19. Both 11 and 19 showed over 3 orders of magnitude enhanced HCC827 antiproliferative activity compared to HTS hit 7 and also inhibited gefitinib-resistant double mutant (DM, T790M/L858R) EGFR kinase at nanomolar concentration. Moreover, treatment with 19 shrinked tumor in nude mice xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100607r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100607r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100607r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100607r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100607r&amp;href=/doi/10.1021/jm100607r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7316-7326</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100504d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100727t" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chia-Hsien++Wu">Chia-Hsien Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohane+Selvaraj++Coumar">Mohane Selvaraj Coumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chang-Ying++Chu">Chang-Ying Chu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wen-Hsing++Lin">Wen-Hsing Lin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Rong++Chen">Yi-Rong Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiung-Tong++Chen">Chiung-Tong Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui-Yi++Shiao">Hui-Yi Shiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaik++Rafi">Shaik Rafi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sing-Yi++Wang">Sing-Yi Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Hsu">Hui Hsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chun-Hwa++Chen">Chun-Hwa Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chun-Yu++Chang">Chun-Yu Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teng-Yuan++Chang">Teng-Yuan Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tzu-Wen++Lien">Tzu-Wen Lien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Yu++Fang">Ming-Yu Fang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kai-Chia++Yeh">Kai-Chia Yeh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ching-Ping++Chen">Ching-Ping Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teng-Kuang++Yeh">Teng-Kuang Yeh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Su-Huei++Hsieh">Su-Huei Hsieh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.-A.++Hsu">John T.-A. Hsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chun-Chen++Liao">Chun-Chen Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Sheng++Chao">Yu-Sheng Chao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsing-Pang++Hsieh">Hsing-Pang Hsieh</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Institute of Biotechnology and Pharmaceutical Research</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Division of Molecular & Genomic Medicine</span></div><div class="aff-info" id="aff6"><span class="aff-text">National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan, ROC</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Department of Chemistry, National Tsing Hua University, 101 Section 2, Kuang Fu Road, Hsinchu 300, Taiwan, ROC</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Department of Biological Science and Technology, National Chiao Tung University, 1001 University Road, Hsinchu 300, Taiwan, ROC</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">Department of Chemistry, Chung Yuan Christian University, 200 Chung Pei Road, Chung Li 320, Taiwan, ROC</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For W.-H.L.: phone, (+) 886-37-246166 ext 35771; fax, (+) 886-37-586-456; E-mail, <a href="/cdn-cgi/l/email-protection#e1959692958093a18f899388cf8e9386cf9596"><span class="__cf_email__" data-cfemail="33474440475241735d5b415a1d5c41541d4744">[emailÂ protected]</span></a>. For H.-P.H.: phone, (+) 886-37-246166 ext 35708; fax, (+) 886-37-586-456; E-mail, <a href="/cdn-cgi/l/email-protection#731b031b001a161b331d1b011a5d1c01145d0704"><span class="__cf_email__" data-cfemail="93fbe3fbe0faf6fbd3fdfbe1fabdfce1f4bde7e4">[emailÂ protected]</span></a></div><div class="corresp-fn" id="fn1">#These authors contributed equally to this work</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100607r&amp;href=/doi/10.1021%2Fjm100607r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7316â7326</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 23, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 May 2010</li><li><span class="item_label"><b>Published</b> online</span>23 September 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 October 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100607r" title="DOI URL">https://doi.org/10.1021/jm100607r</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7316%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChia-Hsien%2BWu%252C%2BMohane%2BSelvaraj%2BCoumar%252C%2BChang-Ying%2BChu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D20%26contentID%3Djm100607r%26title%3DDesign%2Band%2BSynthesis%2Bof%2BTetrahydropyridothieno%255B2%252C3-d%255Dpyrimidine%2BScaffold%2BBased%2BEpidermal%2BGrowth%2BFactor%2BReceptor%2B%2528EGFR%2529%2BKinase%2BInhibitors%253A%2BThe%2BRole%2Bof%2BSide%2BChain%2BChirality%2Band%2BMichael%2BAcceptor%2BGroup%2Bfor%2BMaximal%2BPotency%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7326%26publicationDate%3DOctober%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100607r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4372</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">80</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100607r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Tetrahydropyridothieno[2,3-d]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chia-Hsien&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Mohane&quot;,&quot;last_name&quot;:&quot;Selvaraj Coumar&quot;},{&quot;first_name&quot;:&quot;Chang-Ying&quot;,&quot;last_name&quot;:&quot;Chu&quot;},{&quot;first_name&quot;:&quot;Wen-Hsing&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Yi-Rong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Chiung-Tong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Hui-Yi&quot;,&quot;last_name&quot;:&quot;Shiao&quot;},{&quot;first_name&quot;:&quot;Shaik&quot;,&quot;last_name&quot;:&quot;Rafi&quot;},{&quot;first_name&quot;:&quot;Sing-Yi&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Chun-Hwa&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Chun-Yu&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Teng-Yuan&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Tzu-Wen&quot;,&quot;last_name&quot;:&quot;Lien&quot;},{&quot;first_name&quot;:&quot;Ming-Yu&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Kai-Chia&quot;,&quot;last_name&quot;:&quot;Yeh&quot;},{&quot;first_name&quot;:&quot;Ching-Ping&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Teng-Kuang&quot;,&quot;last_name&quot;:&quot;Yeh&quot;},{&quot;first_name&quot;:&quot;Su-Huei&quot;,&quot;last_name&quot;:&quot;Hsieh&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T.-A. Hsu&quot;},{&quot;first_name&quot;:&quot;Chun-Chen&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Yu-Sheng&quot;,&quot;last_name&quot;:&quot;Chao&quot;},{&quot;first_name&quot;:&quot;Hsing-Pang&quot;,&quot;last_name&quot;:&quot;Hsieh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7316-7326&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100607r&quot;},&quot;abstract&quot;:&quot;HTS hit 7 was modified through hybrid design strategy to introduce a chiral side chain followed by introduction of Michael acceptor group to obtain potent EGFR kinase inhibitors 11 and 19. Both 11 and 19 showed over 3 orders of magnitude enhanced HCC827 antiproliferative activity compared to HTS hit 7 and also inhibited gefitinib-resistant double mutant (DM, T790M/L858R) EGFR kinase at nanomolar concentration. Moreover, treatment with 19 shrinked tumor in nude mice xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100607r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100607r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100607r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100607r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100607r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100607r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100607r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100607r&amp;href=/doi/10.1021/jm100607r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100607r" /></input><a href="/doi/pdf/10.1021/jm100607r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100607r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100607r%26sid%3Dliteratum%253Aachs%26pmid%3D20961149%26genre%3Darticle%26aulast%3DWu%26date%3D2010%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BTetrahydropyridothieno%255B2%252C3-d%255Dpyrimidine%2BScaffold%2BBased%2BEpidermal%2BGrowth%2BFactor%2BReceptor%2B%2528EGFR%2529%2BKinase%2BInhibitors%253A%2BThe%2BRole%2Bof%2BSide%2BChain%2BChirality%2Band%2BMichael%2BAcceptor%2BGroup%2Bfor%2BMaximal%2BPotency%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D20%26spage%3D7316%26epage%3D7326%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291264" title="Kinase inhibitors">Kinase inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jmcmar.2010.53.issue-20/production/jmcmar.2010.53.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">HTS hit <b>7</b> was modified through hybrid design strategy to introduce a chiral side chain followed by introduction of Michael acceptor group to obtain potent EGFR kinase inhibitors <b>11</b> and <b>19</b>. Both <b>11</b> and <b>19</b> showed over 3 orders of magnitude enhanced HCC827 antiproliferative activity compared to HTS hit <b>7</b> and also inhibited gefitinib-resistant double mutant (DM, T790M/L858R) EGFR kinase at nanomolar concentration. Moreover, treatment with <b>19</b> shrinked tumor in nude mice xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lung cancer is the most common human cancer, with 85% being nonsmall cell lung cancer (NSCLC<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: ATP, adenosine triphosphate; DM, double mutant (L858R/T790M); EGFR, epidermal growth factor receptor; HTS, high-throughput screening; LCMS, liquid chromatography coupled mass spectrometry; NSCLC, nonsmall cell lung cancer; PK, pharmacokinetic; TK, tyrosine kinase; WT, wild type.</p></div>). In â¼50% of NSCLC patients, epidermal growth factor receptor (EGFR) is overexpressed with concomitant dysregulation in their downstream signaling pathway, and this overexpression is correlated with poor prognosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> EGFR is a transmembrane protein with an external ligand binding receptor domain and an intracellular tyrosine kinase activity domain. Once a native ligand (eg., EGF) binds to the extracellular domain, it dimerizes with another EGFR family member (eg, EGFR, Her2), resulting in activation of the intracellular tyrosine kinase (TK) activity. This results in autoposphorylation of EGFR and further activation of downstream signaling pathway affects cell survival and proliferation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Gefitinib (<b>1</b>) and erlotinib (<b>2</b>) were approved by US FDA in 2002 and 2004, respectively, for the treatment of NSCLC (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Gefitinib or erlotinib competitively binds to the adenosine triphosphate (ATP) binding pocket of intracellular EGFR TK domain and inhibit its activity, thereby blocking the aberrant EGFR downstream signaling essential for tumor survival and proliferation. Although the two drugs showed high response rates in specific subsets of NSCLC patients, for most patients, who respond initially to gefitinib or erlotinib, drug resistance often occurs as a result of a secondary mutation such as the Thr<sup>790</sup> â Met<sup>790</sup> (T790M) mutation.<a onclick="showRef(event, 'ref1 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref4">(1, 3, 4)</a> Therefore, identification of second-generation EGFR tyrosine kinase inhibitors that overcome the acquired T790M mutation (such as the EGFR<sup>L858R/T790M</sup> double mutation) can be beneficial for the treatment of gefinitib- or erlotinib-resistant NSCLC.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversible and irreversible EGFR tyrosine kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have recently used an EGFR-transfected 32D cell-based high-throughput screening (HTS) assay to identify compounds that inhibit EGFR activation and/or EGFR-mediated downstream signaling pathway.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This cell-based screening protocol allowed us to identify several leads which disrupt cell proliferation mediated by aberrant EGFR signaling, among which <b>7</b>, a novel tricyclic tetrahydrobenzothieno[2,3-<i>d</i>]pyrimidine core compound, was identified as an initial hit with an enzyme inhibition IC<sub>50</sub> = 2.6 Î¼M (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In this brief communication, we describe the development path of hit <b>7</b>, a weak EGFR kinase inhibitor, to that of potent EGFR kinase inhibitor <b>11</b> (IC<sub>50</sub> = 8 nM) and <b>19</b> (IC<sub>50</sub> = 6 nM), which can also inhibit gefitinib resistant EGFR<sup>L858R/T790M</sup> double mutant kinase. Further, in vivo activity for <b>19</b> is demonstrated in HCC827 (NSCLC cell line with Del722-726 mutation) xenograft nude mice model, proving the potential of <b>19</b> for cancer treatment.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of novel and potent tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine scaffold EGFR tyrosine kinase inhibitors, through knowledge-based design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initial attempts to improve the activity of <b>7</b> through increasing the side chain length (<b>7a</b>), substitution in the phenyl ring (<b>7b</b>,<b>c</b>), or converting the fused cyclohexyl ring to cyclopentyl ring (<b>7d</b>) led to decreased EGFR kinase activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Meanwhile, through a concurrent program for the development of aurora kinase inhibitors, we have synthesized a set of kinase-targeted compound library based on furanopyrimidine scaffold. This library was counter-screened for EGFR kinase inhibition, leading to the identification of an EGFR kinase selective furanopyrimidine inhibitor <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with an EGFR kinase IC<sub>50</sub> = 223 nM (aurora A kinase IC<sub>50</sub> > 10 Î¼M).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of EGFR WT Kinase by <b>7</b> and <b>7a</b>â<b>d</b> Analogues<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0002.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">EGFR-WT kinase % inhibition at 20 Î¼M</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="char" char=".">76.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="char" char=".">44.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>(4-OCH<sub>3</sub>-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>(4-F-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">52.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="char" char=".">69.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">WT: wild type kinase.</p></div></div></div><div class="NLM_p">Scrutinizing both the structures of HTS hit <b>7</b> and kinase library hit <b>8</b> revealed that even though both have different core structures (scaffolds), they have very similar side chain. The kinase library hit <b>8</b> possessed a chiral <i>S</i>-2-phenyl-2-aminoethanol side chain, which is very similar to that of the HTS hit <b>7</b> except for the presence of methanol branching with an <i>S</i>-configuration. This novel chiral phenylaminoethanol side chain is not present in any of the EGFR kinase inhibitors reported so far. As a majority of EGFR kinase inhibitors in market or in development bear anilino type side chains linked to quinazoline/quinoline cores (<b>1</b>, <b>2</b>, <b>4</b>â<b>6</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), we contemplated the development of new EGFR kinase inhibitors with this novel chiral phenylaminoethanol side chain, both to explore the importance of chirality for EGFR inhibition and to develop novel proprietary molecules. It should also be noted that a closely related <i>R</i>-1-phenylethylamino side chain has been reported a few times in EGFR kinase inhibitors,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and compound <b>3</b> (AEE788)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> bearing <i>R</i>-1-phenylethylamino side chain is reported to be in clinical testing; however, the importance of chirality for EGFR inhibition has not been explored in much detail through structureâactivity relationship (SAR) studies in those reports.</div><div class="NLM_p">With this agenda, we synthesized the hybrid compound <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) possessing the tricyclic core of hit <b>7</b> and the chiral phenylaminoethanol side chain of hit <b>8</b>. Subsequently, the hybrid compound <b>9</b> showed submicromolar EGFR kinase inhibition (IC<sub>50</sub> = 720 nM) and further exhibited potent antiproliferative activity in HCC827 cell lines (IC<sub>50</sub> = 198 nM), which is over 50-fold better than that of the original HTS hit <b>7</b>. On the basis of these findings, new lead <b>9</b> was selected for further structural modification to deeply investigate SAR in order to optimize both the kinase and cell-based activity.</div><div class="NLM_p">It was found that either removal of the secondary hydroxyl group (<b>9a</b>) or phenyl group (<b>9b</b>) from the side chain of <b>9</b> led to decreased EGFR kinase inhibition, particularly removal of the phenyl group led to complete loss of activity, showing the indispensible nature of the phenyl ring in maintaining activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Moreover, the orientation of the phenyl ring is critical, as the <i>R</i>-enantiomer (<b>9c</b>) of <b>9</b> was found to be completely inactive. Also, converting the six-membered carbocyclic ring fused to the thienopyrimidine to five-membered ring (<b>9d</b>) did not improve the activity. Although compounds <b>9</b> and <b>9d</b> showed nanomolar level inhibition in wild-type enzyme and cell-based assay, both were not capable of inhibiting double mutant EGFR kinase (<50% inhibition at 10 Î¼M), which could overcome gefitinib resistance.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of EGFR-WT Kinase and HCC827 Cell Line by <b>9</b> and <b>9a</b>â<b>d</b> Analogues<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0003.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">EGFR-WT kinase inhibition IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">HCC827 IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">0.720</td><td class="colsep0 rowsep0" align="char" char=".">0.198</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">3.240</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="right" char=".">>20<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="right" char=".">>20<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">1.090</td><td class="colsep0 rowsep0" align="char" char=".">0.324</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">WT: wild type kinase.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">Values are expressed as the mean of at least two independent experiments and are mostly within 15% error margins.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last"><50% enzyme inhibition at 20 Î¼M.</p></div></div></div><div class="NLM_p">Recent research reveals that a possible way to overcome gefitinib-resistant T790M mutant EGFR kinase is through irreversible inhibition of the enzyme by covalent modification of Cys733 residue in the ATP binding domain of the kinase.<a onclick="showRef(event, 'ref1 ref4 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref10 ref11">(1, 4, 10, 11)</a> This has been achieved with three clinical trial compounds <b>4</b> (HKI-272),<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a><b>5</b> (EKB-569),<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and <b>6</b> (BIBW2992)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> for the treatment of gefitinib-resistant NSCLC. These clinical trial compounds possess a Michael acceptor group in common, which plays a crucial role in inhibiting gefitinib resistant T790M mutant kinase irreversibly through covalent modification of cysteine residue.<a onclick="showRef(event, 'ref11 ref16'); return false;" href="javascript:void(0);" class="ref ref11 ref16">(11, 16)</a> This knowledge stimulated us to introduce a Michael acceptor group in our series of compounds to incorporate activity toward gefitinib-resistant T790M mutant kinase. One possibility to introduce a Michael acceptor group into the tricyclic core of <b>9</b> is through the introduction of additional diversity point by replacing one methylene unit with a nitrogen in the six-membered carbocyclic ring to form <b>10</b>. Then the newly designed tricyclic tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine core was used to construct <b>11</b> incorporating an acrylamide Michael acceptor group at the diversity point (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_p">First, the hybrid compound <b>11</b> with the acrylamide Michael acceptor group was examined for both wild-type and double mutant EGFR kinase inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). It not only displayed an excellent wild-type enzyme inhibition but also displayed double mutant kinase inhibition at nanomolar level. Compared to <b>9</b>, <b>11</b> displayed 90-fold enhanced EGFR wild-type kinase inhibition. Most interestingly, <b>11</b> displayed significantly enhanced double mutant kinase inhibition, which is over 25-fold better than gefitinib. In addition to showing potent EGFR kinase inhibition, <b>11</b> also showed potent antiproliferative activity in HCC827 cell line, with growth inhibition in the single-digit nanomolar range (IC<sub>50</sub> = 3 nM). It should be noted that compound <b>10</b>, a close analogue of <b>11</b> lacking the Michael acceptor acrylamide function shows complete loss of activity. Thus incorporation of acrylamide Michael acceptor group had resulted in both enhancing the wild-type enzyme inhibition as well as imparting potent activity toward gefitinib-resistant double mutant kinase. Further, the importance of the acrylamide Michael acceptor group in imparting EGFR activity was shown by complete inactivity of <b>12</b>, wherein the terminal double bond of <b>11</b> is reduced to give a simple propanamide functional group. Next, we attempted to replace the acrylamide group with butynamide (<b>13</b>) or with vinyl sulfonamide (<b>14</b>) as different Michael acceptor groups, both of which led to loss of activity. The butynamide analogue <b>13</b> showed poor activity in both wild and double mutant kinase, while the vinyl sulfonamide analogue <b>14</b> inhibited the double mutant kinase in a range very similar to that of gefitinib, suggesting the superiority of acrylamide <b>11</b> as an EGFR inhibitor.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of EGFR Kinase and HCC827 Cell Line by <b>7</b>, <b>9</b>â<b>27</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="d">d</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0004.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0005.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values are expressed as the mean of at least two independent experiments and are mostly within 15% error margins.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><50% enzyme inhibition at 20 Î¼M.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last"><50% enzyme inhibition at 10 Î¼M.</p></div><div class="footnote" id="tbl3-fn1"><sup>d</sup><p class="last">WT: wildâtype EGFR kinase. DM: double mutant EGFR kinase.</p></div></div></div><div class="NLM_p">Second, the full potential of <b>11</b> was probed by evaluating its ability to interfere with EGFR signaling inside the cell by carrying out Western blotting analysis. For this purpose, HCC827 cells were treated with <b>11</b> in dose-dependent manner and then analyzed for EGFR autophosphorylation (pEGFR at residue Tyr1068) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). When compared to gefitinib, <b>11</b> showed better inhibition of EGFR autoposphorylation, further demonstrating the potential of <b>11</b> as an EGFR kinase inhibitor.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis using anti-phospho-EGFR Y1068 and anti-EGFR immunoblots of HCC827 cell lysates treated with <b>1</b> or <b>11</b> for 2 h. A representative anti-tubulin immunoblot is shown as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Third, we carried out in vivo pharmacokinetic (PK) study in rat for <b>11</b>, which showed that the compound could not be detected in appreciable amounts in plasma within 10 min of IV injection (data not shown). The poor PK properties precluded testing of <b>11</b> for in vivo efficacy, and hence further efforts were aimed at identifying potent compounds with improved PK profile compared to that of <b>11</b>. For this purpose, we first turned our attention to the chiral phenylaminoethanol side chain linked to the pyrimidine core. When the <i>S</i>-enatiomer <b>11</b> was converted to <i>R</i>-enatiomer <b>15</b>, the compound lost EGFR wild and double mutant kinase activity over 200-fold compared to that of <b>11</b>. However, either the removal of hydroxyl group (<b>16</b>) or converting it to methyl group (<b>17</b>) led to loss of 3â6-fold potency for wild-type and 8â22-fold loss of potency for double mutant kinase compared to that of <b>11</b>. These results suggest that presence of hydroxyl group plays an important role in maintaining potent activity for both wild-type and double mutant EGFR kinase. Hence, by retaining the chiral phenylaminoethanol side chain linked to the pyrimidine core, we attempted modification in the Michael acceptor region of <b>11</b> in order to identify potent compounds.</div><div class="NLM_p">Introduction of a hydrophobic phenyl ring at the terminal double bond (<b>18</b>) led to complete loss of potency for both wild-type and double mutant kinase. On the basis of this observation, a hydrophilic <i>N</i>,<i>N</i>-dimethyl group was introduced through a methylene linker to the terminal double bond of <b>11</b> to get <b>19</b>, which retained the wild-type kinase activity and led to only a 3-fold loss of activity for double mutant kinase compared to that of <b>11</b>. When the size of the hydrophilic moiety was increased by changing the <i>N</i>,<i>N</i>-dimethyl group (<b>19</b>) to <i>N</i>,<i>N</i>-diethyl (<b>20</b>), morpholine (<b>21</b>), or <i>N</i>-methyl piperazine (<b>22</b>), both the wild-type as well as double mutant kinase activity decreased; the loss of potency was more prominent in the case of double mutant kinase activity, particularly <i>N</i>-methyl piperazine analogue <b>22</b> was completely inactive.</div><div class="NLM_p">As compound <b>19</b> is found to be better than related analogues <b>20</b>â<b>22</b> by retaining the <i>N</i>,<i>N</i>-dimethyl side chain on the Michael acceptor side of <b>19</b>, we further attempted to explore the SAR in the chiral phenylaminoethanol side chain linked to the pyrimidine core. It was found that the <i>R</i>-enatiomer (<b>23</b>) again lost the activity for both wild and double mutant kinase completely. Removal of hydroxyl group (<b>24</b>) only led to 2-fold loss of wild-type and double mutant kinase activity, while converting it to methyl group (<b>25</b>) led to loss of double mutant kinase activity (IC<sub>50</sub> > 5 Î¼M) without much affecting the wild-type kinase activity compared to that of <b>19</b>. These findings in the chiral phenylaminoethanol side chain are very similar to the SAR observation in <b>11</b> containing the acrylamide Michael acceptor group. This demonstrates that apart from the presence of Michael acceptor functionality, the presence of the hydroxyl group and the orientation of the phenyl group in the side chain has played a critical role determining the activity in this series, in particular for double mutant kinase activity. To further explore the role of the phenyl group, it was moved one carbon away from the chiral center or completely removed from the side chain, which resulted in <b>26</b> and <b>27</b>, respectively. Both moving the phenyl group through chain extension or removing the phenyl group had resulted in drastic loss of activity for both wild-type and double mutant kinase, with compound <b>27</b> being completely inactive toward both enzymes and <b>26</b> still maintaining nanomolar level wild-type kinase inhibition. These studies further demonstrate that the presence as well as orientation of the phenyl group in the side chain is essential for potent EGFR kinase activity in this series of compounds.</div><div class="NLM_p">Having identified <b>19</b>, which has similar EGFR kinase inhibition profile as that of <b>11</b>, we carried out PK evaluation of <b>19</b> in rats and found that <b>19</b> showed better IV PK profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) compared to that of <b>11</b>, suggesting that <b>19</b> is a more suitable candidate for in vivo efficacy evaluation. The in vivo efficacy of <b>19</b> was evaluated in nude mice bearing HCC827 tumor xenografts. Treatment mice received <b>19</b> as IV injection through the tail veins for 5 days/week for 2 consecutive weeks (days 1â5 and 8â12). At the dosage of 5 and 15 mg/kg, <b>19</b> shrank tumor growth significantly (<i>p</i> < 0.05), indicating potent in vivo anticancer activity for <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Administration of reference compound gefitinib (<b>1</b>) 100 mg/kg by perioral route using the same dosing schedule also shrinks the tumor significantly (<i>p</i> < 0.05).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Intravenous (iv) Pharmacokinetics Profile of <b>19</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">unit</th><th class="colsep0 rowsep0" align="center">value (SE)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose</td><td class="colsep0 rowsep0" align="left">mg/kg</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">hr</td><td class="colsep0 rowsep0" align="left">1.4 (0.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clearance</td><td class="colsep0 rowsep0" align="left">mL/min/kg</td><td class="colsep0 rowsep0" align="left">248.7 (7.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub></td><td class="colsep0 rowsep0" align="left">L/kg</td><td class="colsep0 rowsep0" align="left">27.3 (3.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (0ââ)</td><td class="colsep0 rowsep0" align="left">ng/mLÂ·h</td><td class="colsep0 rowsep0" align="left">337 (7)</td></tr></tbody></table></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo antitumor effect of <b>19</b> in human nonsmall cell lung cancer (HCC827) xenograft nude mice model. The growth of HCC827 tumor xenograft is inhibited by <b>19</b> (5 mg/kg, iv or 15 mg/kg, iv) and gefitinib (100 mg/kg, po) with <i>p</i> < 0.05. Drug treatment on days 1â5 and 8â12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Synthesis</h3><div class="NLM_p">Compounds <b>7</b>, <b>7a</b>â<b>d</b>, <b>9</b>, and <b>9a</b>â<b>d</b> were synthesized as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Appropriate cyclic ketones <b>28a</b>,<b>b</b> were condensed with ethyl cyanoacetate under basic condition and then cyclized in the presence of sulfur to construct the thiophene cores <b>29a</b>,<b>b</b> through Gewald reaction.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The thieno[2,3-<i>d</i>]pyrimidine ring system was then constructed using a modified Niementowski quinazoline synthesis by condensation of <b>29a</b>,<b>b</b> with formamide to afford <b>30a</b>,<b>b</b>. Finally, chlorination of pyrimidone <b>30a</b>,<b>b</b> with phosphrous oxychloride gave the intermediate <b>31a</b>,<b>b</b>, which underwent nucleophilic reaction with appropriate amines to give the desired compounds <b>7</b>, <b>7a</b>â<b>d</b>, <b>9</b>, and <b>9a</b>â<b>d</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NCCH<sub>2</sub>CO<sub>2</sub>Et, S<sub>8</sub>, EtOH, Et<sub>3</sub>N, reflux or rt, 16 h; (b) formamide, reflux, 2 h or formamidine acetate, DMF, 100 Â°C, 16 h; (c) POCl<sub>3</sub>, 0 â 60 Â°C, 3 h; (d) primary amine (R<sup>1</sup>R<sup>2</sup>CHNH<sub>2</sub>), <i>n</i>-BuOH, reflux, 8 h.</p></p></figure><div class="NLM_p">For the preparation of thieonpyrimidines <b>11</b>â<b>27</b> with the nitrogen bridge in the alicyclic ring, the key intermediate <b>31c</b> was constructed starting from 4-oxo-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>28c</b>) using a similar sequence of reaction as that for obtaining <b>31a</b>,<b>b</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Nucleophilic reaction of <b>31c</b> with appropriate primary amines gave <b>32a</b>â<b>f</b>, which were then subjected to Boc deprotection using TFA resulting in the intermediates <b>33a</b>â<b>f</b>. The desired compounds <b>11</b>â<b>13</b> and <b>15</b>â<b>18</b> were obtained by amide coupling reaction of appropriate secondary amine (<b>33</b>) and the acid (RCO<sub>2</sub>H) using EDCI as a coupling agent. For the preparation of compounds <b>19</b>â<b>27</b>, a two-step reaction sequence was utilized to get the final products; an initial amide coupling of 4-bromo crotonoic acid with appropriate intermediate <b>33</b>, followed by S<sub>N</sub>2 reaction with different secondary amines (R<sub>2</sub>NH), was carried out. For the sulphonamide derivative <b>14</b>, acylation of <b>33a</b> with sulphonyl chloride was carried out (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine (R<sup>1</sup>R<sup>2</sup>CHNH<sub>2</sub>), EtOH, reflux, 8 h; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C â rt, 2 h; (c) acid (RCO<sub>2</sub>H), EDCI, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (d) Cl(CH<sub>2</sub>)<sub>2</sub>SO<sub>2</sub>Cl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; (e) (i) (<i>E</i>)-BrCH<sub>2</sub>CHâCHCO<sub>2</sub>H, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (ii) secondary amine (R<sub>2</sub>NH), THF, 0 Â°C, 2 h.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, HTS hit <b>7</b> identified from cell-based screening strategy was modified through a knowledge-based design approach to obtain potent and novel tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine scaffold compounds as EGFR kinase inhibitors. Designing-in an unusual <i>S</i>-chiral 2-phenyl-2-aminoethanol side chain identified from counter-screening approach, and then introduction of Michael acceptor group into the tricyclic core through a diversity point âNHâ in HTS hit <b>7</b>, led to the development of <b>11</b> and <b>19</b>. Both <b>11</b> and <b>19</b> showed >300-fold enhanced EGFR wild-type kinase inhibition and >3000-fold enhanced HCC827 antiproliferative activity compared to HTS hit <b>7</b> and also inhibited gefitinib-resistant double mutant (DM, T790M/L858R) EGFR kinase at nanomolar concentration. Detailed SAR study in this series reveals that, in the presence of the side chain, the nature of chirality and the presence of the phenyl group are very critical for maintaining activity, while the presence of secondary hydroxyl function provides maximum potency. The presence of <i>S</i>-chiral 2-phenyl-2-aminoethanol side chain along with the acrylamide-type Michael acceptor group imparts maximal activity toward gefitinib-resistant double mutant EGFR kinase. Six of the compounds (<b>11</b>, <b>19</b>â<b>21</b>, <b>24</b>, <b>25</b>) possess excellent antiproliferative activity against HCC827 lung cancer cell line in single-digit nanomolar range, with compound <b>19</b> showing in vivo efficacy in nude mice bearing HCC827 tumor xenografts. Further testing could identify the full potential of this novel series for the treatment of cancers.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Methods</h3><div class="NLM_p last">All commercial chemicals and solvents are reagent grade and were used without further treatment unless otherwise noted. All reactions were carried out under an atmosphere of dry nitrogen. Reactions were monitored by TLC using Merck 60 F<sub>254</sub> silica gel glass backed plates (5 cm Ã 10 cm); zones were detected visually under ultraviolet irradiation (254 nm) or by spraying with phosphomolybdic acid reagent (Aldrich), followed by heating at 80 Â°C. Flash column chromatography was done using silica gel (Merck Kieselgel 60, no. 9385, 230â400 mesh ASTM). <sup>1</sup>H NMR spectra were obtained with a Varian Mercury-300 spectrometer operating at 300 MHz. Chemical shifts were recorded in parts per million (ppm, Î´) and were reported relative to the solvent peak or TMS. High-resolution mass spectra (HRMS) were measured with a Finnigan (MAT-95XL) electron impact (EI) or by using Finnigan/Thermo Quest MAT 95XL FAB mass spectrometer. LCMS data were measured on an Agilent MSD-1100 ESI-MS/MS System. Purity of the final compounds were determined with an Hitachi 2000 series HPLC system using C-18 column (Agilent ZORBAX Eclipse XDB-C18 5 Î¼m. 4.6 mm Ã 150 mm) using mobile phase A-acetonitrile and mobile phase B-water containing 0.1% formic acid + 10 mmol NH<sub>4</sub>OAc. Elution condition, at 0 min phase A 10% + phase B 90%; at 45 min phase A 90% + phase B 10%; at 50 min phase A 10% + phase B 90%; at 60 min phase A 10% + phase B 90%. The flow-rate was 0.5 mL/min, and the injection volume was 5 Î¼L. The system operated at 25 Â°C. Peaks were detected at 210 nm. Purity of all the tested compounds were found to be â¥95% unless otherwise stated.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Ethyl 2-Amino-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene-3-carboxylate (<b>29a</b>)</h3><div class="NLM_p last">To a mixture of cyclohexanone (<b>28a</b>) (9.80 g, 100.0 mmol), ethyl cyanoacetate (11.32 g, 100.0 mmol), and sulfur (3.20 g, 100.0 mmol) in absolute ethanol (200 mL) was added triethylamine (20 mL) and refluxed for 16 h; the reaction mixture was concentrated and the residue was partitioned between water and ethyl acetate. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated, and the crude product was purified by silica gel column chromatography using a mixture of hexanes:ethyl acetate (4:1), to give <b>29a</b> (18.6 g, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 1.31 (t, 3H, <i>J</i> = 7.2 Hz), 1.68â1.77 (m, 4H), 2.45â2.49 (m, 2H), 2.66â2.69 (m, 2H), 4.23 (q, 2H, <i>J</i> = 7.2 Hz), 5.90 (brs, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 226.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Ethyl 2-Amino-5,6-dihydro-4<i>H</i>-cyclopenta[<i>b</i>]thiophene-3-carboxylate (<b>29b</b>)</h3><div class="NLM_p last">Compound <b>29b</b> was synthesized in 78% yield from cyclopentanone (<b>28b</b>), in a manner similar to <b>29a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.30 (t, 3H, <i>J</i> = 7.2 Hz), 2.28 (dddd, 2H, <i>J</i> = 7.2, 7.2, 7.2, 7.2 Hz), 2.66â2.71 (m, 2H), 2.77â2.81 (m, 2H), 4.21 (q, 2H, 7.2 Hz), 5.59 (brs, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 212.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 6-(<i>tert</i>-Butyl) 3-Ethyl 2-Amino-4,5,6,7-tetrahydrothieno[2,3-<i>c</i>]pyridine-3,6-dicarboxylate (<b>29c</b>)</h3><div class="NLM_p last">To a mixture of 4-oxo-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>28c</b>) (12.90 g, 64.7 mmol), ethyl cyanoacetate (7.31 g, 64.7 mmol), and sulfur (2.07 g, 64.7 mmol) in absolute ethanol (50 mL) was added triethylamine (9 mL). After stirring for 16 h at room temperature, the precipitate was collected by filtration and washed with ethanol to give <b>29c</b> (18.7 g, 88%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.30 (t, 3H, <i>J</i> = 7.2 Hz), 1.44 (s, 9H), 2.72â2.80 (brs, 2H), 3.58 (t, 2H, <i>J</i> = 6.0 Hz), 4.23 (q, 2H, <i>J</i> = 7.2 Hz), 4.31 (s, 2H), 6.02 (s, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 327.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 3,4,5,6,7,8-Hexahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-one (<b>30a</b>)</h3><div class="NLM_p last">A mixture of <b>29a</b> (0.90 g, 4.0 mmol) and formamide (10 mL) was refluxed for 2 h. The reaction mixture was cooled, water was added, and the precipitate formed was collected by filtration, and washed thoroughly with water to give <b>30a</b> (0.8 g, 77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.83â2.02 (m, 4H), 2.76â2.79 (m, 2H), 2.99â3.02 (m, 2H), 7.91 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 207.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 3,5,6,7-Tetrahydro-4<i>H</i>-cyclopenta[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-one (<b>30b</b>)</h3><div class="NLM_p last">Compound <b>30b</b> was synthesized in 83% yield from <b>29b</b>, in a manner similar to <b>30a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.47 (dddd, 2H, <i>J</i> = 7.2, 7.2, 7.2, 7.2 Hz), 2.95â2.98 (m, 2H), 3.05â3.09 (m, 2H), 8.03 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 193.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>tert</i>-Butyl 4-Oxo-3,4,5,6,7,8-hexahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>30c</b>)</h3><div class="NLM_p last">A mixture of <b>29c</b> (18.50 g, 56.7 mmol) and formamidine acetate (8.85 g, 85.0 mmol) in DMF (100 mL) were heated at 100 Â°C for 16 h. The reaction mixture was cooled, DMF removed under vacuum, and the solid obtained was washed thoroughly with water to give <b>30c</b> (15.8 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 1.42 (s, 9H), 3.02â3.08 (brs, 2H), 3.62â3.70 (brs, 2H), 4.56â4.62 (brs, 2H), 7.88 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 308.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Chloro-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidine (<b>31a</b>)</h3><div class="NLM_p last">A mixture of <b>30a</b> (12.0 g, 58.2 mmol) and POCl<sub>3</sub> (10 mL) was heated at 55â65 Â°C for 3 h. The reaction mixture was cooled in an ice bath and then carefully neutralized by the addition of aqueous sodium bicarbonate solution. The resulting mixture was extracted with ethyl acetate, the organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated, and the crude product was purified by silica gel column chromatography using a mixture of hexanes:ethyl acetate (20:1), to give <b>31a</b> (9.6 g, 73%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.89â1.92 (m, 4H), 2.88â2.86 (m, 2H), 3.10â3.07 (m, 2H), 8.69 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 225.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-Chloro-6,7-dihydro-5<i>H</i>-cyclopenta[4,5]thieno[2,3-<i>d</i>]pyrimidine (<b>31b</b>)</h3><div class="NLM_p last">Compound <b>31b</b> was synthesized in 88% yield from <b>30b</b> in a manner similar to <b>31a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.48â2.56 (m, 2H), 3.04â3.08 (m, 2H), 3.13â3.17 (m, 2H), 8.70 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 210.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>tert</i>-Butyl 4-Chloro-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>31c</b>)</h3><div class="NLM_p last">To a mixture of POCl<sub>3</sub> (3 mL) and triethylamine (3 mL) at 0 Â°C was added <b>30c</b> (2.3 g, 7.5 mmol). The reaction mixture was heated at 55â60 Â°C for 3 h, then the reaction mixture was cooled, excess of POCl<sub>3</sub> removed under vacuum, and the remaining residue neutralized carefully by adding saturated aqueous sodium bicarbonate solution. The resulting mixture was extracted with dichloromethane, the organic layer separated, dried over MgSO<sub>4</sub>, concentrated, and the crude product obtained was purified by silica gel column chromatography using a mixture of hexane:ethyl acetate (10:1) to give <b>31c</b> (1.85 g, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 1.46 (s, 9H), 3.14â3.18 (brs, 2H), 3.74 (t, 2H, <i>J</i> = 5.6 Hz), 4.69 (s, 2H), 8.70 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 326.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-Benzyl-<i>N</i>-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>7</b>)</h3><div class="NLM_p last">A mixture of <b>31a</b> (45 mg, 0.2 mmol) and benzylamine (86 mg, 4.0 equiv, 0.8 mmol) in <i>n</i>-butanol (2 mL) was refluxed for 8 h. The reaction mixture was concentrated, and the residue was partitioned between water and dichloromethane. The organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated. The crude product was purified by silica gel column chromatography using a mixture of hexane:ethyl acetate (6:1) to give <b>7</b> (42 mg, 72%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.84â1.88 (m, 4H), 2.75â2.78 (m, 2H), 2.82â2.84 (m, 2H), 4.77 (d, 2H, <i>J</i> = 5.6 Hz), 5.54 (brs, 1H), 7.24â7.34 (m, 5H), 8.38 (s, 1H). HRMS (EI): calcd for C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>S (M<sup>+</sup>) 295.1143, found 295.1129.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-Phenethyl-<i>N</i>-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>7a</b>)</h3><div class="NLM_p last">Compound <b>7a</b> was synthesized in 52% yield from <b>31a</b> and phenylethylamine, in a manner similar to <b>7</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.75â1.80 (m, 4H), 2.49â2.52 (m, 2H), 2.70â2.72 (m, 2H), 2.94 (t, 2H, <i>J</i> = 6.4 Hz), 3.80 (td, 2H, 6.4, 6.4 Hz), 5.19 (m, 1H), 7.19â7.23 (m, 3H), 7.28â7.31 (m, 2H), 8.35 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 310.0 [M + H]<sup>+</sup>. HPLC purity 90.63%.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(4-Methoxybenzyl)-<i>N</i>-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>7b</b>)</h3><div class="NLM_p last">Compound <b>7b</b> was synthesized in 65% yield from <b>31a</b> and 4-methoxybenzylamine, in a manner similar to <b>7</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.80â1.85 (m, 4H), 2.75â2.78 (m, 2H), 2.80â2.82 (m, 2H), 3.78 (s, 3H), 4.68 (d, 2H, <i>J</i> = 5.2 Hz), 5.45 (m, 1H), 6.85â6.88 (m, 2H), 7.26â7.28 (m, 2H), 8.39 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 326.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(4-Fluorobenzyl)-<i>N</i>-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>7c</b>)</h3><div class="NLM_p last">Compound <b>7c</b> was synthesized in 76% yield from <b>31a</b> and 4-fluorobenzylamine, in a manner similar to <b>7</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.86â1.91 (m, 4H), 2.80â2.82 (m, 2H), 2.85â2.88 (m, 2H), 4.77 (d, 2H, <i>J</i> = 6.0 Hz), 5.53 (m, 1H), 7.01â7.06 (m, 2H), 7.32â7.35 (m, 2H), 8.41 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 314.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-Benzyl-<i>N</i>-(6,7-dihydro-5<i>H</i>-cyclopenta[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>7d</b>)</h3><div class="NLM_p last">Compound <b>7d</b> was synthesized in 79% yield from <b>31b</b> and benzylamine in a manner similar to <b>7</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.45â2.53 (m, 2H), 2.94â2.98 (m, 4H), 4.80 (d, 2H, <i>J</i> = 5.6 Hz), 5.37 (m, 1H), 7.24â7.35 (m, 5H), 8.40 (s, 1H). HRMS (EI): calcd for C<sub>16</sub>H<sub>15</sub>N<sub>3</sub>S (M<sup>+</sup>) 281.0987, found 281.1009.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (2<i>S</i>)-2-Phenyl-2-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)ethan-1-ol (<b>9</b>)</h3><div class="NLM_p last">A mixture of <b>31a</b> (0.05 g, 0.2 mmol) and <i>S</i>-(+)-2-amino-2-phenyl-ethanol (0.04 g, 1.5 equiv, 0.3 mmol) in <i>n</i>-butanol (2 mL) was refluxed for 8 h. The reaction mixture was concentrated, and the residue was partitioned between water and dichloromethane. The organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated. The crude product was purified by silica gel column chromatography using a mixture of dichloromethane:methanol (30:1), to give <b>9</b> (0.048 g, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.83â1.88 (m, 4H), 2.74 (m, 2H), 2.88â2.93 (m, 2H), 3.95â3.99 (m, 2H), 5.36 (dd, 1H, <i>J</i> = 5.6, 9.6 Hz), 6.14 (d, 1H, <i>J</i> = 6.0 Hz), 7.26â7.34 (m, 5H), 8.20 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 22.3 (CH<sub>2</sub>), 22.4 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>), 26.1 (CH<sub>2</sub>), 57.0 (CH), 67.1 (CH<sub>2</sub>), 116.2 (C), 125.3 (C), 126.4 (CH), 127.7 (CH). 128.8 (CH), 133.6 (C), 139.7 (C), 152.4 (CH), 156.8 (C), 165.0 (C). HRMS (EI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>OS (M<sup>+</sup>) 325.1249, found 325.1247.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-[(1<i>R</i>)-1-Phenylethyl]-<i>N</i>-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>9a</b>)</h3><div class="NLM_p last">Compound <b>9a</b> was synthesized in 94% yield from <b>31a</b> and <i>R</i>-(+)-methylbenzylamine in a manner similar to <b>9</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.60 (d, 3H, <i>J</i> = 6.6 Hz), 1.85â1.92 (m, 4H), 2.76â2.81 (m, 2H), 2.89â2.91 (m, 2H), 5.51â5.52 (m, 1H), 7.25â7.39 (m, 5H), 8.33 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 22.4 (CH<sub>2</sub>), 22.5 (CH<sub>2</sub>), 22.6 (CH<sub>3</sub>), 25.4 (CH<sub>2</sub>), 26.3 (CH<sub>2</sub>), 49.7 (CH), 115.9 (C), 125.2 (C), 126.0 (CH), 127.3 (CH), 128.3 (CH), 133.2 (C), 143.7 (C), 153.0 (CH), 156.5 (C), 165.3 (C). HRMS (EI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>S (M<sup>+</sup>) 309.1300, found 309.1296.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)-1-ethanol (<b>9b</b>)</h3><div class="NLM_p last">Compound <b>9b</b> was synthesized in 88% yield from <b>31a</b> and ethanolamine in a manner similar to <b>9</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.78â1.84 (m, 4H), 2.70â2.72 (m, 2H), 2.82â2.84 (m, 2H), 3.66 (dt, 2H, <i>J</i> = 5.2, 5.2 Hz), 3.82 (t, 2H, <i>J</i> = 5.2 Hz), 5.80 (t, 1H, <i>J</i> = 5.2 Hz), 8.24 (s,1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 22.3 (CH<sub>2</sub>), 22.3 (CH<sub>2</sub>), 25.2 (CH<sub>2</sub>), 26.1 (CH<sub>2</sub>), 43.9 (CH<sub>2</sub>), 62.0 (CH<sub>2</sub>), 116.1 (C), 125.5 (C), 133.3 (C), 152.2 (CH), 157.4 (C), 164.7 (C). HRMS (EI): calcd for C<sub>12</sub>H<sub>15</sub>N<sub>3</sub>OS (M<sup>+</sup>) 249.0936, found 249.0958.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>R</i>)-2-Phenyl-2-(5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)ethan-1-ol (<b>9c</b>)</h3><div class="NLM_p last">Compound <b>9c</b> was synthesized in 59% yield from <b>31a</b> and <i>R</i>-(â)-2-amino-2-phenyl-ethanol in a manner similar to <b>9</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.82â1.88 (m, 4H), 2.73â2.76 (m, 2 H), 2.88â2.93 (m, 2 H), 3.93â3.99 (m, 2 H), 5.35â5.38 (m, 1 H), 6.11 (d, 1 H, <i>J</i> = 6.4 Hz), 7.25â7.34 (m, 5 H), 8.20 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 22.3 (CH<sub>2</sub>), 22.4 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>), 26.1 (CH<sub>2</sub>). 57.0 (CH), 67.1 (CH<sub>2</sub>), 116.2 (C), 125.3 (C), 126.4 (CH), 127.7 (CH), 128.8 (CH), 133.6 (C), 139.7 (C), 152.4 (CH), 156.8 (C), 165.0 (C). HRMS (EI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>OS (M<sup>+</sup>) 325.1249, found 325.1254.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>S</i>)-2-(6,7-Dihydro-5<i>H</i>-cyclopenta[4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)-2-phenylethan-1-ol (<b>9d</b>)</h3><div class="NLM_p last">Compound <b>9d</b> was synthesized in 94% yield from <b>31b</b> and <i>S</i>-(+)-2-amino-2-phenyl-ethanol in a manner similar to <b>9</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.48â2.55 (m, 2H), 2.93â3.06 (m, 4H), 3.83 (brs, 1H), 4.00 (dd, 2H, <i>J</i> = 5.2, 5.2 Hz), 5.34 (ddd, 1H, <i>J</i> = 5.2, 5.2, 5.2 Hz), 5.80 (d, 1H, <i>J</i> = 6.0 Hz), 7.29â7.40 (m, 5H), 8.31 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 27.9 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 57.1 (CH), 67.2 (CH<sub>2</sub>), 113.4 (C), 126.4 (CH), 127.8 (CH), 128.9 (CH), 134.3 (C), 139.1 (C), 139.6 (C), 152.5 (CH), 156.3 (C), 165.0 (C). HRMS (EI): calcd for C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>OS (M<sup>+</sup>) 311.1092, found 311.1096.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl 4-[(1<i>S</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>32a</b>)</h3><div class="NLM_p last">A mixture of <b>31c</b> (0.25 g, 0.7 mmol) and <i>S</i>-(+)-2-amino-2-phenyl-ethanol (0.13 g, 1.1 mmol) in ethanol (1 mL) was refluxed for 8 h. The reaction mixture was concentrated, and the residue was partitioned between water and dichloromethane; the organic layer separated, dried over MgSO<sub>4</sub>, and concentrated, and the crude product was purified by silica gel column chromatography using a mixture of dichloromethane:methanol (20:1) to give <b>32a</b> (0.31 g, 95%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.46 (s, 9H), 2.90â3.08 (m, 2H), 3.72â3.81 (m, 2H), 3.97â4.02 (m, 2H), 4.62 (s, 2H), 5.36â5.43 (m, 1H), 6.04 (d, 1H, <i>J</i> = 6.6 Hz), 7.26â7.38 (m, 5H), 8.25 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 427.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 4-[(1<i>R</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>32b</b>)</h3><div class="NLM_p last">Compound <b>32b</b> was synthesized in 99% yield from <b>31c</b> and <i>R</i>-(â)-2-amino-2-phenyl-ethanol in a manner similar to <b>32a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.46 (s, 9H), 2.98â3.02 (m, 2H), 3.73â3.76 (m, 2H), 3.96â3.99 (m, 2H), 4.61 (s, 2H), 5.37â5.38 (m, 1H), 6.04 (d, 1H, <i>J</i> = 6.0 Hz), 7.26â7.34 (m, 5H), 8.23 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 25.8 (CH<sub>2</sub>), 27.7 (CH<sub>2</sub>), 28.1 (CH<sub>3</sub>), 39.8 (CH<sub>2</sub>), 40.9 (CH<sub>2</sub>), 42.6 (CH<sub>2</sub>), 43.4 (CH<sub>2</sub>), 56.0 (CH), 65.7 (CH<sub>2</sub>), 80.3 (C), 115.3 (C), 124.4 (C), 126.3 (CH), 127.2 (CH), 128.4 (CH), 129.2 (C), 139.6 (C), 152.7 (CH), 154.0 (C), 156.5 (C), 164.9 (C). LCMS (ESI): <i>m</i>/<i>z</i> 427.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 4-[(1<i>R</i>)-1-Phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>32c</b>)</h3><div class="NLM_p last">Compound <b>32c</b> was synthesized in 90% yield from <b>31c</b> and <i>R</i>-(+)-methylbenzylamine in a manner similar to <b>32a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.47 (s, 9H), 1.57 (d, 3H, <i>J</i> = 9.6 Hz), 2.95â3.03 (m, 2H), 3.73â3.79 (m, 2H), 4.62 (brs, 2H), 5.35â5.37 (m, 1H), 5.49â5.54 (m, 1H), 7.24â7.38 (m, 5H), 8.37 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 411.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl 4-[(1<i>R</i>)-1-phenylpropyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>32d</b>)</h3><div class="NLM_p last">Compound <b>32d</b> was synthesized in 95% yield from <b>31c</b> and <i>R</i>-(+)-1-phenylpropylamine in a manner similar to <b>32a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.93 (t, 3H, <i>J</i> = 7.2 Hz), 1.42 (s, 9H), 1.87â2.00 (m, 2H), 2.98â3.00 (m, 2H), 3.77â3.78 (m, 2H), 4.62 (s, 2H), 5.29 (td, 1H, <i>J</i> = 7.2, 7.2 Hz), 5.41 (d, 1H, <i>J</i> = 7.2 Hz), 7.22â7.33 (m, 5H), 8.33 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 425.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl 4-[(1<i>S</i>)-1-Benzyl-2-hydroxyethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>32e</b>)</h3><div class="NLM_p last">Compound <b>32e</b> was synthesized in 87% yield from <b>31c</b> and <i>S</i>-(â)-2-amino-3-phenyl-1-propanol in a manner similar to <b>32a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.46 (s, 9H), 2.37â2.44 (m, 1H), 2.66â2.71 (m, 1H), 2.91 (dd, 1H, <i>J</i> = 8.4, 13.8 Hz), 3.06 (dd, 1H, <i>J</i> = 6.6, 13.8 Hz), 3.60 (m, 2H), 3.72 (dd, 1H, <i>J</i> = 5.4, 10.8 Hz), 3.84 (dd, 1H, <i>J</i> = 2.4, 10.8 Hz), 4.43â4.48 (m, 1H), 4.56 (s, 2H), 5.37 (d, 1H, <i>J</i> = 5.7 Hz), 7.20â7.32 (m, 5H), 8.32 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 25.8 (CH<sub>2</sub>), 28.3 (CH<sub>3</sub>), 37.2 (CH<sub>2</sub>), 39.9 (CH<sub>2</sub>), 41.0 (CH<sub>2</sub>), 42.9 (CH<sub>2</sub>), 43.6 (CH<sub>2</sub>), 54.7 (CH), 65.1 (CH<sub>2</sub>), 80.6 (C), 115.5 (C), 124.5 (C), 127.0 (CH), 128.8 (CH), 129.3 (CH), 137.2 (C), 152.7 (CH), 154.2 (C), 157.0 (C), 165.8 (C). LCMS (ESI): <i>m</i>/<i>z</i> 441.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 4-[(2-Hydroxyethyl)amino]-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate (<b>32f</b>)</h3><div class="NLM_p last">Compound <b>32f</b> was synthesized in 91% yield from <b>31c</b> and ethanolamine in a manner similar to <b>32a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.46 (s, 9H), 2.97â3.00 (m, 2H), 3.71â3.77 (m, 4H), 3.84â3.88 (m, 2H), 4.62 (s, 2H), 5.81â5.83 (m, 1H), 8.33 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 25.9 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 39.9 (CH<sub>2</sub>), 41.0 (CH<sub>2</sub>), 43.5 (CH<sub>2</sub>), 61.3 (CH<sub>2</sub>), 80.6 (C), 115.3 (C), 124.5 (C), 129.3 (C), 152.6 (CH), 154.3 (C), 157.3 (C), 165.0 (C). LCMS (ESI): <i>m</i>/<i>z</i> 351.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>S</i>)-2-Phenyl-2-(5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)ethan-1-ol (<b>33a</b>/<b>10</b>)</h3><div class="NLM_p last">To a mixture of <b>32a</b> (0.6 g, 1.4 mmol) in dichloromethane (2 mL) at 0 Â°C was added trifluoroacetic acid (TFA) (1 mL) and then warmed to room temperature. The reaction mixture was stirred for 2 h, removed the solvent under vacuum, and neutralized the residue by slow addition of sodium bicarbonate solution. The precipitate formed was collected by filtration and washed with water to give <b>33a</b>/<b>10</b> (0.4 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 2.84â3.04 (m, 2H), 3.20 (t, 2H, <i>J</i> = 4.4 Hz), 3.99 (d, 2H, <i>J</i> = 3.2 Hz), 4.01 (d, 2H, <i>J</i> = 7.6 Hz), 5.38 (d, 1H, <i>J</i> = 4.8 Hz), 6.04 (d, 1H, <i>J</i> = 6.4 Hz), 7.26â7.38 (m, 5H), 8.28 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 327.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (2<i>R</i>)-2-Phenyl-2-(5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)ethan-1-ol (<b>33b</b>)</h3><div class="NLM_p last">Compound <b>33b</b> was synthesized in 97% yield from <b>32b</b> in a manner similar to <b>33a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): Î´ 3.14â3.17 (m, 2H), 3.21â3.24 (m, 2H), 3.89â3.97 (m, 2H), 4.03â4.04 (m, 2H), 5.38 (dd, 1H, <i>J</i> = 5.6, 5.6 Hz), 7.21â7.25 (m, 1H), 7.29â7.33 (m, 2H), 7.38â7.41 (m, 2H), 8.15 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 327.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-[(1<i>R</i>)-1-Phenylethyl]-<i>N</i>-(5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>33c</b>)</h3><div class="NLM_p last">Compound <b>33c</b> was synthesized in 90% yield from <b>32c</b> in a manner similar to <b>33a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.60 (d, 3H, <i>J</i> = 6.8 Hz), 2.89â2.95 (m, 2H), 3.21â3.44 (m, 2H), 4.04 (brs, 2H), 5.26â5.41 (m, 1H), 5.49â5.53 (m, 1H), 7.24â7.38 (m, 5H), 8.35 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 311.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[(1<i>R</i>)-1-Phenylpropyl]-<i>N</i>-(5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl)amine (<b>33d</b>)</h3><div class="NLM_p last">Compound <b>33d</b> was synthesized in 82% yield from <b>32d</b> in a manner similar to <b>33a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 0.93 (t, 3H, <i>J</i> = 7.6 Hz), 1.89â1.97 (m, 2H), 2.90â3.00 (m, 2H), 3.24 (t, 2H, 5.6 Hz), 4.04 (s, 2H), 5.30 (td, 1H, 7.2, 7.2 Hz), 5.46 (d, 1H, 7.2 Hz), 7.22â7.33 (m, 5H), 8.32 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 10.6 (CH<sub>3</sub>), 27.2 (CH<sub>2</sub>), 29.6 (CH<sub>2</sub>), 42.9 (CH<sub>2</sub>), 45.0 (CH<sub>2</sub>), 55.6 (CH), 115.7 (C), 123.9 (C), 126.4 (CH), 127.2 (CH), 128.6 (CH), 132.2 (C), 142.4 (C), 153.3 (CH), 156.9 (C), 165.4 (C). LCMS (ESI): <i>m</i>/<i>z</i> 325.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>)-3-Phenyl-2-(5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)propan-1-ol (<b>33e</b>)</h3><div class="NLM_p last">Compound <b>33e</b> was synthesized in 96% yield from <b>32e</b> in a manner similar to <b>33a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.38â2.42 (m, 1H), 2.67â2.71 (m, 1H), 2.89â2.95 (m, 1H), 3.03â3.19 (m, 3H), 3.73 (dd, 1H, <i>J</i> = 5.6, 11.2 Hz), 3.76 (dd, 1H, <i>J</i> = 2.8, 11.2 Hz), 4.05 (s, 2H), 4.44â4.47 (m, 1H), 5.37 (d, 1H, <i>J</i> = 6.0 Hz), 7.22â7.31 (m, 5H), 8.32 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 341.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(5,6,7,8-Tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-ylamino)-1-ethanol (<b>33f</b>)</h3><div class="NLM_p last">Compound <b>33f</b> was synthesized in 49% yield from <b>32f</b>, in a manner similar to <b>33a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.96 (t, 2H, <i>J</i> = 5.6 Hz), 3.18 (t, 2H, <i>J</i> = 5.6 Hz), 3.65 (t, 2H, <i>J</i> = 5.6 Hz), 3.76 (t, 2H, <i>J</i> = 5.6 Hz), 4.00 (s, 2H), 8.18 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 26.6 (CH<sub>2</sub>), 43.1 (CH<sub>2</sub>), 44.1 (CH<sub>2</sub>), 44.9 (CH<sub>2</sub>), 61.3 (CH<sub>2</sub>), 116.9 (C), 126.4 (C), 131.1 (C), 153.8 (CH), 158.6 (C), 165.6 (C). LCMS (ESI): <i>m</i>/<i>z</i> 251.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(4-(((1<i>S</i>)-2-Hydroxy-1-phenylethyl)amino)-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-propen-1-one (<b>11</b>)</h3><div class="NLM_p last">A mixture of acrylic acid (12 mg, 0.16 mmol) and EDCI (32 mg, 0.16 mmol) in anhydrous dicloromethane was stirred for 2 h and <b>33a</b>/<b>10</b> (50 mg, 0.15 mmol) was then added. The resulting mixture was stirred for 15 min, then partitioned between water and ethyl acetate; the organic layer was dried over MgSO<sub>4</sub> and concentrated and the residue was purified by silica gel column chromatography using a mixture of dichloromethane:methanol (20:1) to give <b>11</b> (35 mg, 60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 3.06â3.12 (m, 2H), 3.94â3.99 (m, 4H), 4.76â4.83 (m, 2H), 5.39 (m, 1H), 5.75 (dd, 1H, <i>J</i> = 10.4, 0.8 Hz), 5.96â6.11 (m, 1H), 6.27â6.39 (m, 1H), 6.52â6.64 (m,1H), 7.25â7.36 (m, 5H), 8.26 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 25.8 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 39.3 (CH<sub>2</sub>), 42.0 (CH<sub>2</sub>), 42.9 (CH<sub>2</sub>), 45.3 (CH<sub>2</sub>), 56.6 (CH), 66.8 (CH<sub>2</sub>), 115.4 (C), 123.6 (C), 125.4 (C), 126.4 (CH), 126.9 (CH), 127.3 (CH), 127.8 (CH), 128.5 (C), 128.9 (CH), 130.0 (C), 139.4 (C), 153.2 (CH), 156.8 (C), 165.7 (C). HRMS (EI) calcd for C<sub>20</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>S (M<sup>+</sup>) 380.1307, found 380.1310.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(4-[(1<i>S</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-1-propanone (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was synthesized in 63% yield from <b>33a</b> and propionic acid in a manner similar to <b>11</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): Î´ 1.12 (t, 1.2H, <i>J</i> = 7.6 Hz), 1.17 (t, 1.8 H, <i>J</i> = 7.6 Hz), 2.48 (q, 0.8 H, <i>J</i> = 7.6 Hz), 2.55 (q, 1.2H, <i>J</i> = 7.6 Hz), 3.14â3.26 (m, 2H), 3.87â3.98 (m, 4H), 4.77â4.79 (m, 2H), 5.38â5.40 (m, 1H), 7.20â7.23 (m, 1H), 7.24â7.33 (m, 2H), 7.38â7.42 (m, 2H), 8.15 (s, 1H). HRMS (EI): calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub>S (M<sup>+</sup>) 382.1463, found 382.1466.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(4-[(1<i>S</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-butyn-1-one (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was synthesized in 68% yield from <b>33a</b> and 2-butynoic acid in a manner similar to <b>11</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 1.97â2.03 (m, 3H), 2.96â3.24 (m, 2H), 3.84â4.15 (m, 4H), 4.67â4.82 (m, 1H), 4.92 (s, 1H), 5.35â5.45 (m, 1H), 6.13â6.16 (m, 1H), 7.23â7.36 (m, 5H), 8.22 (s, 0.5H), 8.24 (s, 0.5H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 4.1 (CH<sub>3</sub>), 25.7 (CH<sub>2</sub>), 26.7 (CH<sub>2</sub>), 29.6 (C), 38.4 (CH<sub>2</sub>), 41.0 (CH<sub>2</sub>), 43.7 (CH<sub>2</sub>), 46.2 (CH<sub>2</sub>), 56.5 (CH), 56.7 (CH), 66.4 (CH<sub>2</sub>), 66.5 (CH<sub>2</sub>), 72.4 (C), 72.5 (C), 90.1 (C), 91.3 (C), 115.3 (C), 115.4 (C), 124.0 (C), 124.9 (C), 126.4 (CH), 126.5 (C), 127.7 (C), 127.8 (CH), 128.6 (CH), 128.8 (C), 128.8 (C), 129.0 (C), 139.3 (C), 139.4 (C), 152.8 (C), 153.2 (CH), 153.3 (CH), 156.7 (C), 156.9 (C), 164.9 (C), 165.1 (C). HRMS (EI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>S (M<sup>+</sup>) 392.1307, found 392.1311.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>S</i>)-2-Phenyl-2-[7-(vinylsulfonyl)-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-4-yl]aminoethan-1-ol (<b>14</b>)</h3><div class="NLM_p last">A mixture of <b>33a</b> (88 mg, 0.27 mmol), Et<sub>3</sub>N (0.2 mL, 5 equiv), and 2-chloroethanesulfonyl chloride (175 mg, 1.08 mmol) in dichloromethane (2 mL) was stirred at room temperature for 4 h. The reaction mixture was concentrated, and the residue was partitioned between water and dichloromethane; the organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated under vacuo. The crude product was purified by silica gel column chromatography using a mixture of dichloromethane:methanol (40:1), to give <b>14</b> (66 mg, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 3.04â3.18 (m, 2H), 3.63 (t, 2H, <i>J</i> = 4.8 Hz), 3.96â4.23 (m, 2H), 4.47 (s, 2H), 5.41 (m, 1H), 5.99 (d, 1H, <i>J</i> = 6.4 Hz), 6.02 (d, 1H, <i>J</i> = 9.6 Hz), 6.32 (d, 1H, <i>J</i> = 16.4 Hz), 6.44 (dd, 1H, <i>J</i> = 9.6, 16.4 Hz), 7.28â7.39 (m, 5H), 8.32 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 26.2 (CH<sub>2</sub>), 42.5 (CH<sub>2</sub>), 44.6 (CH<sub>2</sub>), 56.9 (CH), 66.9 (CH<sub>2</sub>), 115.3 (C), 124.0 (C), 126.4 (CH), 128.0 (CH), 128.3 (C), 128.9 (CH), 129.0 (CH<sub>2</sub>), 133.2 (CH), 139.3 (C), 153.2 (CH), 156.9 (C), 165.7 (C). HRMS (EI): calcd for C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M<sup>+</sup>) 416.0977, found 416.0977. HPLC purity 92.63%.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-(4-[(1<i>R</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno [2,3-<i>d</i>]pyrimidin-7-yl)-2-propen-1-one (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was synthesized in 68% yield from <b>33b</b> and acrylic acid in a manner similar to <b>11</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): Î´ 3.25â3.27 (m, 2H), 3.89 (dd, 2H, <i>J</i> = 6.0, 11.2 Hz), 3.94â4.04 (m, 2H), 4.90 (m, 2H), 5.39 (dd, 1H, <i>J</i> = 5.2, 5.2 Hz), 5.79â5.84 (m, 1H), 6.25â6.30 (m, 1H), 6.80â6.93 (m, 1H), 7.20â7.24 (m, 1H), 7.29â7.33 (m, 2H), 7.39â7.41 (m, 2H), 8.16 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 381.1 [M + H]<sup>+</sup>. HPLC purity 93.46%.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(4-[(1<i>R</i>)-1-Phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-propen-1-one (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was synthesized in 74% yield from <b>33c</b> and acrylic acid in a manner similar to <b>11</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ 1.61 (d, 3H, <i>J</i> = 7.2 Hz), 3.01â3.22 (m, 2H), 3.91â4.05 (m, 2H), 4.78â5.01 (m, 2H), 5.48 (dd, 1H, <i>J</i> = 6.9, 13.8 Hz), 5.81 (d, 1H, <i>J</i> = 10.8 Hz), 6.26 (d, 1H, <i>J</i> = 16.5 Hz), 6.75â6.93 (m, 1H), 7.18â7.42 (m, 5H), 8.20 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 365.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(4-[(1<i>R</i>)-1-Phenylpropyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-propen-1-one (<b>17</b>)</h3><div class="NLM_p last">Compound <b>17</b> was synthesized in 60% yield from <b>33d</b> and acrylic acid in a manner similar to <b>11</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 0.86 (t, 3H, <i>J</i> = 7.6 Hz), 1.81â2.01 (m, 2H), 2.97â3.11 (m, 2H), 3.81â4.10 (m, 2H), 4.74â4.95 (m, 2H), 5.26â5.43 (m, 2H), 5.74â5.78 (m, 1H), 6.24â6.36 (m, 1H), 6.52â6.67 (m, 1H), 7.21â7.35 (m, 5H), 8.33 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 379.1 [M + H]<sup>+</sup>. HPLC purity 92.06%.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>E</i>)-1-(4-[(1<i>S</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-3-phenyl-2-propen-1-one (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was synthesized in 73% yield from <b>33a</b> and <i>trans</i>-cinnamic acid in a manner similar to <b>11</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 3.08 (br, 2H), 3.92â4.04 (m, 4H), 4.75â4.92 (m, 2H), 5.41 (s, 1H), 6.16 (s, 1H), 6.91 (d, 1H, <i>J</i> = 15.6 Hz), 7.24â7.27 (m, 8H), 7.47â7.52 (m, 2H), 7.67 (d, 1H, <i>J</i> = 15.6 Hz), 8.23 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 25.8 (CH<sub>2</sub>), 27.1 (CH<sub>2</sub>), 39.4 (CH<sub>2</sub>), 42.2 (CH<sub>2</sub>), 42.9 (CH<sub>2</sub>), 45.2 (CH<sub>2</sub>), 56.7 (CH), 66.4 (CH<sub>2</sub>), 115.4 (C), 116.2 (CH), 116.6 (CH), 123.9 (C), 125.5 (C), 126.5 (CH), 127.8 (CH), 128.8 (CH), 128.8 (CH), 129.0 (C), 129.9 (CH), 134.7 (C), 139.4 (C), 143.8 (CH), 152.7 (CH), 156.8 (C), 165.0 (C), 165.8 (C). HRMS (EI): calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>S (M<sup>+</sup>) 456.1620, found 456.1616. HPLC purity 92.65%.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>E</i>)-4-(Dimethylamino)-1-(4-[(1<i>S</i>)-2-hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-buten-1-one (<b>19</b>)</h3><div class="NLM_p last">A mixture of 4-bromocrotonoic acid (49 mg, 0.33 mmol) and EDCI (63 mg, 0.33 mmol) in anhydrous dichloromethane (3 mL) was stirred for 15 min, and <b>33a</b> (0.100 g, 0.30 mmol) was then added. The resulting mixture was stirred for 2 h, and then the solvent was removed under vacuum. The residue was reconstituted in THF (3 mL), <i>N</i>,<i>N</i>-dimethylamine (0.5 mL, 28% aqueous solution) was added, and stirring was continued for another 2 h. At the end of the reaction, the resulting mixture was partitioned between water and ethyl acetate; the organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated, and the residue was purified by silica gel column chromatography using a mixture of dichloromethane:methanol (5:1) to give <b>19</b> (88 mg, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.24 (s, 6 H), 3.01â3.20 (m, 4H), 3.90â3.99 (m, 2H), 4.00â4.12 (m, 2H), 4.78 (s, 1H), 4.86 (s, 1H), 5.39 (s, 1H), 6.03 (d, 1H, <i>J</i> = 13.6 Hz), 6.38â6.57 (m, 1H), 6.80â6.98 (brs, 1H), 7.28â7.40 (m, 5H), 8.30 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 25.6 (CH<sub>2</sub>), 26.9 (CH<sub>2</sub>), 39.2 (CH<sub>2</sub>), 41.9 (CH<sub>2</sub>), 42.7 (CH<sub>2</sub>), 45.1 (CH<sub>2</sub>), 45.1 (CH<sub>3</sub>), 56.0 (CH), 60.2 (CH<sub>2</sub>), 65.8 (CH<sub>2</sub>), 115.2 (C), 121.8 (CH), 123.8 (C), 125.4 (C), 126.3 (CH), 127.3 (CH), 128.0 (C), 128.5 (CH), 129.5 (C), 139.8 (C), 142.8 (CH), 142.3 (CH), 153.1 (CH), 153.2 (CH), 156.6 (C), 156.7 (C), 165.1 (C), 165.4 (C). HRMS (EI): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>S (M<sup>+</sup>) 437.1885, found 437.1869.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>E</i>)-4-(Diethylamino)-1-(4-(((1<i>R</i>)-2-hydroxy-1-phenylethyl)amino)-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-buten-1-one (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was synthesized in 59% yield from <b>33a</b>, 4-bromocrotonoic acid, and <i>N</i>,<i>N</i>-diethylamine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): Î´ 0.96â1.06 (m, 6H), 2.55â2.58 (m, 4H), 3.11â3.28 (m, 4H), 3.93â4.02 (m, 2H), 4.08â4.13 (m, 2H), 4.80â4.85 (m, 1H), 4.85â4.92 (m, 1H), 5.39â5.44 (m, 1H), 6.08 (s, 1H), 6.52 (dd, 1H, <i>J</i> = 14.7, 15.6 Hz), 6.90â6.97 (m, 1H), 7.27â7.41 (m, 5H), 8.32 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 11.6 (CH<sub>3</sub>), 25.7 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 39.2 (CH<sub>2</sub>), 42.0 (CH<sub>2</sub>), 42.8 (CH<sub>2</sub>), 45.1 (CH<sub>2</sub>), 47.0 (CH<sub>2</sub>), 54.1 (CH<sub>2</sub>), 56.3 (CH), 66.3 (CH<sub>2</sub>), 115.3 (C), 121.4 (CH), 122.2 (CH<sub>2</sub>), 123.7 (CH<sub>2</sub>), 126.4 (CH), 127.6 (CH), 128.2 (CH<sub>2</sub>), 128.7 (CH), 129.8 (CH<sub>2</sub>), 139.7 (C), 143.0 (CH), 144.5 (CH), 153.2 (CH), 153.3 (CH), 156.7 (C), 165.5 (C), 165.6 (C). HRMS (EI): calcd for C<sub>25</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>S (M<sup>+</sup>) 465.2198, found 465.2195.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>E</i>)-1-(4-[(1<i>R</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-4-morpholino-2-buten-1-one (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was synthesized in 61% yield from <b>33a</b>, 4-bromocrotonoic acid, and morpholine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.42 (m, 4H), 3.10â3.11 (m, 4H), 3.60â3.67 (m, 4H), 3.88â3.97 (m, 4H), 4.79 (m, 1H), 4.74 (m, 1H), 4.81 (m, 1H), 5.36â5.38 (m, 1H), 6.04â6.09 (m, 1H), 6.53 (t, 1H, <i>J</i> = 16.2 Hz), 6.84â6.88 (m, 1H), 7.22â7.33 (m, 5H), 8.23 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): Î´ 25.8 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 39.4 (CH<sub>2</sub>), 42.0 (CH<sub>2</sub>), 42.9 (CH<sub>2</sub>), 45.2 (CH<sub>2</sub>), 53.6 (CH<sub>2</sub>), 56.5 (CH), 59.9 (CH<sub>2</sub>), 66.6 (CH<sub>2</sub>), 66.7 (CH<sub>2</sub>), 115.3 (C), 121.9 (CH), 122.2 (CH), 123.6 (C), 125.5 (C), 126.4 (CH), 127.7 (CH), 128.3 (C), 128.8 (CH), 130.0 (C), 139.5 (C), 142.9 (CH), 153.2 (CH), 153.3 (CH), 156.7 (C), 165.2 (C), 165.8 (C). HRMS (EI): calcd for C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>S (M<sup>+</sup>) 479.1991, found 479.1991.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>E</i>)-1-(4-[(1<i>S</i>)-2-Hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-4-(4-methylpiperazino)-2-buten-1-one (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was synthesized in 55% yield from <b>33a</b>, 4-bromocrotonoic acid, and <i>N</i>-methylpiperazine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.28 (s, 3H), 2.60 (m, 8H), 3.13â3.16 (m, 4H), 3.89â4.03 (m, 4H), 4.76â4.88 (m, 2H), 5.35â5.40 (m, 1H), 6.09 (d, 1H, <i>J</i> = 1.6 Hz), 6.40â6.50 (m, 1H), 6.82â6.88 (m, 1H), 7.25â7.37 (m, 5H), 8.28 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 25.8 (CH<sub>2</sub>), 27.2 (CH<sub>2</sub>), 39.4 (CH<sub>2</sub>), 42.1 (CH<sub>2</sub>), 43.0 (CH<sub>2</sub>), 45.3 (CH<sub>2</sub>), 45.8 (CH<sub>3</sub>), 52.8 (CH<sub>2</sub>), 53.1 (CH<sub>2</sub>), 54.8 (CH<sub>2</sub>), 56.4 (CH), 56.7 (CH), 59.5 (CH<sub>2</sub>), 66.6 (CH<sub>2</sub>), 115.4 (C), 122.1 (CH), 122.4 (CH), 123.6 (C), 125.5 (C), 126.4 (CH), 127.8 (CH), 128.9 (CH), 130.1 (C), 139.7 (C), 142.4 (CH), 143.4 (CH), 153.4 (CH), 156.9 (C), 165.5 (C), 166.0 (C). HRMS (EI): calcd for C<sub>26</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>S (M<sup>+</sup>) 492.2307, found 492.2316.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>E</i>)-4-(Dimethylamino)-1-(4-[(1<i>R</i>)-2-hydroxy-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-buten-1-one (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was synthesized in 68% yield from <b>33b</b>, 4-bromocrotonoic acid, and <i>N</i>,<i>N</i>-dimethylamine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.14 (s, 3H), 2.33 (s, 3H), 2.97â3.20 (m, 4H), 4.08â4.09 (m, 2H), 4.73â4.96 (m, 4H), 5.36 (dd, 1H, <i>J</i> = 6.0, 10.4 Hz), 6.07 (d, 1H, <i>J</i> = 6.0 Hz), 6.48â6.72 (m, 1H), 6.81â6.86 (m, 1H), 7.23â7.39 (m, 5H), 8.28 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 438.1. HPLC purity 93.89%.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>E</i>)-4-(Dimethylamino)-1-(4-[(1<i>R</i>)-1-phenylethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-buten-1-one (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was synthesized in 79% yield from <b>33c</b>, 4-bromocrotonoic acid, and <i>N</i>,<i>N</i>-dimethylamine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 1.62 (d, 3H, <i>J</i> = 6.4 Hz), 2.27 (m, 6H), 3.03â3.11 (m, 4H), 3.93â3.99 (m, 2H), 4.80â4.89 (m, 2H), 5.32â5.40 (m, 1H), 5.52â5.53 (m, 1H), 6.48 (m, 1H), 6.91 (d, 1H, <i>J</i> = 14.8 Hz), 7.27â7.38 (m, 5H), 8.39 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 22.2 (CH<sub>3</sub>), 25.9 (CH<sub>2</sub>), 27.2 (CH<sub>2</sub>), 39.4 (CH<sub>2</sub>), 42.1 (CH<sub>2</sub>), 42.9 (CH<sub>2</sub>), 44.6 (CH<sub>2</sub>), 45.3 (CH<sub>3</sub>), 49.9 (CH), 60.1 (CH<sub>2</sub>), 115.0 (C), 122.0 (CH), 123.4 (C), 125.2 (CH), 126.0 (CH), 127.4 (CH), 128.2 (C), 128.8 (CH), 129.7 (C), 142.7 (C), 143.2 (C), 153.7 (CH), 156.5 (C), 165.5 (C), 165.9 (C). HRMS (EI): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>OS (M<sup>+</sup>) 421.1936, found 421.1941.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>E</i>)-4-(Dimethylamino)-1-(4-[(1<i>S</i>)-1-phenylpropyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-2-buten-1-one (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was synthesized in 67% yield from <b>33d</b>, 4-bromocrotonoic acid, and <i>N</i>,<i>N</i>-dimethylamine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 0.95 (t, 3H, <i>J</i> = 7.2 Hz), 1.85â2.04 (m, 2H), 2.17 (s, 3H), 2.37 (s, 3H), 3.13â3.17 (m, 4H), 3.84â4.03 (m, 2H), 4.80â4.89 (m, 2H), 5.30â5.46 (m, 2H), 6.45â6.60 (m, 1H), 6.89â6.94 (m, 1H), 7.25â7.36 (m, 5H), 8.37 (s, 1H). HRMS (EI): calcd for C<sub>24</sub>H<sub>29</sub>N<sub>5</sub>OS (M<sup>+</sup>) 435.2093, found 435.2095.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>E</i>)-1-(4-[(1<i>R</i>)-1-Benzyl-2-hydroxyethyl]amino-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl)-4-(dimethylamino)-2-buten-1-one (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was synthesized in 52% yield from <b>33e</b>, 4-bromocrotonoic acid, and <i>N</i>,<i>N</i>-dimethylamine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 2.27 (s, 3H), 2.33 (s, 3H), 2.49 (m, 1H), 2.77 (m, 1H), 2.92â2.95 (m, 1H), 3.07â3.15 (m, 3H), 3.60â3.93 (m, 4H), 4.46â4.49 (m, 1H), 4.76 (m, 1H), 4.85 (m, 1H), 5.37 (d, 1H, <i>J</i> = 11.6 Hz), 6.47 (dd, 1H, <i>J</i> = 16.0, 24.0 Hz), 6.87â7.00 (m, 1H), 7.27â7.36 (m, 5H), 8.36 (s, 1H). HRMS (EI): calcd for C<sub>24</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S (M<sup>+</sup>) 451.2042, found 451.2048.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>E</i>)-4-(Dimethylamino)-1-4-[(2-hydroxyethyl)amino]-5,6,7,8-tetrahydropyrido[4â²,3â²:4,5]thieno[2,3-<i>d</i>]pyrimidin-7-yl-2-buten-1-one (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was synthesized in 42% yield from <b>33f</b>, 4-bromocrotonoic acid, and <i>N</i>,<i>N</i>-dimethylamine in a manner similar to <b>19</b>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): Î´ 2.27 (s, 3H), 2.29 (s, 3H), 3.14â3.18 (m, 4H), 3.67â3.78 (m, 4H), 4.00 (dd, 2H, 6.0, 6.0 Hz), 4.83 (m, 2H), 6.63â6.88 (m, 2H), 8.25 (s, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): Î´ 26.6 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 40.5 (CH<sub>2</sub>), 43.0 (CH<sub>2</sub>), 44.0 (CH<sub>2</sub>), 44.2 (CH<sub>2</sub>), 45.3 (CH<sub>3</sub>), 46.1 (CH<sub>2</sub>), 61.2 (CH<sub>2</sub>), 61.3 (CH<sub>2</sub>), 116.6 (C), 124.1 (CH), 124.5 (CH), 126.5 (C), 127.3 (C), 129.3 (C), 129.9 (C), 143.3 (CH), 154.0 (CH), 158.7 (C), 166.0 (C), 167.3 (C). LCMS-ESI (<i>m</i>/<i>z</i>) 362.1 [M + H]<sup>+</sup>. HPLC purity 93.35%.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> EGFR WT and DM Kinase Inhibition Assay</h3><div class="NLM_p last">GST-EGFR-KD<sup>WT</sup> containing the EGFR kinase catalytic domain (residues 696â1022) and GST-EGFR-KD<sup>L858RT/790M</sup> containing the EGFR kinase catalytic domain (residues from 696 to 1022 and with L858R/T790M) were expressed in Sf9 insect cells transfected the baculovirus containing pBac-PAK8-GST-EGFR-KD plasmid, respectively. GST-EGFR-KD<sup>WT</sup> protein expression and purification and kinase assay were done in a manner as reported earlier.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The EGFR<sup>L858R/T790M</sup> Kinase-Glo assays were carried out in 96-well plates at 37 Â°C for 60 min in a final volume of 50 Î¼L including the following components: 200 ng GST-EGFR-KD<sup>L858R/T790M</sup> proteins, 25 mM HEPES, pH 7.4, 4 mM MnCl<sub>2</sub>, 2 mM DTT, 10 mM MgCl<sub>2</sub>, 0.1 mg/mL bovine serum albumin, 10 Î¼M poly(Glu,Tyr) 4:1, 0.5 mM Na<sub>3</sub>VO<sub>4</sub>, and 1 Î¼M ATP. Following incubation, 50 Î¼L Kinase-Glo Plus reagent (Promega) was added and the mixture was incubated at 25 Â°C for 20 min. A 70 Î¼L aliquot of each reaction mixture was transferred to a black microtiter plate, and the luminescence was measured on Wallac Vector 1420 multilabel counter (PerkinElmer).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> HCC827 Antiproliferation Assay</h3><div class="NLM_p last">HCC827 cell viability was examined by the MTS assay (Promega, Madison, WI). One thousand HCC827 cells in 100 Î¼L of RPMI1640 with 10% FBS medium were seeded in each well of a 96-well plate. After 96 h incubation with the test compound, the cells were further incubated with 20 Î¼L of a MTS/PMS mixture (MTS/PMS ratio: 20:1) in each well of the 96-well plate for 2 h at 37 Â°C in a humidified incubator with 5% CO<sub>2</sub> to allow viable cells to convert the tetrazolium salt (MTS) into formazan. The amount/concentration of formazan, which indicates the number of live cells, was determined by measuring its absorbance at 490 nm using a PerkinElmer Victor2 plate reader (PerkinElmer, Shelton, CT).</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Cell Extract Preparation and Western Blot Analyses</h3><div class="NLM_p last">HCC827 cells were seeded into 12-well plates at a concentration of 2.5 Ã 10<sup>5</sup> cells per well. After 16 h of growth in serum-containing media, cells were incubated in serum-free media for 24 h. Compounds was then added for 1 h, at which time cells were stimulated for 5 min with 100 ng/mL EGF. Whole-cell lysates were prepared by suspending 2.5 Ã 10<sup>5</sup> cells in 100 Î¼L lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% (v/v) Triton X-100, 0.5% (v/v), sodium deoxycholate, 0.1% (w/v) SDS, 500 Î¼M PMSF, 1 mM DTT, and 1 mM Na<sub>3</sub>VO<sub>4</sub>). The cell lysates were kept on ice and vigorously vortexed four times at 5 min intervals. The lysate was cleared by centrifugation at 15000<i>g</i> for 10 min at 4 Â°C. After adding SDS sample buffer, the supernatants were heated at 95 Â°C for 5 min and cell extract samples (25 Î¼g) were resolved by 8% SDS-polyacrylamide gel electrophoresis and then transferred to a nitrocellulose membrane (Sartorius Stedim Biotech). After transfer, the membrane was first incubated in TBST buffer (20 mM Tris, pH 7.6, 135 mM NaCl, and 0.1% (v/v) Tween 20) with 5% (w/v) skim milk powder, then incubated with the indicated primary antibody (dilution of antibodies was performed according to the manufacturerâs instructions), washed, and blotted with horseradish-peroxidase-conjugated secondary antibody. Primary antibodies included the following: p-EGFR(Y1068), EGFR (Cell Signaling Technology, Danvers, MA), and Î±-tubulin (Sigma, Natick, MA). The membrane was then developed using Western Lightning<sup></sup><i>plus</i>-ECL reagent (PerkinElmer, Shelton, CT) and exposed to X-ray film.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> In Vivo Pharmacokinetics Evaluation of <b>19</b> in Rats</h3><div class="NLM_p last">This study was approved by Institutional Animal Care and Use Committee of National Health Research Institutes. A solution of test compound (10 mg/mL) was prepared by dissolving appropriate amount compound in a mixture of PEG 400/dehydrated ethanol/Solutol (20:30:50, v/v/v) and was diluted with two parts of physiological saline to make the dosing solution of 3.3 mg/mL before dosing. Male SpragueâDawley rats, weighing 250â350 g each (8â10 weeks old), were obtained from BioLASCO, Ilan, Taiwan. Compound <b>19</b> was administered to three male rats each intravenously (5 mg/kg dose) by a bolus injection to the jugular vein. The volume of dosing solution administered was adjusted according to the body weight recorded before dose administration. At 0 (prior to dosing), 2, 5, 15, and 30 min and at 1, 2, 4, 6, 8, and 24 h after dosing, a blood sample (â¼150 Î¼L) was collected from each animal via the jugular-vein cannula and stored in ice (0â4 Â°C). Plasma was separated from the blood by centrifugation (14000<i>g</i> for 15 min at 4 Â°C in a Beckman model AllegraTM 6R centrifuge) and stored in a freezer (â60 Â°C). All samples were analyzed for the test compound by LC-MS/MS (ABI3000). Data were acquired via multiple reactions monitoring. Plasma concentration data were analyzed with standard noncompartmental method with WinNonLin software program (version 1.1, Pharsight Corporation, CA).</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> In Vivo HCC827 Xenograft Evaluation of <b>19</b> in Mice</h3><div class="NLM_p last">Adult male nude mice (Nu-Fox1nu) were purchased from BioLasco, Taiwan Co., Ltd. Animals had access to food and water ad libitum. Experimental procedures using animals were approved by the Institutional Animal Care and Use Committees of The National Health Research Institutes. Human HCC827 cells were cultured in RPMI-1640 supplemented with 10% heat-inactived bovine serum (FBS) and incubated at 37 Â°C in humidified atmosphere consisting 5% CO<sub>2</sub>. Eight-week-old nude mice were inoculated with HCC827 cells subcutaneously at 5 Ã 10<sup>6</sup> cells per mouse mixed with equal volume of Matrigel (Becton Bickinson) in 0.1 mL via a 24-gauge needle. Tumor volume was measured by using an electronic caliper and calculated with the formula length Ã width<sup>2</sup> Ã 0.5, twice a week. When the size of a growing tumor â¼200 mm<sup>3</sup>, the HCC827 tumor bearing mice were administered compound <b>19</b> (dissolved in 10% DMSO + 20% Cremophor EL +70% normal saline) IV via the tail veins for 5 days per week for 2 consecutive weeks at 15 and 5 mg/kg dose (<i>n</i> = 7). Gefitinib was administered (dissolved in 1% Tween 80 in water) as reference compound periorally at 100 mg/kg dose (<i>n</i> = 8). Also a control group received vehicle alone (10% DMSO + 20% Cremophor EL +70% normal saline) as IV injection (<i>n</i> = 7). Tumor size and animal body weight were measured twice a week after drug treatments. At the end of the experiments, animals were euthanized with carbon dioxide, followed by cervical dislocation.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen-Hsing Lin</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84f0f3f7f0e5f6c4eaecf6edaaebf6e3aaf0f3a4ecf4ecf7ede1ecc4eaecf6edaaebf6e3aaf0f3"><span class="__cf_email__" data-cfemail="2a5e5d595e4b586a444258430445584d045e5d">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="721a021a011b171a321c1a001b5c1d00155c0605">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsing-Pang Hsieh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#30444743445142705e5842591e5f42571e44471058405843595558705e5842591e5f42571e4447"><span class="__cf_email__" data-cfemail="394d4e4a4d584b7957514b5017564b5e174d4e">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="fb938b9388929e93bb95938992d594899cd58f8c">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chia-Hsien Wu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, National Tsing Hua University, 101 Section 2, Kuang Fu Road, Hsinchu 300, Taiwan, ROC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohane Selvaraj Coumar</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chang-Ying Chu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Rong Chen</span> - <span class="hlFld-Affiliation affiliation">Division of Molecular & Genomic Medicine</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiung-Tong Chen</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui-Yi Shiao</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaik Rafi</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sing-Yi Wang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Hsu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chun-Hwa Chen</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chun-Yu Chang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teng-Yuan Chang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tzu-Wen Lien</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Yu Fang</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kai-Chia Yeh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ching-Ping Chen</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teng-Kuang Yeh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Su-Huei Hsieh</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T.-A. Hsu</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Biological Science and Technology, National Chiao Tung University, 1001 University Road, Hsinchu 300, Taiwan, ROC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chun-Chen Liao</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, National Tsing Hua University, 101 Section 2, Kuang Fu Road, Hsinchu 300, Taiwan, ROC</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department of Chemistry, Chung Yuan Christian University, 200 Chung Pei Road, Chung Li 320, Taiwan, ROC</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Sheng Chao</span> - <span class="hlFld-Affiliation affiliation">Institute of Biotechnology and Pharmaceutical Research</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100607r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The study was financially supported by National Health Research Institutes, National Science Council (grant no, NSC-95-2113-M-400-001-MY3, for H.-P.H.) and Department of Health (grant nos. DOH98-TD-G-111-019, for Y.-S.C. and DOH98-TD-G-111-020, for H.-P.H.), Taiwan, ROC.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 17 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sharma, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor mutations in lung cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">â</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1038%2Fnrc2088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=17318210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=169-181&author=S.+V.+Sharmaauthor=D.+W.+Bellauthor=J.+Settlemanauthor=D.+A.+Haber&title=Epidermal+growth+factor+receptor+mutations+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor mutations in lung cancer</span></div><div class="casAuthors">Sharma, Sreenath V.; Bell, Daphne W.; Settleman, Jeffrey; Haber, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-181</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The development and clin. application of inhibitors that target the epidermal growth factor receptor (EGFR) provide important insights for new lung cancer therapies, as well as for the broader field of targeted cancer therapies.  We review the results of genetic, biochem. and clin. studies focused on somatic mutations of EGFR that are assocd. with the phenomenon of oncogene addiction, describing 'oncogenic shock' as a mechanistic explanation for the apoptosis that follows the acute treatment of susceptible cells with kinase inhibitors.  Understanding the genetic heterogeneity of epithelial tumors and devising strategies to circumvent their rapid acquisition of resistance to targeted kinase inhibitors are essential to the successful use of targeted therapies in common epithelial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMKw7Y4FUFM7Vg90H21EOLACvtfcHk0li-uqVs3c80rQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrsbo%253D&md5=46219ea3ae7b9f0977e4a4b7243fd875</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2088%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BV.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520mutations%2520in%2520lung%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D169%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span> </span><span class="NLM_article-title">EGFR antagonists in cancer treatment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">â</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1056%2FNEJMra0707704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=18337605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ahsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=1160-1174&author=F.+Ciardielloauthor=G.+Tortora&title=EGFR+antagonists+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR antagonists in cancer treatment</span></div><div class="casAuthors">Ciardiello, Fortunato; Tortora, Giampaolo</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1160-1174</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on epidermal growth factor receptor (EGFR) in human carcinogenesis, development of EGFR antagonists for anticancer therapy, and clin. efficacy of EGFR antagonists in human cancers.  Predicting the response to anti-EGFR drugs and future directions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGNHvRENSffLVg90H21EOLACvtfcHk0lizTMUEuZClfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ahsL4%253D&md5=2834999545fd643c6f727d80d357134d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0707704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0707704%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DTortora%26aufirst%3DG.%26atitle%3DEGFR%2520antagonists%2520in%2520cancer%2520treatment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D1160%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yun, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">â</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.+H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.+K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+mutation+in+EGFR+kinase+causes+drug+resistance+by+increasing+the+affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0lizTMUEuZClfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.%2BH.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520mutation%2520in%2520EGFR%2520kinase%2520causes%2520drug%2520resistance%2520by%2520increasing%2520the%2520affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayaram, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocher, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenen, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span> </span><span class="NLM_article-title">EGFR mutation and resistance of non-small-cell lung cancer to gefitinib</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">â</span> <span class="NLM_lpage">792</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1056%2FNEJMoa044238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=15728811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFCiurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=786-792&author=S.+Kobayashiauthor=T.+J.+Boggonauthor=T.+Dayaramauthor=P.+A.+Janneauthor=O.+Kocherauthor=M.+Meyersonauthor=B.+E.+Johnsonauthor=M.+J.+Eckauthor=D.+G.+Tenenauthor=B.+Halmos&title=EGFR+mutation+and+resistance+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR mutation and resistance of non-small-cell lung cancer to gefitinib</span></div><div class="casAuthors">Kobayashi, Susumu; Boggon, Titus J.; Dayaram, Tajhal; Jaenne, Pasi A.; Kocher, Olivier; Meyerson, Matthew; Johnson, Bruce E.; Eck, Michael J.; Tenen, Daniel G.; Halmos, Balizs</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">786-792</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Mutations of the epidermal growth factor receptor (EGFR) gene were identified in specimens from patients with non-small-cell lung cancer who have a response to anilinoquinazoline EGFR inhibitors.  Despite the dramatic responses to such inhibitors, most patients ultimately have a relapse.  The mechanism of the drug resistance is unknown.  Here the authors report the case of a patient with EGFR-mutant, gefitinib-responsive, advanced non-small-cell lung cancer who had a relapse after 2 years of complete remission during treatment with gefitinib.  The DNA sequence of the EGFR gene in his tumor biopsy specimen at relapse revealed the presence of a second point mutation, resulting in threonine-to-methionine amino acid change at position 790 of EGFR.  Structural modeling and biochem. studies showed that this second mutation led to gefitinib resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8XXhT1hrbe7Vg90H21EOLACvtfcHk0ljueRsFQ9LAKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFCiurk%253D&md5=808223ad566e2a3748977727cc5a9846</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa044238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa044238%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DDayaram%26aufirst%3DT.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DKocher%26aufirst%3DO.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DTenen%26aufirst%3DD.%2BG.%26aulast%3DHalmos%26aufirst%3DB.%26atitle%3DEGFR%2520mutation%2520and%2520resistance%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D786%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. R.</span><span> </span><span class="NLM_article-title">A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=89-94&author=W.+H.+Linauthor=J.+S.+Songauthor=T.+Y.+Changauthor=C.+Y.+Changauthor=Y.+N.+Fuauthor=C.+L.+Yehauthor=S.+H.+Wuauthor=Y.+W.+Huangauthor=M.+Y.+Fangauthor=T.+W.+Lienauthor=H.+P.+Hsiehauthor=Y.+S.+Chaoauthor=S.+F.+Huangauthor=S.+F.+Tsaiauthor=L.+M.+Wangauthor=J.+T.+Hsuauthor=Y.+R.+Chen&title=A+cell-based+high-throughput+screen+for+epidermal+growth+factor+receptor+pathway+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DChang%26aufirst%3DT.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DFu%26aufirst%3DY.%2BN.%26aulast%3DYeh%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DHuang%26aufirst%3DY.%2BW.%26aulast%3DFang%26aufirst%3DM.%2BY.%26aulast%3DLien%26aufirst%3DT.%2BW.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DHuang%26aufirst%3DS.%2BF.%26aulast%3DTsai%26aufirst%3DS.%2BF.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DHsu%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DY.%2BR.%26atitle%3DA%2520cell-based%2520high-throughput%2520screen%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520pathway%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D377%26spage%3D89%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Coumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C., W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leou, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittimalla, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span> </span><span class="NLM_article-title">Fast-forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification. <i>J</i></span> <span class="citation_source-journal">Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4980</span><span class="NLM_x">â</span> <span class="NLM_lpage">4988</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000198" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFyhs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4980-4988&author=M.+S.+Coumarauthor=C.+Y.+Chuauthor=C.%2C+W.+Linauthor=H.+Y.+Shiaoauthor=Y.+L.+Hoauthor=R.+Reddyauthor=W.+H.+Linauthor=C.+H.+Chenauthor=Y.+H.+Pengauthor=J.+S.+Leouauthor=T.+W.+Lienauthor=C.+T.+Huangauthor=M.+Y.+Fangauthor=S.+H.+Wuauthor=S.+K.+Chittimallaauthor=J.+S.+Songauthor=J.+T.+A.+Hsuauthor=S.+Y.+Wuauthor=C.+C.+Liaoauthor=Y.+S.+Chaoauthor=H.+P.+Hsieh&title=Fast-forwarding+Hit+to+Lead%3A+Aurora+and+Epidermal+Growth+Factor+Receptor+Kinase+Inhibitor+Lead+Identification.+J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fast-Forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification</span></div><div class="casAuthors">Coumar, Mohane Selvaraj; Chu, Chang-Ying; Lin, Cheng-Wei; Shiao, Hui-Yi; Ho, Yun-Lung; Reddy, Randheer; Lin, Wen-Hsing; Chen, Chun-Hwa; Peng, Yi-Hui; Leou, Jiun-Shyang; Lien, Tzu-Wen; Huang, Chin-Ting; Fang, Ming-Yu; Wu, Szu-Huei; Wu, Jian-Sung; Chittimalla, Santhosh Kumar; Song, Jen-Shin; Hsu, John T.-A.; Wu, Su-Ying; Liao, Chun-Chen; Chao, Yu-Sheng; Hsieh, Hsing-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4980-4988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Furanopyrimidines such as I [R = (S)-HOCH2CHPh; R1 = 3-(H2C:CCONH)C6H4] are prepd. as Aurora A kinase and epidermal growth factor receptor (EGFR) inhibitors by prepn. of a combinatorial library of approx. 350 furanopyridines and optimization of the inhibitors found from the library.  The initial hit compd. I (R = HOCH2CH2; R1 = Ph) was modified to better fit the back pocket to produce the potent Aurora A kinase inhibitor I (R = 4-PhNHCONHC6H4; R1 = Ph) with submicromolar antiproliferative activity in the HCT-116 human colon cancer cell line.  On the basis of docking studies with EGFR hit I [R = (S)-HOCH2CHPh; R1 = Ph], introduction of an acrylamide Michael acceptor group led to I [R = (S)-HOCH2CHPh; R1 = 3-(H2C:CCONH)C6H4], which inhibited both the wild and mutant EGFR kinases and also showed antiproliferative activity in the gefitinib-resistant HCC827 human lung cancer cells.  The X-ray cocrystal structures of I (R = HOCH2CH2, 4-PhNHCONHC6H4; R1 = Ph) bound to Aurora A kinase and the crystal structure of I [R = (S)-HOCH2CHPh; R1 = 3-(H2C:CCONH)C6H4] bound to EGFR confirmed their hypothesized binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCOPMtJ1xilrVg90H21EOLACvtfcHk0ljpan3jCYdxhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFyhs7s%253D&md5=8064e99d8d31603c7186b5fa33e019a6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm1000198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000198%26sid%3Dliteratum%253Aachs%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DChu%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DC.%252C%2BW.%26aulast%3DShiao%26aufirst%3DH.%2BY.%26aulast%3DHo%26aufirst%3DY.%2BL.%26aulast%3DReddy%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DW.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DPeng%26aufirst%3DY.%2BH.%26aulast%3DLeou%26aufirst%3DJ.%2BS.%26aulast%3DLien%26aufirst%3DT.%2BW.%26aulast%3DHuang%26aufirst%3DC.%2BT.%26aulast%3DFang%26aufirst%3DM.%2BY.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DChittimalla%26aufirst%3DS.%2BK.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DHsu%26aufirst%3DJ.%2BT.%2BA.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DLiao%26aufirst%3DC.%2BC.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26atitle%3DFast-forwarding%2520Hit%2520to%2520Lead%253A%2520Aurora%2520and%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Kinase%2520Inhibitor%2520Lead%2520Identification.%2520J%26jtitle%3DMed.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4980%26epage%3D4988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(alpha-phenethylamino)quinazolines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1651</span><span class="NLM_x">â</span> <span class="NLM_lpage">1656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=1651-1656&author=A.+J.+Bridgesauthor=D.+R.+Codyauthor=H.+Zhouauthor=A.+McMichaelauthor=D.+W.+Fry&title=Enantioselective+inhibition+of+the+epidermal+growth+factor+receptor+tyrosine+kinase+by+4-%28alpha-phenethylamino%29quinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DEnantioselective%2520inhibition%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520by%25204-%2528alpha-phenethylamino%2529quinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1995%26volume%3D3%26spage%3D1651%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sercel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 16. 6,5,6-Tricyclic benzothieno[3, 2-<i>d</i>]pyrimidines and pyrimido[5,4-<i>b</i>]- and -[4,5-<i>b</i>]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5464</span><span class="NLM_x">â</span> <span class="NLM_lpage">5474</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9903949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5464-5474&author=H.+D.+Showalterauthor=A.+J.+Bridgesauthor=H.+Zhouauthor=A.+D.+Sercelauthor=A.+McMichaelauthor=D.+W.+Fry&title=Tyrosine+kinase+inhibitors.+16.+6%2C5%2C6-Tricyclic+benzothieno%5B3%2C+2-d%5Dpyrimidines+and+pyrimido%5B5%2C4-b%5D-+and+-%5B4%2C5-b%5Dindoles+as+potent+inhibitors+of+the+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm9903949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9903949%26sid%3Dliteratum%253Aachs%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSercel%26aufirst%3DA.%2BD.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252016.%25206%252C5%252C6-Tricyclic%2520benzothieno%255B3%252C%25202-d%255Dpyrimidines%2520and%2520pyrimido%255B5%252C4-b%255D-%2520and%2520-%255B4%252C5-b%255Dindoles%2520as%2520potent%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5464%26epage%3D5474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegrini, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosios, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McSheehy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span> </span><span class="NLM_article-title">AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4931</span><span class="NLM_x">â</span> <span class="NLM_lpage">4941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4931-4941&author=P.+Traxlerauthor=P.+R.+Allegriniauthor=R.+Brandtauthor=J.+Brueggenauthor=R.+Cozensauthor=D.+Fabbroauthor=K.+Grosiosauthor=H.+A.+Laneauthor=P.+McSheehyauthor=J.+Mestanauthor=T.+Meyerauthor=C.+Tangauthor=M.+Wartmannauthor=J.+Woodauthor=G.+Caravatti&title=AEE788%3A+a+dual+family+epidermal+growth+factor+receptor%2FErbB2+and+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DAllegrini%26aufirst%3DP.%2BR.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGrosios%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DMcSheehy%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DCaravatti%26aufirst%3DG.%26atitle%3DAEE788%253A%2520a%2520dual%2520family%2520epidermal%2520growth%2520factor%2520receptor%252FErbB2%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4931%26epage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greis, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hook, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherwood, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span> </span><span class="NLM_article-title">Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">12022</span><span class="NLM_x">â</span> <span class="NLM_lpage">12027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1073%2Fpnas.95.20.12022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=9751783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADyaK1cXmsV2ht7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12022-12027&author=D.+W.+Fryauthor=A.+J.+Bridgesauthor=W.+A.+Dennyauthor=A.+Dohertyauthor=K.+D.+Greisauthor=J.+L.+Hicksauthor=K.+E.+Hookauthor=P.+R.+Kellerauthor=W.+R.+Leopoldauthor=J.+A.+Looauthor=D.+J.+McNamaraauthor=J.+M.+Nelsonauthor=V.+Sherwoodauthor=J.+B.+Smaillauthor=S.+Trumpp-Kallmeyerauthor=E.+M.+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor</span></div><div class="casAuthors">Fry, David W.; Bridges, Alexander J.; Denny, William A.; Doherty, Annette; Greis, Kenneth D.; Hicks, James L.; Hook, Kenneth E.; Keller, Paul R.; Leopold, Wilbur R.; Loo, Joseph A.; McNamara, Dennis J.; Nelson, James M.; Sherwood, Veronika; Smaill, Jeff B.; Trumpp-Kallmeyer, Susanne; Dobrusin, Ellen M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12022-12027</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A class of high-affinity inhibitors is disclosed that selectively target and irreversibly inactivate the epidermal growth factor receptor tyrosine kinase through specific, covalent modification of a cysteine residue present in the ATP binding pocket.  A series of expts. employing MS, mol. modeling, site-directed mutagenesis, and 14C-labeling studies in viable cells unequivocally demonstrate that these compds. selectively bind to the catalytic domain of the epidermal growth factor receptor with a 1:1 stoichiometry and alkylate Cys-773.  While the compds. are essentially non-reactive in soln., they are subject to rapid nucleophilic attack by this particular amino acid when bound in the ATP pocket.  The mol. orientation and positioning of the acrylamide group in these inhibitors in relation to Cys-773 entirely support these results as detd. from docking expts. in a homol.-built mol. model of the ATP site.  Evidence is also presented to indicate that the compds. interact in an analogous fashion with erbB2 but have no activity against the other receptor tyrosine kinases or intracellular tyrosine kinases that were tested in this study.  Finally, a direct comparison between 6-acrylamido-4-anilinoquinazoline and an equally potent but reversible analog shows that the irreversible inhibitor has far superior in vivo antitumor activity in a human epidermoid carcinoma xenograft model with no overt toxicity at therapeutically active doses.  The activity profile for this compd. is prototypical of a generation of tyrosine kinase inhibitors with great promise for therapeutic significance in the treatment of proliferative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpibFpkhNyxDLVg90H21EOLACvtfcHk0lg2rDBLmPwYpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsV2ht7g%253D&md5=a89b0b8123511fb1bbb889c01a3f9df2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.20.12022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.20.12022%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DDoherty%26aufirst%3DA.%26aulast%3DGreis%26aufirst%3DK.%2BD.%26aulast%3DHicks%26aufirst%3DJ.%2BL.%26aulast%3DHook%26aufirst%3DK.%2BE.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DLoo%26aufirst%3DJ.%2BA.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DSherwood%26aufirst%3DV.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D1998%26volume%3D95%26spage%3D12022%26epage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">The development of HKI-272 and related compounds for the treatment of cancer</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">â</span> <span class="NLM_lpage">477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=465-477&author=A.+Wissnerauthor=T.+S.+Mansour&title=The+development+of+HKI-272+and+related+compounds+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DThe%2520development%2520of%2520HKI-272%2520and%2520related%2520compounds%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%2529%26date%3D2008%26volume%3D341%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tsou, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek-Klumpers, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">â</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1107-1131&author=H.+R.+Tsouauthor=E.+G.+Overbeek-Klumpersauthor=W.+A.+Hallettauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=R.+S.+Michalakauthor=R.+Nilakantanauthor=C.+Discafaniauthor=J.+Golasauthor=S.+K.+Rabindranauthor=R.+Shenauthor=X.+Shiauthor=Y.+F.+Wangauthor=J.+Upeslacisauthor=A.+Wissner&title=Optimization+of+6%2C7-disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+orally+active%2C+irreversible+inhibitors+of+human+epidermal+growth+factor+receptor-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.%2BR.%26aulast%3DOverbeek-Klumpers%26aufirst%3DE.%2BG.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMichalak%26aufirst%3DR.%2BS.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DUpeslacis%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DOptimization%2520of%25206%252C7-disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520orally%2520active%252C%2520irreversible%2520inhibitors%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520kinase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1107%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3958</span><span class="NLM_x">â</span> <span class="NLM_lpage">3965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1158%2F0008-5472.CAN-03-2868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=15173008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3958-3965&author=S.+K.+Rabindranauthor=C.+M.+Discafaniauthor=E.+C.+Rosfjordauthor=M.+Baxterauthor=M.+B.+Floydauthor=J.+Golasauthor=W.+A.+Hallettauthor=B.+D.+Johnsonauthor=R.+Nilakantanauthor=E.+Overbeekauthor=M.+F.+Reichauthor=R.+Shenauthor=X.+Shiauthor=H.+R.+Tsouauthor=Y.+F.+Wangauthor=A.+Wissner&title=Antitumor+activity+of+HKI-272%2C+an+orally+active%2C+irreversible+inhibitor+of+the+HER-2+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase</span></div><div class="casAuthors">Rabindran, Sridhar K.; Discafani, Carolyn M.; Rosfjord, Edward C.; Baxter, Michelle; Floyd, M. Brawner; Golas, Jonathan; Hallett, William A.; Johnson, Bernard D.; Nilakantan, Ramaswamy; Overbeek, Elsebe; Reich, Marvin F.; Shen, Ru; Shi, Xiaoqing; Tsou, Hwei-Ru; Wang, Yu-Fen; Wissner, Allan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3958-3965</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HER-2 belongs to the ErbB family of receptor tyrosine kinases, which has been implicated in a variety of cancers.  Overexpression of HER-2 is seen in 25-30% of breast cancer patients and predicts a poor outcome in patients with primary disease.  Trastuzumab (Herceptin), a monoclonal antibody to HER-2, is specifically approved for HER-2-pos. breast cancer but is active only in a subset of these tumors.  Blocking HER-2 function by a small mol. kinase inhibitor, therefore, represents an attractive alternate strategy to inhibit the growth of HER-2-pos. tumors.  HKI-272 is a potent inhibitor of HER-2 and is highly active against HER-2-overexpressing human breast cancer cell lines in vitro.  It also inhibits the epidermal growth factor receptor (EGFR) kinase and the proliferation of EGFR-dependent cells.  HKI-272 reduces HER-2 receptor autophosphorylation in cells at doses consistent with inhibition of cell proliferation and functions as an irreversible binding inhibitor, most likely by targeting a cysteine residue in the ATP-binding pocket of the receptor.  In agreement with the predicted effects of HER-2 inactivation, HKI-272 treatment of cells results in inhibition of downstream signal transduction events and cell cycle regulatory pathways.  This leads to arrest at the G1-S (Gap 1/DNA synthesis)-phase transition of the cell division cycle, ultimately resulting in decreased cell proliferation.  In vivo, HKI-272 is active in HER-2- and EGFR-dependent tumor xenograft models when dosed orally on a once daily schedule.  On the basis of its favorable preclin. pharmacol. profile, HKI-272 has been selected as a candidate for addnl. development as an antitumor agent in breast and other HER-2-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2xeLXlAwWvbVg90H21EOLACvtfcHk0ljM8rEWPgzHSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D&md5=60accd0599b7c489e4c3753d4f39cab4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-2868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-2868%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DBaxter%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DTsou%26aufirst%3DH.%2BR.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DAntitumor%2520activity%2520of%2520HKI-272%252C%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520HER-2%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3958%26epage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H. R.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020241c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=49-63&author=A.+Wissnerauthor=E.+Overbeekauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=E.+C.+Rosfjordauthor=C.+Discafaniauthor=R.+Davisauthor=X.+Shiauthor=S.+K.+Rabindranauthor=B.+C.+Gruberauthor=F.+Yeauthor=W.+A.+Hallettauthor=R.+Nilakantanauthor=R.+Shenauthor=Y.+F.+Wangauthor=L.+M.+Greenbergerauthor=H.+R.+Tsou&title=Synthesis+and+structure%E2%88%92activity+relationships+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles.+The+design+of+an+orally+active%2C+irreversible+inhibitor+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+the+human+epidermal+growth+factor+receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm020241c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020241c%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DTsou%26aufirst%3DH.%2BR.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles.%2520The%2520design%2520of%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yoshimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, M.</span><span> </span><span class="NLM_article-title">EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2006&pages=363-368&author=N.+Yoshimuraauthor=S.+Kudohauthor=T.+Kimuraauthor=S.+Mitsuokaauthor=K.+Matsuuraauthor=K.+Hirataauthor=K.+Matsuiauthor=S.+Negoroauthor=K.+Nakagawaauthor=M.+Fukuoka&title=EKB-569%2C+a+new+irreversible+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+with+clinical+activity+in+patients+with+non-small+cell+lung+cancer+with+acquired+resistance+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DN.%26aulast%3DKudoh%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DMitsuoka%26aufirst%3DS.%26aulast%3DMatsuura%26aufirst%3DK.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DK.%26aulast%3DNegoro%26aufirst%3DS.%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DFukuoka%26aufirst%3DM.%26atitle%3DEKB-569%252C%2520a%2520new%2520irreversible%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520with%2520clinical%2520activity%2520in%2520patients%2520with%2520non-small%2520cell%2520lung%2520cancer%2520with%2520acquired%2520resistance%2520to%2520gefitinib%26jtitle%3DLung%2520Cancer%26date%3D2006%26volume%3D51%26spage%3D363%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrogio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirieac, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padera, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelsbach, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span> </span><span class="NLM_article-title">BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4702</span><span class="NLM_x">â</span> <span class="NLM_lpage">4711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=4702-4711&author=D.+Liauthor=L.+Ambrogioauthor=T.+Shimamuraauthor=S.+Kuboauthor=M.+Takahashiauthor=L.+R.+Chirieacauthor=R.+F.+Paderaauthor=G.+I.+Shapiroauthor=A.+Baumauthor=F.+Himmelsbachauthor=W.+J.+Rettigauthor=M.+Meyersonauthor=F.+Solcaauthor=H.+Greulichauthor=K.+K.+Wong&title=BIBW2992%2C+an+irreversible+EGFR%2FHER2+inhibitor+highly+effective+in+preclinical+lung+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DAmbrogio%26aufirst%3DL.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DKubo%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DChirieac%26aufirst%3DL.%2BR.%26aulast%3DPadera%26aufirst%3DR.%2BF.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DHimmelsbach%26aufirst%3DF.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSolca%26aufirst%3DF.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DBIBW2992%252C%2520an%2520irreversible%2520EGFR%252FHER2%2520inhibitor%2520highly%2520effective%2520in%2520preclinical%2520lung%2520cancer%2520models%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D4702%26epage%3D4711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gewald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BÃ¶ttcher, H.</span><span> </span><span class="NLM_article-title">Heterocyclen aus CH-aciden Nitrilen, VIII. 2-Amino-thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und Schwefel</span> <span class="citation_source-journal">Chem. Ber</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">â</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1966&pages=94-100&author=K.+Gewaldauthor=E.+Schinkeauthor=H.+B%C3%B6ttcher&title=Heterocyclen+aus+CH-aciden+Nitrilen%2C+VIII.+2-Amino-thiophene+aus+methylenaktiven+Nitrilen%2C+Carbonylverbindungen+und+Schwefel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGewald%26aufirst%3DK.%26aulast%3DSchinke%26aufirst%3DE.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DH.%26atitle%3DHeterocyclen%2520aus%2520CH-aciden%2520Nitrilen%252C%2520VIII.%25202-Amino-thiophene%2520aus%2520methylenaktiven%2520Nitrilen%252C%2520Carbonylverbindungen%2520und%2520Schwefel%26jtitle%3DChem.%2520Ber%26date%3D1966%26volume%3D99%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 80 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jimin Hwang, Lydia Borgelt, <span class="NLM_string-name hlFld-ContribAuthor">Peng Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Petasis Reaction for the Synthesis of Functionalized 2-Aminothiophenes and Thienodiazepines. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (10)
                                     , 495-499. <a href="https://doi.org/10.1021/acscombsci.0c00173" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00173%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DMulticomponent%252BPetasis%252BReaction%252Bfor%252Bthe%252BSynthesis%252Bof%252BFunctionalized%252B2-Aminothiophenes%252Band%252BThienodiazepines%26aulast%3DHwang%26aufirst%3DJimin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D18092020%26date%3D28092020%26volume%3D22%26issue%3D10%26spage%3D495%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tim J. Fyfe, Barbara Zarzycka, Herman D. Lim, Barrie Kellam, Shailesh N. Mistry, Vsevolod Katrich, Peter J. Scammells, J. Robert Lane, <span class="NLM_string-name hlFld-ContribAuthor">Ben Capuano</span>. </span><span class="cited-content_cbyCitation_article-title">A Thieno[2,3-d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 174-206. <a href="https://doi.org/10.1021/acs.jmedchem.7b01565" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01565%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BThieno%25255B2%25252C3-d%25255Dpyrimidine%252BScaffold%252BIs%252Ba%252BNovel%252BNegative%252BAllosteric%252BModulator%252Bof%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DFyfe%26aufirst%3DTim%2BJ.%26date%3D2019%26date%3D2018%26date%3D2017%26date%3D30102017%26date%3D15052018%26date%3D23042018%26volume%3D62%26issue%3D1%26spage%3D174%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Julie A.  Spicer</span>, <span class="hlFld-ContribAuthor ">Helen  Lee</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Sexton</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Black</span>, <span class="hlFld-ContribAuthor ">Adrian  Blaser</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Stephen  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">Ken  Hook</span>, <span class="hlFld-ContribAuthor ">Florence O. J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Freddy  Rivault</span>, <span class="hlFld-ContribAuthor ">Kevin  Schlosser</span>, <span class="hlFld-ContribAuthor ">Teresa  Ellis</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">Erin  Trachet</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Haile  Tecle</span>, and <span class="hlFld-ContribAuthor ">Alexander  Bridges</span>  . </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8103-8124. <a href="https://doi.org/10.1021/acs.jmedchem.6b00883" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTyrosine%252BKinase%252BInhibitors.%252B20.%252BOptimization%252Bof%252BSubstituted%252BQuinazoline%252Band%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252Bas%252BOrally%252BActive%25252C%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BFamily%26aulast%3DSmaill%26aufirst%3DJeff%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15062016%26date%3D22082016%26date%3D08092016%26date%3D04082016%26volume%3D59%26issue%3D17%26spage%3D8103%26epage%3D8124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Shanshan  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Youwen  Zhou</span>, and <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>  . </span><span class="cited-content_cbyCitation_article-title">Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6580-6594. <a href="https://doi.org/10.1021/acs.jmedchem.5b00840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChallenges%252Band%252BPerspectives%252Bon%252Bthe%252BDevelopment%252Bof%252BSmall-Molecule%252BEGFR%252BInhibitors%252Bagainst%252BT790M-Mediated%252BResistance%252Bin%252BNon-Small-Cell%252BLung%252BCancer%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D02062015%26date%3D26022016%26date%3D28072016%26date%3D16022016%26volume%3D59%26issue%3D14%26spage%3D6580%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinde  Vidyacharan</span>, <span class="hlFld-ContribAuthor ">Arumugavel  Murugan</span>, and <span class="hlFld-ContribAuthor ">Duddu S.  Sharada</span>  . </span><span class="cited-content_cbyCitation_article-title">C(sp2)âH Functionalization of 2H-Indazoles at C3-Position via Palladium(II)-Catalyzed Isocyanide Insertion Strategy Leading to Diverse Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (7)
                                     , 2837-2848. <a href="https://doi.org/10.1021/acs.joc.6b00048" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00048%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DC%252528sp2%252529%2525E2%252580%252593H%252BFunctionalization%252Bof%252B2H-Indazoles%252Bat%252BC3-Position%252Bvia%252BPalladium%252528II%252529-Catalyzed%252BIsocyanide%252BInsertion%252BStrategy%252BLeading%252Bto%252BDiverse%252BHeterocycles%26aulast%3DVidyacharan%26aufirst%3DShinde%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19012016%26date%3D18032016%26date%3D01042016%26date%3D08032016%26volume%3D81%26issue%3D7%26spage%3D2837%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Jessica E.    Reed </span><span class="hlFld-ContribAuthor "> Jeff B.    Smaill </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Dacomitinib, a Potent Irreversible EGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 207-233. <a href="https://doi.org/10.1021/bk-2016-1239.ch008" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BDacomitinib%25252C%252Ba%252BPotent%252BIrreversible%252BEGFR%252BInhibitor%26aulast%3DReed%26aufirst%3DJessica%2BE.%26date%3D2016%26date%3D2016%26spage%3D207%26epage%3D233%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dora  Toledo Warshaviak</span>, <span class="hlFld-ContribAuthor ">Gali  Golan</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Borrelli</span>, <span class="hlFld-ContribAuthor ">Kai  Zhu</span>, and <span class="hlFld-ContribAuthor ">Ori  Kalid</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (7)
                                     , 1941-1950. <a href="https://doi.org/10.1021/ci500175r" title="DOI URL">https://doi.org/10.1021/ci500175r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500175r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500175r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure-Based%252BVirtual%252BScreening%252BApproach%252Bfor%252BDiscovery%252Bof%252BCovalently%252BBound%252BLigands%26aulast%3DToledo%2BWarshaviak%26aufirst%3DDora%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18032014%26date%3D26062014%26date%3D28072014%26date%3D16062014%26volume%3D54%26issue%3D7%26spage%3D1941%26epage%3D1950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Ku</span>, <span class="hlFld-ContribAuthor ">Fang  Bai</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, and <span class="hlFld-ContribAuthor ">Honglin  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7821-7837. <a href="https://doi.org/10.1021/jm401045n" title="DOI URL">https://doi.org/10.1021/jm401045n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401045n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401045n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPteridin-7%2525288H%252529-one-Based%252BIrreversible%252BInhibitors%252BTargeting%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BKinase%252BT790M%25252FL858R%252BMutant%26aulast%3DZhou%26aufirst%3DWei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03042013%26date%3D09102013%26date%3D24102013%26date%3D22092013%26volume%3D56%26issue%3D20%26spage%3D7821%26epage%3D7837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Yang</span>, <span class="hlFld-ContribAuthor ">Li-Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Ren-Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Pan  Ji</span>, <span class="hlFld-ContribAuthor ">Chun-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen-Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-Dong  Lin</span>, <span class="hlFld-ContribAuthor ">Lin-Li  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Quan  Wei</span>, and <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Optimization and StructureâActivity Relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine Derivatives, a New Class of Reversible Kinase Inhibitors Targeting both EGFR-Activating and Resistance Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (23)
                                     , 10685-10699. <a href="https://doi.org/10.1021/jm301365e" title="DOI URL">https://doi.org/10.1021/jm301365e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301365e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301365e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BOptimization%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BN2-%2525284-%2525284-Methylpiperazin-1-yl%252529phenyl%252529-N8-phenyl-9H-purine-2%25252C8-diamine%252BDerivatives%25252C%252Ba%252BNew%252BClass%252Bof%252BReversible%252BKinase%252BInhibitors%252BTargeting%252Bboth%252BEGFR-Activating%252Band%252BResistance%252BMutations%26aulast%3DYang%26aufirst%3DJiao%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D21092012%26date%3D16112012%26date%3D13122012%26date%3D01112012%26volume%3D55%26issue%3D23%26spage%3D10685%26epage%3D10699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tjeerd  Barf</span> and <span class="hlFld-ContribAuthor ">Allard  Kaptein</span>  . </span><span class="cited-content_cbyCitation_article-title">Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (14)
                                     , 6243-6262. <a href="https://doi.org/10.1021/jm3003203" title="DOI URL">https://doi.org/10.1021/jm3003203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3003203%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIrreversible%252BProtein%252BKinase%252BInhibitors%25253A%252BBalancing%252Bthe%252BBenefits%252Band%252BRisks%26aulast%3DBarf%26aufirst%3DTjeerd%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07032012%26date%3D08062012%26date%3D26072012%26date%3D23052012%26volume%3D55%26issue%3D14%26spage%3D6243%26epage%3D6262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Shilin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yingxue  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Duanqing  Pei</span>, and <span class="hlFld-ContribAuthor ">Ke  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine790 â Methionine790 Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2711-2723. <a href="https://doi.org/10.1021/jm201591k" title="DOI URL">https://doi.org/10.1021/jm201591k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201591k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201591k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BThreonine790%252B%2525E2%252586%252592%252BMethionine790%252BMutant%26aulast%3DChang%26aufirst%3DShaohua%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25112011%26date%3D01032012%26date%3D22032012%26date%3D16022012%26volume%3D55%26issue%3D6%26spage%3D2711%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Souad A.  El-Metwally</span>, <span class="hlFld-ContribAuthor ">Mohsen M.  Abou-El-Regal</span>, <span class="hlFld-ContribAuthor ">Ibrahim H.  Eissa</span>, <span class="hlFld-ContribAuthor ">Ahmed B.M.  Mehany</span>, <span class="hlFld-ContribAuthor ">Hazem A.  Mahdy</span>, <span class="hlFld-ContribAuthor ">Hazem  Elkady</span>, <span class="hlFld-ContribAuthor ">Alaa  Elwan</span>, <span class="hlFld-ContribAuthor ">Eslam B.  Elkaeed</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>112 </em>, 104947. <a href="https://doi.org/10.1016/j.bioorg.2021.104947" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104947%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine-based%252Bderivatives%252Bas%252Bpotent%252BVEGFR-2%252Bkinase%252Binhibitors%252Band%252Banti-cancer%252Bagents%26aulast%3DEl-Metwally%26aufirst%3DSouad%2BA.%26date%3D2021%26volume%3D112%26spage%3D104947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shen</span>, <span class="hlFld-ContribAuthor ">Fa-Wu  Su</span>, <span class="hlFld-ContribAuthor ">Yin-Rong  Xie</span>, <span class="hlFld-ContribAuthor ">Li-Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi-Long  Wu</span>, <span class="hlFld-ContribAuthor ">Yun  Niu</span>, <span class="hlFld-ContribAuthor ">Dong-Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-Ting  Zi</span>, <span class="hlFld-ContribAuthor ">Xuan-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Perbutyrylated Glucose Derivatives of (â)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (14)
                                     , 4361. <a href="https://doi.org/10.3390/molecules26144361" title="DOI URL">https://doi.org/10.3390/molecules26144361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26144361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26144361%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BPerbutyrylated%252BGlucose%252BDerivatives%252Bof%252B%252528%2525E2%252580%252593%252529-Epigallocatechin-3-Gallate%252BInhibit%252BCancer%252BCells%252BProliferation%252Bby%252BDecreasing%252BPhosphorylation%252Bof%252Bthe%252BEGFR%25253A%252BSynthesis%25252C%252BCytotoxicity%25252C%252Band%252BMolecular%252BDocking%26aulast%3DWang%26aufirst%3DYa%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D14%26spage%3D4361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Infante</span>, <span class="hlFld-ContribAuthor ">Alessio  Malfanti</span>, <span class="hlFld-ContribAuthor ">Deborah  Quaglio</span>, <span class="hlFld-ContribAuthor ">Silvia  Balducci</span>, <span class="hlFld-ContribAuthor ">Sara  De Martin</span>, <span class="hlFld-ContribAuthor ">Francesca  Bufalieri</span>, <span class="hlFld-ContribAuthor ">Francesca  Mastrotto</span>, <span class="hlFld-ContribAuthor ">Irene  Basili</span>, <span class="hlFld-ContribAuthor ">Mariangela  Garofalo</span>, <span class="hlFld-ContribAuthor ">Ludovica  Lospinoso Severini</span>, <span class="hlFld-ContribAuthor ">Mattia  Mori</span>, <span class="hlFld-ContribAuthor ">Isabella  Manni</span>, <span class="hlFld-ContribAuthor ">Marta  Moretti</span>, <span class="hlFld-ContribAuthor ">Carmine  Nicoletti</span>, <span class="hlFld-ContribAuthor ">Giulia  Piaggio</span>, <span class="hlFld-ContribAuthor ">Paolo  Caliceti</span>, <span class="hlFld-ContribAuthor ">Bruno  Botta</span>, <span class="hlFld-ContribAuthor ">Francesca  Ghirga</span>, <span class="hlFld-ContribAuthor ">Stefano  Salmaso</span>, <span class="hlFld-ContribAuthor ">Lucia  Di Marcotullio</span>. </span><span class="cited-content_cbyCitation_article-title">Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2021,</strong> <em>499 </em>, 220-231. <a href="https://doi.org/10.1016/j.canlet.2020.11.028" title="DOI URL">https://doi.org/10.1016/j.canlet.2020.11.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2020.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2020.11.028%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DGlabrescione%252BB%252Bdelivery%252Bby%252Bself-assembling%252Bmicelles%252Befficiently%252Binhibits%252Btumor%252Bgrowth%252Bin%252Bpreclinical%252Bmodels%252Bof%252BHedgehog-dependent%252Bmedulloblastoma%26aulast%3DInfante%26aufirst%3DPaola%26date%3D2021%26volume%3D499%26spage%3D220%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed F.  Saber</span>, <span class="hlFld-ContribAuthor ">Mostafa  Sayed</span>, <span class="hlFld-ContribAuthor ">Mahmoud S.  Tolba</span>, <span class="hlFld-ContribAuthor ">Adel M.  Kamal El-Dean</span>, <span class="hlFld-ContribAuthor ">Reda  Hassanien</span>, <span class="hlFld-ContribAuthor ">Mostafa  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">A facile method for preparation and evaluation of the antimicrobial efficiency of various heterocycles containing thieno[2,3-
              d
              ]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>51 </em>
                                    (3)
                                     , 398-409. <a href="https://doi.org/10.1080/00397911.2020.1829645" title="DOI URL">https://doi.org/10.1080/00397911.2020.1829645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1829645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1829645%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DA%252Bfacile%252Bmethod%252Bfor%252Bpreparation%252Band%252Bevaluation%252Bof%252Bthe%252Bantimicrobial%252Befficiency%252Bof%252Bvarious%252Bheterocycles%252Bcontaining%252Bthieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%26aulast%3DSaber%26aufirst%3DAhmed%2BF.%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D3%26spage%3D398%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajib  Mistri</span>, <span class="hlFld-ContribAuthor ">Bidyapati  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Supported Transition Metal Catalysts for Organic Fine Chemical Synthesis: A Review. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2021,</strong> <em>33 </em>
                                    (3)
                                     , 489-498. <a href="https://doi.org/10.14233/ajchem.2021.23025" title="DOI URL">https://doi.org/10.14233/ajchem.2021.23025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2021.23025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2021.23025%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DSupported%252BTransition%252BMetal%252BCatalysts%252Bfor%252BOrganic%252BFine%252BChemical%252BSynthesis%25253A%252BA%252BReview%26aulast%3DMistri%26aufirst%3DRajib%26date%3D2021%26date%3D2021%26volume%3D33%26issue%3D3%26spage%3D489%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Kaliraj</span>, <span class="hlFld-ContribAuthor ">R.  Jeyalakshmi</span>, <span class="hlFld-ContribAuthor ">M.K.  Kathiravan</span>, <span class="hlFld-ContribAuthor ">T.  Madhavan</span>, <span class="hlFld-ContribAuthor ">Arikketh  Devi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Molecular Docking and Biological Evaluation of
Fused Thienopyrimidines and Quinazoline. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2021,</strong> <em>33 </em>
                                    (3)
                                     , 537-544. <a href="https://doi.org/10.14233/ajchem.2021.23062" title="DOI URL">https://doi.org/10.14233/ajchem.2021.23062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2021.23062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2021.23062%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BMolecular%252BDocking%252Band%252BBiological%252BEvaluation%252Bof%252BFused%252BThienopyrimidines%252Band%252BQuinazoline%26aulast%3DKaliraj%26aufirst%3DS.%26date%3D2021%26date%3D2021%26volume%3D33%26issue%3D3%26spage%3D537%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mona M.  Abdel-Atty</span>, <span class="hlFld-ContribAuthor ">Nahla A.  Farag</span>, <span class="hlFld-ContribAuthor ">Rabah A. T.  Serya</span>, <span class="hlFld-ContribAuthor ">Khaled A. M.  Abouzid</span>, <span class="hlFld-ContribAuthor ">Samar  Mowafy</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design, synthesis and
              in vitro
              biological evaluation of thienopyrimidineâhydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1290-1312. <a href="https://doi.org/10.1080/14756366.2021.1933465" title="DOI URL">https://doi.org/10.1080/14756366.2021.1933465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1933465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1933465%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bbiological%252Bevaluation%252Bof%252Bthienopyrimidine%2525E2%252580%252593hydroxamic%252Bacids%252Bas%252Bchimeric%252Bkinase%252BHDAC%252Binhibitors%25253A%252Ba%252Bchallenging%252Bapproach%252Bto%252Bcombat%252Bcancer%26aulast%3DAbdel-Atty%26aufirst%3DMona%2BM.%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1290%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lun K.  Tsou</span>, <span class="hlFld-ContribAuthor ">Shiu-Hwa  Yeh</span>, <span class="hlFld-ContribAuthor ">Shau-Hua  Ueng</span>, <span class="hlFld-ContribAuthor ">Chun-Ping  Chang</span>, <span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Mine-Hsine  Wu</span>, <span class="hlFld-ContribAuthor ">Hsiao-Fu  Chang</span>, <span class="hlFld-ContribAuthor ">Sheng-Ren  Chen</span>, <span class="hlFld-ContribAuthor ">Chuan  Shih</span>, <span class="hlFld-ContribAuthor ">Chiung-Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-73681-1" title="DOI URL">https://doi.org/10.1038/s41598-020-73681-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-73681-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-73681-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DComparative%252Bstudy%252Bbetween%252Bdeep%252Blearning%252Band%252BQSAR%252Bclassifications%252Bfor%252BTNBC%252Binhibitors%252Band%252Bnovel%252BGPCR%252Bagonist%252Bdiscovery%26aulast%3DTsou%26aufirst%3DLun%2BK.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Tukur  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Adamu  Uzairu</span>, <span class="hlFld-ContribAuthor ">Gideon Adamu  Shallangwa</span>, <span class="hlFld-ContribAuthor ">Sani  Uba</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided molecular modeling studies of some 2, 3-dihydro-[1, 4] dioxino [2, 3-f] quinazoline derivatives as EGFRWT inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Beni-Suef University Journal of Basic and Applied Sciences</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s43088-020-00047-x" title="DOI URL">https://doi.org/10.1186/s43088-020-00047-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s43088-020-00047-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs43088-020-00047-x%26sid%3Dliteratum%253Aachs%26jtitle%3DBeni-Suef%2520University%2520Journal%2520of%2520Basic%2520and%2520Applied%2520Sciences%26atitle%3DComputer-aided%252Bmolecular%252Bmodeling%252Bstudies%252Bof%252Bsome%252B2%25252C%252B3-dihydro-%25255B1%25252C%252B4%25255D%252Bdioxino%252B%25255B2%25252C%252B3-f%25255D%252Bquinazoline%252Bderivatives%252Bas%252BEGFRWT%252Binhibitors%26aulast%3DIbrahim%26aufirst%3DMuhammad%2BTukur%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ding  Xue</span>, <span class="hlFld-ContribAuthor ">Wenmin  Chen</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, structure-activity relationship study and biological evaluation of 2-thioureidothiophene-3-carboxylates as a novel class of C-X-C chemokine receptor 2 (CXCR2) antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112387. <a href="https://doi.org/10.1016/j.ejmech.2020.112387" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112387%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bstructure-activity%252Brelationship%252Bstudy%252Band%252Bbiological%252Bevaluation%252Bof%252B2-thioureidothiophene-3-carboxylates%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252BC-X-C%252Bchemokine%252Breceptor%252B2%252B%252528CXCR2%252529%252Bantagonists%26aulast%3DXue%26aufirst%3DDing%26date%3D2020%26volume%3D204%26spage%3D112387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emad M.  Gad</span>, <span class="hlFld-ContribAuthor ">Mohamed S.  Nafie</span>, <span class="hlFld-ContribAuthor ">Elsayed H.  Eltamany</span>, <span class="hlFld-ContribAuthor ">Magdy S. A. G.  Hammad</span>, <span class="hlFld-ContribAuthor ">Assem  Barakat</span>, <span class="hlFld-ContribAuthor ">Ahmed T. A.  Boraei</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[b]Thiophene-3-Carboxylate: Synthesis, In Vitro, and In Vivo Activity Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (11)
                                     , 2523. <a href="https://doi.org/10.3390/molecules25112523" title="DOI URL">https://doi.org/10.3390/molecules25112523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25112523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25112523%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNew%252BApoptosis-Inducing%252BAgents%252Bfor%252BBreast%252BCancer%252BBased%252Bon%252BEthyl%252B2-Amino-4%25252C5%25252C6%25252C7-Tetra%252BHydrobenzo%25255Bb%25255DThiophene-3-Carboxylate%25253A%252BSynthesis%25252C%252BIn%252BVitro%25252C%252Band%252BIn%252BVivo%252BActivity%252BEvaluation%26aulast%3DGad%26aufirst%3DEmad%2BM.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D11%26spage%3D2523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Yu</span>, <span class="hlFld-ContribAuthor ">Minghui  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhaoping  Pan</span>, <span class="hlFld-ContribAuthor ">Fengbo  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Guo</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel akt1 inhibitor induces autophagy associated death in hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112076. <a href="https://doi.org/10.1016/j.ejmech.2020.112076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bakt1%252Binhibitor%252Binduces%252Bautophagy%252Bassociated%252Bdeath%252Bin%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DYu%26aufirst%3DMeng%26date%3D2020%26volume%3D189%26spage%3D112076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranza  Elrayess</span>, <span class="hlFld-ContribAuthor ">Yasmine M.  Abdel Aziz</span>, <span class="hlFld-ContribAuthor ">Mohamed S.  Elgawish</span>, <span class="hlFld-ContribAuthor ">Marwa  Elewa</span>, <span class="hlFld-ContribAuthor ">Hosam A.  Elshihawy</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Said</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling, 3DâQSAR, synthesis, and antiâlung cancer evaluation of novel thieno[2,3â
              d
              ][1,2,3]triazines targeting EGFR. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (2)
                                     , 1900108. <a href="https://doi.org/10.1002/ardp.201900108" title="DOI URL">https://doi.org/10.1002/ardp.201900108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900108%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DPharmacophore%252Bmodeling%25252C%252B3D%2525E2%252580%252590QSAR%25252C%252Bsynthesis%25252C%252Band%252Banti%2525E2%252580%252590lung%252Bcancer%252Bevaluation%252Bof%252Bnovel%252Bthieno%25255B2%25252C3%2525E2%252580%252590%252Bd%252B%25255D%25255B1%25252C2%25252C3%25255Dtriazines%252Btargeting%252BEGFR%26aulast%3DElrayess%26aufirst%3DRanza%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D2%26spage%3D1900108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin</span>, <span class="hlFld-ContribAuthor ">Chuang</span>, <span class="hlFld-ContribAuthor ">Cheng</span>, <span class="hlFld-ContribAuthor ">Lin</span>, <span class="hlFld-ContribAuthor ">Fang</span>. </span><span class="cited-content_cbyCitation_article-title">High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2019,</strong> <em>11 </em>
                                    (11)
                                     , 569. <a href="https://doi.org/10.3390/pharmaceutics11110569" title="DOI URL">https://doi.org/10.3390/pharmaceutics11110569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics11110569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics11110569%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DHigh%252BPotency%252Bof%252BSN-38-Loaded%252BBovine%252BSerum%252BAlbumin%252BNanoparticles%252BAgainst%252BTriple-Negative%252BBreast%252BCancer%26aulast%3DLin%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mamdouh F.A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Bahaa G.M.  Youssif</span>, <span class="hlFld-ContribAuthor ">Montaser Sh. A.  Shaykoon</span>, <span class="hlFld-ContribAuthor ">Mostafa H.  Abdelrahman</span>, <span class="hlFld-ContribAuthor ">Bakheet E.M.  Elsadek</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Aboraia</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>. </span><span class="cited-content_cbyCitation_article-title">Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103127. <a href="https://doi.org/10.1016/j.bioorg.2019.103127" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103127%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DUtilization%252Bof%252Btetrahydrobenzo%25255B4%25252C5%25255Dthieno%25255B2%25252C3-d%25255Dpyrimidinone%252Bas%252Ba%252Bcap%252Bmoiety%252Bin%252Bdesign%252Bof%252Bnovel%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DMohamed%26aufirst%3DMamdouh%2BF.A.%26date%3D2019%26volume%3D91%26spage%3D103127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Xie</span>, <span class="hlFld-ContribAuthor ">Jingjing  Wang</span>, <span class="hlFld-ContribAuthor ">Miao  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Di  Jiao</span>, <span class="hlFld-ContribAuthor ">Qingqing  Ma</span>, <span class="hlFld-ContribAuthor ">Zhe  Jin</span>, <span class="hlFld-ContribAuthor ">Qingguo  Meng</span>, <span class="hlFld-ContribAuthor ">Chun  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-bromo-1,4-dihydrothieno[3â,2â:5,6]thiopyrano[4,3-c]pyrazole-3-carboxamide derivatives as the potential epidermal growth factor receptors for tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (7)
                                     , 1000-1009. <a href="https://doi.org/10.1007/s00044-019-02354-0" title="DOI URL">https://doi.org/10.1007/s00044-019-02354-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02354-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02354-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDiscovery%252Bof%252B7-bromo-1%25252C4-dihydrothieno%25255B3%2525E2%252580%252599%25252C2%2525E2%252580%252599%25253A5%25252C6%25255Dthiopyrano%25255B4%25252C3-c%25255Dpyrazole-3-carboxamide%252Bderivatives%252Bas%252Bthe%252Bpotential%252Bepidermal%252Bgrowth%252Bfactor%252Breceptors%252Bfor%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DXie%26aufirst%3DQian%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D7%26spage%3D1000%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Ridong  Li</span>, <span class="hlFld-ContribAuthor ">Han  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships of novel dithiocarbamates containing Î±,Î²-unsaturated ketone fragment as potent anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (7)
                                     , 1027-1038. <a href="https://doi.org/10.1007/s00044-019-02356-y" title="DOI URL">https://doi.org/10.1007/s00044-019-02356-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02356-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02356-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructure-activity%252Brelationships%252Bof%252Bnovel%252Bdithiocarbamates%252Bcontaining%252B%2525CE%2525B1%25252C%2525CE%2525B2-unsaturated%252Bketone%252Bfragment%252Bas%252Bpotent%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DYuanqiang%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D7%26spage%3D1027%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Souad A.  Elmetwally</span>, <span class="hlFld-ContribAuthor ">Khaled F.  Saied</span>, <span class="hlFld-ContribAuthor ">Ibrahim H.  Eissa</span>, <span class="hlFld-ContribAuthor ">Eslam B.  Elkaeed</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>88 </em>, 102944. <a href="https://doi.org/10.1016/j.bioorg.2019.102944" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102944%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bevaluation%252Bof%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bdual%252BEGFR%25252FHER2%252Binhibitors%252Band%252Bapoptosis%252Binducers%26aulast%3DElmetwally%26aufirst%3DSouad%2BA.%26date%3D2019%26volume%3D88%26spage%3D102944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingchao  He</span>, <span class="hlFld-ContribAuthor ">Can  Ren</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Junzi  Li</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Lin</span>, <span class="hlFld-ContribAuthor ">Chuanxiang  Ye</span>, <span class="hlFld-ContribAuthor ">Wenbo  Hu</span>, <span class="hlFld-ContribAuthor ">Junmin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Water-soluble chiral tetrazine derivatives: towardsÂ the application of circularly polarized luminescence from upper-excited states to photodynamic therapy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2019,</strong> <em>10 </em>
                                    (15)
                                     , 4163-4168. <a href="https://doi.org/10.1039/C9SC00264B" title="DOI URL">https://doi.org/10.1039/C9SC00264B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC00264B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC00264B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DWater-soluble%252Bchiral%252Btetrazine%252Bderivatives%25253A%252Btowards%2525C2%2525A0the%252Bapplication%252Bof%252Bcircularly%252Bpolarized%252Bluminescence%252Bfrom%252Bupper-excited%252Bstates%252Bto%252Bphotodynamic%252Btherapy%26aulast%3DHe%26aufirst%3DTingchao%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D15%26spage%3D4163%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam M.H.  Ali</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Maksoud</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (7)
                                     , 1159-1194. <a href="https://doi.org/10.1016/j.bmc.2019.02.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThieno%25255B2%25252C3-d%25255Dpyrimidine%252Bas%252Ba%252Bpromising%252Bscaffold%252Bin%252Bmedicinal%252Bchemistry%25253A%252BRecent%252Badvances%26aulast%3DAli%26aufirst%3DEslam%2BM.H.%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1159%26epage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Triloknadh  Settypalli</span>, <span class="hlFld-ContribAuthor ">Venkata Rao  Chunduri</span>, <span class="hlFld-ContribAuthor ">Nagaraju  Kerru</span>, <span class="hlFld-ContribAuthor ">Hari Krishna  Nallapaneni</span>, <span class="hlFld-ContribAuthor ">Venkata Ramaiah  Chintha</span>, <span class="hlFld-ContribAuthor ">Trinath  Daggupati</span>, <span class="hlFld-ContribAuthor ">Suneetha  Yeguvapalli</span>, <span class="hlFld-ContribAuthor ">Rajendra  Wudayagiri</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Neuroprotective and Antibacterial Activities of 1,2,4âTriazolo[3,4âb]1,3,4âthiadiazole Linked Thieno[2,3âd]pyrimidine Derivatives and In Silico Docking Studies. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (5)
                                     , 1627-1634. <a href="https://doi.org/10.1002/slct.201803917" title="DOI URL">https://doi.org/10.1002/slct.201803917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803917%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BNeuroprotective%252Band%252BAntibacterial%252BActivities%252Bof%252B1%25252C2%25252C4%2525E2%252580%252590Triazolo%25255B3%25252C4%2525E2%252580%252590b%25255D1%25252C3%25252C4%2525E2%252580%252590thiadiazole%252BLinked%252BThieno%25255B2%25252C3%2525E2%252580%252590d%25255Dpyrimidine%252BDerivatives%252Band%252BIn%252BSilico%252BDocking%252BStudies%26aulast%3DSettypalli%26aufirst%3DTriloknadh%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D5%26spage%3D1627%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Rahul  Pawara</span>, <span class="hlFld-ContribAuthor ">Sanjay J.  Surana</span>. </span><span class="cited-content_cbyCitation_article-title">Current Approaches in the Development of Covalent Irreversible EGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 45-128. <a href="https://doi.org/10.1016/B978-0-08-102661-8.00003-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-102661-8.00003-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102661-8.00003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102661-8.00003-2%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BApproaches%252Bin%252Bthe%252BDevelopment%252Bof%252BCovalent%252BIrreversible%252BEGFR%252BInhibitors%26aulast%3DPatel%26aufirst%3DHarun%2BM.%26date%3D2019%26spage%3D45%26epage%3D128%26pub%3DElsevier%26atitle%3DThird%252BGeneration%252BEGFR%252BInhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahasen M.  Fouad</span>, <span class="hlFld-ContribAuthor ">Eman R.  El-Bendary</span>, <span class="hlFld-ContribAuthor ">Ghada M.  suddek</span>, <span class="hlFld-ContribAuthor ">Ihsan A.  Shehata</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  El-Kerdawy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 587-598. <a href="https://doi.org/10.1016/j.bioorg.2018.09.022" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bantitumor%252Bevaluation%252Bof%252Bsome%252Bnew%252Bthiophenes%252Band%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%26aulast%3DFouad%26aufirst%3DMahasen%2BM.%26date%3D2018%26volume%3D81%26spage%3D587%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harun  Patel</span>, <span class="hlFld-ContribAuthor ">Azim  Ansari</span>, <span class="hlFld-ContribAuthor ">Rahul  Pawara</span>, <span class="hlFld-ContribAuthor ">Iqrar  Ansari</span>, <span class="hlFld-ContribAuthor ">Harsha  Jadhav</span>, <span class="hlFld-ContribAuthor ">Sanjay  Surana</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 2,4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2018,</strong> <em>38 </em>
                                    (5-6)
                                     , 393-412. <a href="https://doi.org/10.1080/10799893.2018.1557207" title="DOI URL">https://doi.org/10.1080/10799893.2018.1557207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2018.1557207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2018.1557207%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B2%25252C4-disubstituted%252Baminopyrimidines%25253A%252Breversible%252Bnon-covalent%252BT790M%252BEGFR%252Binhibitors%26aulast%3DPatel%26aufirst%3DHarun%26date%3D2018%26date%3D2019%26volume%3D38%26issue%3D5-6%26spage%3D393%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivya  James</span>, <span class="hlFld-ContribAuthor ">K.  Ramanathan</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-Based Pharmacophore Screening Strategy: a Pragmatic Approach for Targeting HER Proteins. </span><span class="cited-content_cbyCitation_journal-name">Applied Biochemistry and Biotechnology</span><span> <strong>2018,</strong> <em>186 </em>
                                    (1)
                                     , 85-108. <a href="https://doi.org/10.1007/s12010-018-2724-4" title="DOI URL">https://doi.org/10.1007/s12010-018-2724-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12010-018-2724-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12010-018-2724-4%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Biochemistry%2520and%2520Biotechnology%26atitle%3DLigand-Based%252BPharmacophore%252BScreening%252BStrategy%25253A%252Ba%252BPragmatic%252BApproach%252Bfor%252BTargeting%252BHER%252BProteins%26aulast%3DJames%26aufirst%3DNivya%26date%3D2018%26date%3D2018%26volume%3D186%26issue%3D1%26spage%3D85%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao-Rui  Yang</span>, <span class="hlFld-ContribAuthor ">Bin  Peng</span>, <span class="hlFld-ContribAuthor ">Sheng-Li  Cao</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Ren</span>, <span class="hlFld-ContribAuthor ">Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Fu-Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">You-Shan  Li</span>, <span class="hlFld-ContribAuthor ">Guo  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Shibin  Xu</span>, <span class="hlFld-ContribAuthor ">Ji  Liao</span>, <span class="hlFld-ContribAuthor ">Hailong  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xingzhi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxic evaluation and target identification of thieno[2,3- d ]pyrimidine derivatives with a dithiocarbamate side chain at C2 position. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>154 </em>, 324-340. <a href="https://doi.org/10.1016/j.ejmech.2018.05.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcytotoxic%252Bevaluation%252Band%252Btarget%252Bidentification%252Bof%252Bthieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Bwith%252Ba%252Bdithiocarbamate%252Bside%252Bchain%252Bat%252BC2%252Bposition%26aulast%3DYang%26aufirst%3DChao-Rui%26date%3D2018%26volume%3D154%26spage%3D324%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina Y.  El-Sharkawy</span>, <span class="hlFld-ContribAuthor ">Rowaida A.  El-Sakhawy</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abdel-Halim</span>, <span class="hlFld-ContribAuthor ">Kevin  Lee</span>, <span class="hlFld-ContribAuthor ">Gary A.  Piazza</span>, <span class="hlFld-ContribAuthor ">Christian  Ducho</span>, <span class="hlFld-ContribAuthor ">Rolf W.  Hartmann</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (5)
                                     , 1800018. <a href="https://doi.org/10.1002/ardp.201800018" title="DOI URL">https://doi.org/10.1002/ardp.201800018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800018%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bannulated%252Bthienopyrimidines%252Bas%252Bphosphodiesterase%252B5%252B%252528PDE5%252529%252Binhibitors%26aulast%3DEl-Sharkawy%26aufirst%3DLina%2BY.%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D5%26spage%3D1800018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Makino</span>, <span class="hlFld-ContribAuthor ">Anna  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Ayaka  Tomoike</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Kenji  Arimitsu</span>, <span class="hlFld-ContribAuthor ">Masahiko  Hirata</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Ohmomo</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Nishii</span>, <span class="hlFld-ContribAuthor ">Hidehiko  Okazawa</span>, <span class="hlFld-ContribAuthor ">Yasushi  Kiyono</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1609-1613. <a href="https://doi.org/10.1016/j.bmc.2018.02.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPET%252Bprobe%252Bdetecting%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bsusceptible%252Bto%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%252Binhibitor%252Btherapy%26aulast%3DMakino%26aufirst%3DAkira%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1609%26epage%3D1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxing  Hu</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Jingtao  Wang</span>, <span class="hlFld-ContribAuthor ">Yue  Liu</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective EGFR modulator to inhibit L858R/T790M double mutants bearing a N-9-Diphenyl-9H-purin-2-amine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1810-1822. <a href="https://doi.org/10.1016/j.bmc.2018.02.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bselective%252BEGFR%252Bmodulator%252Bto%252Binhibit%252BL858R%25252FT790M%252Bdouble%252Bmutants%252Bbearing%252Ba%252BN-9-Diphenyl-9H-purin-2-amine%252Bscaffold%26aulast%3DHu%26aufirst%3DJinxing%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1810%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Posa Venkata Sri  Ramya</span>, <span class="hlFld-ContribAuthor ">Sowjanya  Thatikonda</span>, <span class="hlFld-ContribAuthor ">Srinivas  Angapelly</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>, <span class="hlFld-ContribAuthor ">Vegi Ganga Modi  Naidu</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Thieno[2,â3-
              d
              ]pyrimidine-amides as Potential Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (11)
                                     , 3101-3106. <a href="https://doi.org/10.1002/slct.201703061" title="DOI URL">https://doi.org/10.1002/slct.201703061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201703061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201703061%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BThieno%25255B2%25252C%2525E2%252580%2525893-%252Bd%252B%25255Dpyrimidine-amides%252Bas%252BPotential%252BAnticancer%252BAgents%26aulast%3DRamya%26aufirst%3DPosa%2BVenkata%2BSri%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D11%26spage%3D3101%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amna  Ghith</span>, <span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Khairia  Youssef</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (11)
                                     , 1700242. <a href="https://doi.org/10.1002/ardp.201700242" title="DOI URL">https://doi.org/10.1002/ardp.201700242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700242%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DMedicinal%252BAttributes%252Bof%252BThienopyrimidine%252BBased%252BScaffold%252BTargeting%252BTyrosine%252BKinases%252Band%252BTheir%252BPotential%252BAnticancer%252BActivities%26aulast%3DGhith%26aufirst%3DAmna%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D11%26spage%3D1700242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Luo</span>, <span class="hlFld-ContribAuthor ">Chao  Han</span>, <span class="hlFld-ContribAuthor ">Handeng  Lv</span>, <span class="hlFld-ContribAuthor ">Di  Chen</span>, <span class="hlFld-ContribAuthor ">Guoliang  Shen</span>, <span class="hlFld-ContribAuthor ">Kaiqi  Wu</span>, <span class="hlFld-ContribAuthor ">Suwei  Pan</span>, <span class="hlFld-ContribAuthor ">Faqing  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1960. <a href="https://doi.org/10.3390/molecules22111960" title="DOI URL">https://doi.org/10.3390/molecules22111960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22111960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22111960%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivity%252Bof%252BTetrahydrobenzo%25255B4%25252C5%25255Dthieno%25255B2%25252C3-d%25255Dpyrimidine%252BDerivatives%252Bas%252BAnti-Inflammatory%252BAgents%26aulast%3DZhang%26aufirst%3DYuan%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Han</span>, <span class="hlFld-ContribAuthor ">Yongli  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Development of the Second and Third Generation Irreversible Epidermal Growth Factor Receptor Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2017,</strong> <em>14 </em>
                                    (7)
                                     , e1600372. <a href="https://doi.org/10.1002/cbdv.201600372" title="DOI URL">https://doi.org/10.1002/cbdv.201600372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201600372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201600372%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DRecent%252BDevelopment%252Bof%252Bthe%252BSecond%252Band%252BThird%252BGeneration%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%26aulast%3DHan%26aufirst%3DWeiwei%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D7%26spage%3De1600372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianfei  Sheng</span>, <span class="hlFld-ContribAuthor ">Zhihong  Liu</span>, <span class="hlFld-ContribAuthor ">Ming  Yan</span>, <span class="hlFld-ContribAuthor ">Xuejing  Zhang</span>, <span class="hlFld-ContribAuthor ">Dejian  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Ensheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Biomass-involved synthesis of N-substituted benzofuro[2,3-d]pyrimidine-4-amines and biological evaluation as novel EGFR tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (23)
                                     , 4971-4977. <a href="https://doi.org/10.1039/C7OB00793K" title="DOI URL">https://doi.org/10.1039/C7OB00793K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00793K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00793K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DBiomass-involved%252Bsynthesis%252Bof%252BN-substituted%252Bbenzofuro%25255B2%25252C3-d%25255Dpyrimidine-4-amines%252Band%252Bbiological%252Bevaluation%252Bas%252Bnovel%252BEGFR%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DSheng%26aufirst%3DJianfei%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D23%26spage%3D4971%26epage%3D4977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcella  Bassetto</span>, <span class="hlFld-ContribAuthor ">Pieter  Leyssen</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Mark M.  Yerukhimovich</span>, <span class="hlFld-ContribAuthor ">David N.  Frick</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 31-47. <a href="https://doi.org/10.1016/j.ejmech.2016.07.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputer-aided%252Bidentification%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bsubstituted%252Bthienopyrimidines%252Bas%252Bnovel%252Binhibitors%252Bof%252BHCV%252Breplication%26aulast%3DBassetto%26aufirst%3DMarcella%26date%3D2016%26volume%3D123%26spage%3D31%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  Nguyen</span>, <span class="hlFld-ContribAuthor ">Luxi  Chen</span>, <span class="hlFld-ContribAuthor ">Dhiraj  Kumar</span>, <span class="hlFld-ContribAuthor ">Jiyong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of autophagonizer and evaluation of its activity to induce autophagic cell death in apoptosis-defective cell line. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (19)
                                     , 4753-4756. <a href="https://doi.org/10.1016/j.bmcl.2016.08.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252Bautophagonizer%252Band%252Bevaluation%252Bof%252Bits%252Bactivity%252Bto%252Binduce%252Bautophagic%252Bcell%252Bdeath%252Bin%252Bapoptosis-defective%252Bcell%252Bline%26aulast%3DNguyen%26aufirst%3DJennifer%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4753%26epage%3D4756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Harpreet  Singh</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Kinases inhibitors in lung cancer: From benchside to bedside. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2016,</strong> <em>1866 </em>
                                    (1)
                                     , 128-140. <a href="https://doi.org/10.1016/j.bbcan.2016.07.002" title="DOI URL">https://doi.org/10.1016/j.bbcan.2016.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2016.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2016.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DKinases%252Binhibitors%252Bin%252Blung%252Bcancer%25253A%252BFrom%252Bbenchside%252Bto%252Bbedside%26aulast%3DSingh%26aufirst%3DPankaj%2BKumar%26date%3D2016%26volume%3D1866%26issue%3D1%26spage%3D128%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GÃ¡bor  SzÃ¡ntÃ³</span>, <span class="hlFld-ContribAuthor ">Attila  MakÃ³</span>, <span class="hlFld-ContribAuthor ">Imre  Bata</span>, <span class="hlFld-ContribAuthor ">Bence  Farkas</span>, <span class="hlFld-ContribAuthor ">SÃ¡ndor  Kolok</span>, <span class="hlFld-ContribAuthor ">MÃ³nika  Vastag</span>, <span class="hlFld-ContribAuthor ">Attila  CselenyÃ¡k</span>. </span><span class="cited-content_cbyCitation_article-title">New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 3896-3904. <a href="https://doi.org/10.1016/j.bmcl.2016.07.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252BP2X3%252Breceptor%252Bantagonists.%252BPart%252B1%25253A%252BDiscovery%252Band%252Boptimization%252Bof%252Btricyclic%252Bcompounds%26aulast%3DSz%25C3%25A1nt%25C3%25B3%26aufirst%3DG%25C3%25A1bor%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D3896%26epage%3D3904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Han</span>, <span class="hlFld-ContribAuthor ">Svein Jacob  Kaspersen</span>, <span class="hlFld-ContribAuthor ">Sondre  Nervik</span>, <span class="hlFld-ContribAuthor ">Kristin G.  NÃ¸rsett</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">BÃ¥rd Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral 6-aryl-furo[2,3-d]pyrimidin-4-amines as EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>119 </em>, 278-299. <a href="https://doi.org/10.1016/j.ejmech.2016.04.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChiral%252B6-aryl-furo%25255B2%25252C3-d%25255Dpyrimidin-4-amines%252Bas%252BEGFR%252Binhibitors%26aulast%3DHan%26aufirst%3DJin%26date%3D2016%26volume%3D119%26spage%3D278%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H M  Wang</span>, <span class="hlFld-ContribAuthor ">S H  Deng</span>, <span class="hlFld-ContribAuthor ">A H  Zheng</span>, <span class="hlFld-ContribAuthor ">Q Y  Zhang</span>, <span class="hlFld-ContribAuthor ">X B  Chen</span>, <span class="hlFld-ContribAuthor ">X H  Zeng</span>, <span class="hlFld-ContribAuthor ">Y G  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antifungal activities of 3-alkyl substituted thieno[2,3-d]pyrimidinones. </span><span class="cited-content_cbyCitation_journal-name">IOP Conference Series: Earth and Environmental Science</span><span> <strong>2016,</strong> <em>41 </em>, 012015. <a href="https://doi.org/10.1088/1755-1315/41/1/012015" title="DOI URL">https://doi.org/10.1088/1755-1315/41/1/012015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1755-1315/41/1/012015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1755-1315%2F41%2F1%2F012015%26sid%3Dliteratum%253Aachs%26jtitle%3DIOP%2520Conference%2520Series%253A%2520Earth%2520and%2520Environmental%2520Science%26atitle%3DSynthesis%252Band%252Bantifungal%252Bactivities%252Bof%252B3-alkyl%252Bsubstituted%252Bthieno%25255B2%25252C3-d%25255Dpyrimidinones%26aulast%3DWang%26aufirst%3DH%2BM%26date%3D2016%26date%3D2016%26volume%3D41%26spage%3D012015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ke  Zhang</span>, <span class="hlFld-ContribAuthor ">Suyu  Gao</span>, <span class="hlFld-ContribAuthor ">Guihua  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Jinhui  Wang</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent c-MET Inhibitors with New Scaffold Having Different Quinazoline, Pyridine and Tetrahydro-Pyridothienopyrimidine Headgroups. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (5)
                                     , 612. <a href="https://doi.org/10.3390/molecules21050612" title="DOI URL">https://doi.org/10.3390/molecules21050612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21050612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21050612%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BPotent%252Bc-MET%252BInhibitors%252Bwith%252BNew%252BScaffold%252BHaving%252BDifferent%252BQuinazoline%25252C%252BPyridine%252Band%252BTetrahydro-Pyridothienopyrimidine%252BHeadgroups%26aulast%3DJiang%26aufirst%3DYingnan%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D5%26spage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuebao  Wang</span>, <span class="hlFld-ContribAuthor ">Di  Chen</span>, <span class="hlFld-ContribAuthor ">Shufang  Yu</span>, <span class="hlFld-ContribAuthor ">Zaikui  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Qi</span>, <span class="hlFld-ContribAuthor ">Weitao  Fu</span>, <span class="hlFld-ContribAuthor ">Zixin  Xie</span>, <span class="hlFld-ContribAuthor ">Faqing  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Biological and Antitumor Activities of Tetrahydrobenzothieno[2,3-d]Pyrimidine Derivatives as Novel Inhibitors of FGFR1. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>87 </em>
                                    (4)
                                     , 499-507. <a href="https://doi.org/10.1111/cbdd.12687" title="DOI URL">https://doi.org/10.1111/cbdd.12687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12687%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BBiological%252Band%252BAntitumor%252BActivities%252Bof%252BTetrahydrobenzothieno%25255B2%25252C3-d%25255DPyrimidine%252BDerivatives%252Bas%252BNovel%252BInhibitors%252Bof%252BFGFR1%26aulast%3DWang%26aufirst%3DXuebao%26date%3D2016%26date%3D2016%26volume%3D87%26issue%3D4%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ram W.  Sabnis</span>. </span><span class="cited-content_cbyCitation_article-title">The Gewald reaction in dye chemistry. </span><span class="cited-content_cbyCitation_journal-name">Coloration Technology</span><span> <strong>2016,</strong> <em>132 </em>
                                    (1)
                                     , 49-82. <a href="https://doi.org/10.1111/cote.12182" title="DOI URL">https://doi.org/10.1111/cote.12182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cote.12182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcote.12182%26sid%3Dliteratum%253Aachs%26jtitle%3DColoration%2520Technology%26atitle%3DThe%252BGewald%252Breaction%252Bin%252Bdye%252Bchemistry%26aulast%3DSabnis%26aufirst%3DRam%2BW.%26date%3D2016%26date%3D2016%26volume%3D132%26issue%3D1%26spage%3D49%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saadia  Leeza Zaidi</span>, <span class="hlFld-ContribAuthor ">Subhash M.  Agarwal</span>, <span class="hlFld-ContribAuthor ">Porntip  Chavalitshewinkoon-Petmitr</span>, <span class="hlFld-ContribAuthor ">Thidarat  Suksangpleng</span>, <span class="hlFld-ContribAuthor ">Kamal  Ahmad</span>, <span class="hlFld-ContribAuthor ">Fernando  Avecilla</span>, <span class="hlFld-ContribAuthor ">Amir  Azam</span>. </span><span class="cited-content_cbyCitation_article-title">Thienopyrimidine sulphonamide hybrids: design, synthesis, antiprotozoal activity and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (93)
                                     , 90371-90383. <a href="https://doi.org/10.1039/C6RA15181G" title="DOI URL">https://doi.org/10.1039/C6RA15181G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA15181G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA15181G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DThienopyrimidine%252Bsulphonamide%252Bhybrids%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Bantiprotozoal%252Bactivity%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DLeeza%2BZaidi%26aufirst%3DSaadia%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D93%26spage%3D90371%26epage%3D90383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eman Z.  Elrazaz</span>, <span class="hlFld-ContribAuthor ">Rabah A.T.  Serya</span>, <span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>1 </em>
                                    (2)
                                     , 33-41. <a href="https://doi.org/10.1016/j.fjps.2015.09.001" title="DOI URL">https://doi.org/10.1016/j.fjps.2015.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fjps.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fjps.2015.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DThieno%25255B2%25252C3-d%25255Dpyrimidine%252Bbased%252Bderivatives%252Bas%252Bkinase%252Binhibitors%252Band%252Banticancer%252Bagents%26aulast%3DElrazaz%26aufirst%3DEman%2BZ.%26date%3D2015%26volume%3D1%26issue%3D2%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Vivek Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>, <span class="hlFld-ContribAuthor ">Yung Chang  Hsu</span>, <span class="hlFld-ContribAuthor ">Wen-Chieh  Wang</span>, <span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Szu-Huei  Wu</span>, <span class="hlFld-ContribAuthor ">John T. A.  Hsu</span>, <span class="hlFld-ContribAuthor ">Chuan  Shih</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>. </span><span class="cited-content_cbyCitation_article-title">Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep11702" title="DOI URL">https://doi.org/10.1038/srep11702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep11702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep11702%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DHomology%252Bmodeling%252Bof%252BDFG-in%252BFMS-like%252Btyrosine%252Bkinase%252B3%252B%252528FLT3%252529%252Band%252Bstructure-based%252Bvirtual%252Bscreening%252Bfor%252Binhibitor%252Bidentification%26aulast%3DKe%26aufirst%3DYi-Yu%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harinder  Singh</span>, <span class="hlFld-ContribAuthor ">Sandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Deepak  Singla</span>, <span class="hlFld-ContribAuthor ">Subhash M  Agarwal</span>, <span class="hlFld-ContribAuthor ">Gajendra P S  Raghava</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest. </span><span class="cited-content_cbyCitation_journal-name">Biology Direct</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13062-015-0046-9" title="DOI URL">https://doi.org/10.1186/s13062-015-0046-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13062-015-0046-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13062-015-0046-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520Direct%26atitle%3DQSAR%252Bbased%252Bmodel%252Bfor%252Bdiscriminating%252BEGFR%252Binhibitors%252Band%252Bnon-inhibitors%252Busing%252BRandom%252Bforest%26aulast%3DSingh%26aufirst%3DHarinder%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khurshed  Bozorov</span>, <span class="hlFld-ContribAuthor ">Jiang-Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Burkhon  Elmuradov</span>, <span class="hlFld-ContribAuthor ">Apar  Pataer</span>, <span class="hlFld-ContribAuthor ">Haji A.  Aisa</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 552-573. <a href="https://doi.org/10.1016/j.ejmech.2015.08.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bregarding%252Bthe%252Buse%252Bof%252Bthieno%25255B2%25252C3-d%25255Dpyrimidin-4-one%252Bderivatives%252Bin%252Bmedicinal%252Bchemistry%25252C%252Bwith%252Ba%252Bfocus%252Bon%252Btheir%252Bsynthesis%252Band%252Banticancer%252Bproperties%26aulast%3DBozorov%26aufirst%3DKhurshed%26date%3D2015%26volume%3D102%26spage%3D552%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Tzu-Ying  Sung</span>, <span class="hlFld-ContribAuthor ">Chih-Ta  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Yuan  Chiu</span>, <span class="hlFld-ContribAuthor ">John T.-A.  Hsu</span>, <span class="hlFld-ContribAuthor ">Hui-Chen  Hung</span>, <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>, <span class="hlFld-ContribAuthor ">Indrajeet  Barve</span>, <span class="hlFld-ContribAuthor ">Wen-Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Chien  Huang</span>, <span class="hlFld-ContribAuthor ">Chin-Ting  Huang</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Jinn-Moon  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Anchor-based classification and type-C inhibitors for tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep10938" title="DOI URL">https://doi.org/10.1038/srep10938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep10938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep10938%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAnchor-based%252Bclassification%252Band%252Btype-C%252Binhibitors%252Bfor%252Btyrosine%252Bkinases%26aulast%3DHsu%26aufirst%3DKai-Cheng%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steffen  Bugge</span>, <span class="hlFld-ContribAuthor ">Ingri Ullestad  Moen</span>, <span class="hlFld-ContribAuthor ">Kent-Ove  Kragseth Sylte</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">BÃ¥rd Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 175-194. <a href="https://doi.org/10.1016/j.ejmech.2015.03.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTruncated%252Bstructures%252Bused%252Bin%252Bsearch%252Bfor%252Bnew%252Blead%252Bcompounds%252Band%252Bin%252Ba%252Bretrospective%252Banalysis%252Bof%252Bthienopyrimidine-based%252BEGFR%252Binhibitors%26aulast%3DBugge%26aufirst%3DSteffen%26date%3D2015%26volume%3D94%26spage%3D175%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Bugge</span>, <span class="hlFld-ContribAuthor ">E. M.  SkjÃ¸nsfjell</span>, <span class="hlFld-ContribAuthor ">F. B.  Willumsen</span>, <span class="hlFld-ContribAuthor ">E.  Sundby</span>, <span class="hlFld-ContribAuthor ">B. H.  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Improved and Scalable Preparation of 6-Bromo-4-Chlorothieno[2,3-d]Pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (8)
                                     , 1177-1187. <a href="https://doi.org/10.1007/s10593-014-1579-z" title="DOI URL">https://doi.org/10.1007/s10593-014-1579-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1579-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1579-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DImproved%252Band%252BScalable%252BPreparation%252Bof%252B6-Bromo-4-Chlorothieno%25255B2%25252C3-d%25255DPyrimidine%26aulast%3DBugge%26aufirst%3DS.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D8%26spage%3D1177%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-Gen  Hu</span>, <span class="hlFld-ContribAuthor ">Ai-Hua  Zheng</span>, <span class="hlFld-ContribAuthor ">Gao-Jun  Li</span>, <span class="hlFld-ContribAuthor ">Meng-Zhu  Dong</span>, <span class="hlFld-ContribAuthor ">Fang  Ye</span>, <span class="hlFld-ContribAuthor ">Feng  Sun</span>, <span class="hlFld-ContribAuthor ">Zheng-Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Wen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of New Thieno[2,3-
              d
              ]pyrimidin-4(3
              H
              )-one Derivatives for Evaluation as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2014,</strong> <em>51 </em>
                                    (S1)
                                     , E84-E88. <a href="https://doi.org/10.1002/jhet.1823" title="DOI URL">https://doi.org/10.1002/jhet.1823</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.1823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.1823%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DEfficient%252BSynthesis%252Bof%252BNew%252BThieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidin-4%2525283%252BH%252B%252529-one%252BDerivatives%252Bfor%252BEvaluation%252Bas%252BAnticancer%252BAgents%26aulast%3DHu%26aufirst%3DYang-Gen%26date%3D2014%26date%3D2014%26volume%3D51%26issue%3DS1%26spage%3DE84%26epage%3DE88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steffen  Bugge</span>, <span class="hlFld-ContribAuthor ">Svein Jacob  Kaspersen</span>, <span class="hlFld-ContribAuthor ">Synne  Larsen</span>, <span class="hlFld-ContribAuthor ">Unni  Nonstad</span>, <span class="hlFld-ContribAuthor ">Geir  BjÃ¸rkÃ¸y</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">BÃ¥rd Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Structureâactivity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 354-374. <a href="https://doi.org/10.1016/j.ejmech.2014.01.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593activity%252Bstudy%252Bleading%252Bto%252Bidentification%252Bof%252Ba%252Bhighly%252Bactive%252Bthienopyrimidine%252Bbased%252BEGFR%252Binhibitor%26aulast%3DBugge%26aufirst%3DSteffen%26date%3D2014%26volume%3D75%26spage%3D354%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Si-Ning  Li</span>, <span class="hlFld-ContribAuthor ">Huan-Qiu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptor inhibitors: a patent review (2010 â present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 309-321. <a href="https://doi.org/10.1517/13543776.2014.871527" title="DOI URL">https://doi.org/10.1517/13543776.2014.871527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.871527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.871527%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DLi%26aufirst%3DSi-Ning%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D309%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Yongju  Liang</span>, <span class="hlFld-ContribAuthor ">Shun  Bai</span>, <span class="hlFld-ContribAuthor ">Hongwu  He</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Guangzhong  Yang</span>, <span class="hlFld-ContribAuthor ">Liwu  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative evaluation of novel tetrahydrobenzo[4â²,5â²]thieno[3â²,2â²:5,6]pyrido[4,3-d]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (55)
                                     , 29187-29192. <a href="https://doi.org/10.1039/C4RA03535F" title="DOI URL">https://doi.org/10.1039/C4RA03535F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA03535F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA03535F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Bevaluation%252Bof%252Bnovel%252Btetrahydrobenzo%25255B4%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2%25255Dthieno%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A5%25252C6%25255Dpyrido%25255B4%25252C3-d%25255Dpyrimidine%252Bderivatives%26aulast%3DTang%26aufirst%3DChu%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D55%26spage%3D29187%26epage%3D29192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa M.  Hamed</span>, <span class="hlFld-ContribAuthor ">Dalal A.  AbouâElâElla</span>, <span class="hlFld-ContribAuthor ">Adam B.  Keeton</span>, <span class="hlFld-ContribAuthor ">Gary A.  Piazza</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Rolf W.  Hartmann</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>. </span><span class="cited-content_cbyCitation_article-title">6âAryl and Heterocycle Quinazoline Derivatives as Potent EGFR Inhibitors with Improved Activity toward GefitinibâSensitive and âResistant Tumor Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (9)
                                     , 1495-1504. <a href="https://doi.org/10.1002/cmdc.201300147" title="DOI URL">https://doi.org/10.1002/cmdc.201300147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300147%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D6%2525E2%252580%252590Aryl%252Band%252BHeterocycle%252BQuinazoline%252BDerivatives%252Bas%252BPotent%252BEGFR%252BInhibitors%252Bwith%252BImproved%252BActivity%252Btoward%252BGefitinib%2525E2%252580%252590Sensitive%252Band%252B%2525E2%252580%252590Resistant%252BTumor%252BCell%252BLines%26aulast%3DHamed%26aufirst%3DMostafa%2BM.%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3D1495%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. M.  Kamel</span>, <span class="hlFld-ContribAuthor ">A. K.  El-Ansary</span>, <span class="hlFld-ContribAuthor ">Y. R.  Milad</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and cytotoxicity of pyridine, pyrazole, and thiazole derivatives derived from N-alkyl-4,5,6,7-tetrahydro-1-benzothiophene. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2013,</strong> <em>49 </em>
                                    (3)
                                     , 392-403. <a href="https://doi.org/10.1007/s10593-013-1259-4" title="DOI URL">https://doi.org/10.1007/s10593-013-1259-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-013-1259-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-013-1259-4%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bcytotoxicity%252Bof%252Bpyridine%25252C%252Bpyrazole%25252C%252Band%252Bthiazole%252Bderivatives%252Bderived%252Bfrom%252BN-alkyl-4%25252C5%25252C6%25252C7-tetrahydro-1-benzothiophene%26aulast%3DKamel%26aufirst%3DM.%2BM.%26date%3D2013%26date%3D2013%26volume%3D49%26issue%3D3%26spage%3D392%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Venkata Rao</span>, <span class="hlFld-ContribAuthor ">C.  Balakumar</span>, <span class="hlFld-ContribAuthor ">B.  Lakshmi Narayana</span>, <span class="hlFld-ContribAuthor ">D.  Pran Kishore</span>, <span class="hlFld-ContribAuthor ">K.  Rajwinder</span>, <span class="hlFld-ContribAuthor ">A.  Raghuram Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Transesterification of trimethyl orthoacetate: an efficient protocol for the synthesis of 4-alkoxy-2-aminothiophene-3-carbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (10)
                                     , 1274-1278. <a href="https://doi.org/10.1016/j.tetlet.2012.12.090" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.12.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.12.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.12.090%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DTransesterification%252Bof%252Btrimethyl%252Borthoacetate%25253A%252Ban%252Befficient%252Bprotocol%252Bfor%252Bthe%252Bsynthesis%252Bof%252B4-alkoxy-2-aminothiophene-3-carbonitriles%26aulast%3DVenkata%2BRao%26aufirst%3DK.%26date%3D2013%26volume%3D54%26issue%3D10%26spage%3D1274%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuchang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Chinh Tran To  Su</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>, <span class="hlFld-ContribAuthor ">Chee Keong  Kwoh</span>. </span><span class="cited-content_cbyCitation_article-title">CovalentDock: Automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2013,</strong> <em>34 </em>
                                    (4)
                                     , 326-336. <a href="https://doi.org/10.1002/jcc.23136" title="DOI URL">https://doi.org/10.1002/jcc.23136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.23136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.23136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DCovalentDock%25253A%252BAutomated%252Bcovalent%252Bdocking%252Bwith%252Bparameterized%252Bcovalent%252Blinkage%252Benergy%252Bestimation%252Band%252Bmolecular%252Bgeometry%252Bconstraints%26aulast%3DOuyang%26aufirst%3DXuchang%26date%3D2013%26date%3D2012%26volume%3D34%26issue%3D4%26spage%3D326%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinfeng  Shen</span>, <span class="hlFld-ContribAuthor ">Vladimir J. N.  Bykov</span>, <span class="hlFld-ContribAuthor ">Klas G.  Wiman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Mutant p53 for Improved Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 257-273. <a href="https://doi.org/10.1007/978-1-4614-3676-8_14" title="DOI URL">https://doi.org/10.1007/978-1-4614-3676-8_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-3676-8_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-3676-8_14%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BMutant%252Bp53%252Bfor%252BImproved%252BCancer%252BTherapy%26aulast%3DShen%26aufirst%3DJinfeng%26date%3D2013%26date%3D2012%26spage%3D257%26epage%3D273%26pub%3DSpringer%2520New%2520York%26atitle%3Dp53%252Bin%252Bthe%252BClinics%26aulast%3DHainaut%26aufirst%3DPierre%26date%3D2013%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">M  Kukimoto-Niino</span>, <span class="hlFld-ContribAuthor ">L  Parker</span>, <span class="hlFld-ContribAuthor ">N  Handa</span>, <span class="hlFld-ContribAuthor ">T  Terada</span>, <span class="hlFld-ContribAuthor ">T  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Y  Terazawa</span>, <span class="hlFld-ContribAuthor ">M  Wakiyama</span>, <span class="hlFld-ContribAuthor ">M  Sato</span>, <span class="hlFld-ContribAuthor ">S  Sano</span>, <span class="hlFld-ContribAuthor ">T  Kobayashi</span>, <span class="hlFld-ContribAuthor ">T  Tanaka</span>, <span class="hlFld-ContribAuthor ">L  Chen</span>, <span class="hlFld-ContribAuthor ">Z-J  Liu</span>, <span class="hlFld-ContribAuthor ">B-C  Wang</span>, <span class="hlFld-ContribAuthor ">M  Shirouzu</span>, <span class="hlFld-ContribAuthor ">S  Kawa</span>, <span class="hlFld-ContribAuthor ">K  Semba</span>, <span class="hlFld-ContribAuthor ">T  Yamamoto</span>, <span class="hlFld-ContribAuthor ">S  Yokoyama</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2013,</strong> <em>32 </em>
                                    (1)
                                     , 27-38. <a href="https://doi.org/10.1038/onc.2012.21" title="DOI URL">https://doi.org/10.1038/onc.2012.21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2012.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2012.21%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DStructural%252Bbasis%252Bfor%252Bthe%252Baltered%252Bdrug%252Bsensitivities%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer-associated%252Bmutants%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%26aulast%3DYoshikawa%26aufirst%3DS%26date%3D2013%26date%3D2012%26volume%3D32%26issue%3D1%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa M.  Hamed</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Adam B.  Keeton</span>, <span class="hlFld-ContribAuthor ">Gary A.  Piazza</span>, <span class="hlFld-ContribAuthor ">Matthias  Engel</span>, <span class="hlFld-ContribAuthor ">Rolf W.  Hartmann</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: influence of the position 4 substituent. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (8)
                                     , 1202. <a href="https://doi.org/10.1039/c3md00118k" title="DOI URL">https://doi.org/10.1039/c3md00118k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00118k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00118k%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DQuinazoline%252Band%252Btetrahydropyridothieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Birreversible%252BEGFR%252Btyrosine%252Bkinase%252Binhibitors%25253A%252Binfluence%252Bof%252Bthe%252Bposition%252B4%252Bsubstituent%26aulast%3DHamed%26aufirst%3DMostafa%2BM.%26date%3D2013%26volume%3D4%26issue%3D8%26spage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huangyong  Li</span>, <span class="hlFld-ContribAuthor ">Changshui  Chen</span>, <span class="hlFld-ContribAuthor ">Shengzhen  Xu</span>, <span class="hlFld-ContribAuthor ">Xiufang  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Bioevaluation of Thieno[2,3-
              d
              ]pyrimidinone Derivatives as Potential Tumor Cell Growth Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>, 1-6. <a href="https://doi.org/10.1155/2013/692074" title="DOI URL">https://doi.org/10.1155/2013/692074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/692074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F692074%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252BBioevaluation%252Bof%252BThieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidinone%252BDerivatives%252Bas%252BPotential%252BTumor%252BCell%252BGrowth%252BInhibitors%26aulast%3DLi%26aufirst%3DHuangyong%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Galvani</span>, <span class="hlFld-ContribAuthor ">Elisa  Giovannetti</span>, <span class="hlFld-ContribAuthor ">Francesca  Saccani</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Leticia G.  Leon</span>, <span class="hlFld-ContribAuthor ">Henk  Dekker</span>, <span class="hlFld-ContribAuthor ">Roberta  Alfieri</span>, <span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span>, <span class="hlFld-ContribAuthor ">Godefridus J.  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in NonâSmall Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2013,</strong> <em>15 </em>
                                    (1)
                                     , 61-IN18. <a href="https://doi.org/10.1593/neo.121434" title="DOI URL">https://doi.org/10.1593/neo.121434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.121434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.121434%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DMolecular%252BMechanisms%252BUnderlying%252Bthe%252BAntitumor%252BActivity%252Bof%252B3-Aminopropanamide%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252Bin%252BNon%2525E2%252580%252593Small%252BCell%252BLung%252BCancer%26aulast%3DGalvani%26aufirst%3DElena%26date%3D2013%26volume%3D15%26issue%3D1%26spage%3D61%26epage%3DIN18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2012,</strong> <em>84 </em>
                                    (11)
                                     , 1388-1399. <a href="https://doi.org/10.1016/j.bcp.2012.07.031" title="DOI URL">https://doi.org/10.1016/j.bcp.2012.07.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2012.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2012.07.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DClinical%252Bperspectives%252Bfor%252Birreversible%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bcancer%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2012%26volume%3D84%26issue%3D11%26spage%3D1388%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin Jian  Song</span>, <span class="hlFld-ContribAuthor ">Zheng Chao  Duan</span>, <span class="hlFld-ContribAuthor ">Yu  Shao</span>, <span class="hlFld-ContribAuthor ">Xing Gao  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of novel fluorinated thieno[2,3-d]pyrimidine derivatives containing 1,3,4-thiadiazole. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2012,</strong> <em>23 </em>
                                    (5)
                                     , 549-552. <a href="https://doi.org/10.1016/j.cclet.2012.02.007" title="DOI URL">https://doi.org/10.1016/j.cclet.2012.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2012.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2012.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252Bnovel%252Bfluorinated%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bcontaining%252B1%25252C3%25252C4-thiadiazole%26aulast%3DSong%26aufirst%3DXin%2BJian%26date%3D2012%26volume%3D23%26issue%3D5%26spage%3D549%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.M.  Kandeel</span>, <span class="hlFld-ContribAuthor ">Ashraf A.  Mounir</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Refaat</span>, <span class="hlFld-ContribAuthor ">Asmaa E.  Kassab</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Potent Anticancer Thieno[2,3-
              d
              ]Pyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2012,</strong> <em>36 </em>
                                    (5)
                                     , 266-275. <a href="https://doi.org/10.3184/174751912X13333849411283" title="DOI URL">https://doi.org/10.3184/174751912X13333849411283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751912X13333849411283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751912X13333849411283%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DSynthesis%252Bof%252BPotent%252BAnticancer%252BThieno%25255B2%25252C3-%252Bd%252B%25255DPyrimidine%252BDerivatives%26aulast%3DKandeel%26aufirst%3DM.M.%26date%3D2012%26date%3D2012%26volume%3D36%26issue%3D5%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang  Lu</span>, <span class="hlFld-ContribAuthor ">Li-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Xian-Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (4)
                                     , 1411-1416. <a href="https://doi.org/10.1016/j.bmc.2012.01.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-phenylsulfonylnicotinamide%252Bderivatives%252Bas%252Bnovel%252Bantitumor%252Binhibitors%26aulast%3DZhang%26aufirst%3DHui%26date%3D2012%26volume%3D20%26issue%3D4%26spage%3D1411%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Teruhiko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Taketoshi  Kozuki</span>, <span class="hlFld-ContribAuthor ">Naoki  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Hidetaka  Hiyoshi</span>, <span class="hlFld-ContribAuthor ">Kazuto  Umezu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5,6-Disubstituted Thieno[2,3-d]pyrimidines from 4-Chloropyrimidines. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2012,</strong> <em>85 </em>
                                    (6)
                                     , 1405. <a href="https://doi.org/10.3987/COM-12-12463" title="DOI URL">https://doi.org/10.3987/COM-12-12463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-12-12463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-12-12463%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Bof%252B5%25252C6-Disubstituted%252BThieno%25255B2%25252C3-d%25255Dpyrimidines%252Bfrom%252B4-Chloropyrimidines%26aulast%3DKobayashi%26aufirst%3DKazuhiro%26date%3D2012%26volume%3D85%26issue%3D6%26spage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversible and irreversible EGFR tyrosine kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of novel and potent tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine scaffold EGFR tyrosine kinase inhibitors, through knowledge-based design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis using anti-phospho-EGFR Y1068 and anti-EGFR immunoblots of HCC827 cell lysates treated with <b>1</b> or <b>11</b> for 2 h. A representative anti-tubulin immunoblot is shown as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo antitumor effect of <b>19</b> in human nonsmall cell lung cancer (HCC827) xenograft nude mice model. The growth of HCC827 tumor xenograft is inhibited by <b>19</b> (5 mg/kg, iv or 15 mg/kg, iv) and gefitinib (100 mg/kg, po) with <i>p</i> < 0.05. Drug treatment on days 1â5 and 8â12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NCCH<sub>2</sub>CO<sub>2</sub>Et, S<sub>8</sub>, EtOH, Et<sub>3</sub>N, reflux or rt, 16 h; (b) formamide, reflux, 2 h or formamidine acetate, DMF, 100 Â°C, 16 h; (c) POCl<sub>3</sub>, 0 â 60 Â°C, 3 h; (d) primary amine (R<sup>1</sup>R<sup>2</sup>CHNH<sub>2</sub>), <i>n</i>-BuOH, reflux, 8 h.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/medium/jm-2010-00607r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-20/jm100607r/production/images/large/jm-2010-00607r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100607r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine (R<sup>1</sup>R<sup>2</sup>CHNH<sub>2</sub>), EtOH, reflux, 8 h; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C â rt, 2 h; (c) acid (RCO<sub>2</sub>H), EDCI, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h (d) Cl(CH<sub>2</sub>)<sub>2</sub>SO<sub>2</sub>Cl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; (e) (i) (<i>E</i>)-BrCH<sub>2</sub>CHâCHCO<sub>2</sub>H, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (ii) secondary amine (R<sub>2</sub>NH), THF, 0 Â°C, 2 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 17 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sharma, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor mutations in lung cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">â</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1038%2Fnrc2088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=17318210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=169-181&author=S.+V.+Sharmaauthor=D.+W.+Bellauthor=J.+Settlemanauthor=D.+A.+Haber&title=Epidermal+growth+factor+receptor+mutations+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor mutations in lung cancer</span></div><div class="casAuthors">Sharma, Sreenath V.; Bell, Daphne W.; Settleman, Jeffrey; Haber, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-181</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The development and clin. application of inhibitors that target the epidermal growth factor receptor (EGFR) provide important insights for new lung cancer therapies, as well as for the broader field of targeted cancer therapies.  We review the results of genetic, biochem. and clin. studies focused on somatic mutations of EGFR that are assocd. with the phenomenon of oncogene addiction, describing 'oncogenic shock' as a mechanistic explanation for the apoptosis that follows the acute treatment of susceptible cells with kinase inhibitors.  Understanding the genetic heterogeneity of epithelial tumors and devising strategies to circumvent their rapid acquisition of resistance to targeted kinase inhibitors are essential to the successful use of targeted therapies in common epithelial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMKw7Y4FUFM7Vg90H21EOLACvtfcHk0ljwuJHWsd2YLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrsbo%253D&md5=46219ea3ae7b9f0977e4a4b7243fd875</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2088%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BV.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520mutations%2520in%2520lung%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D169%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span> </span><span class="NLM_article-title">EGFR antagonists in cancer treatment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">â</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1056%2FNEJMra0707704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=18337605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ahsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=1160-1174&author=F.+Ciardielloauthor=G.+Tortora&title=EGFR+antagonists+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR antagonists in cancer treatment</span></div><div class="casAuthors">Ciardiello, Fortunato; Tortora, Giampaolo</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1160-1174</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on epidermal growth factor receptor (EGFR) in human carcinogenesis, development of EGFR antagonists for anticancer therapy, and clin. efficacy of EGFR antagonists in human cancers.  Predicting the response to anti-EGFR drugs and future directions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGNHvRENSffLVg90H21EOLACvtfcHk0ljqIDs4XpZlUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ahsL4%253D&md5=2834999545fd643c6f727d80d357134d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0707704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0707704%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DTortora%26aufirst%3DG.%26atitle%3DEGFR%2520antagonists%2520in%2520cancer%2520treatment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D1160%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yun, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">â</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.+H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.+K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+mutation+in+EGFR+kinase+causes+drug+resistance+by+increasing+the+affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0ljqIDs4XpZlUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.%2BH.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520mutation%2520in%2520EGFR%2520kinase%2520causes%2520drug%2520resistance%2520by%2520increasing%2520the%2520affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayaram, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocher, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenen, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span> </span><span class="NLM_article-title">EGFR mutation and resistance of non-small-cell lung cancer to gefitinib</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">â</span> <span class="NLM_lpage">792</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1056%2FNEJMoa044238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=15728811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFCiurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=786-792&author=S.+Kobayashiauthor=T.+J.+Boggonauthor=T.+Dayaramauthor=P.+A.+Janneauthor=O.+Kocherauthor=M.+Meyersonauthor=B.+E.+Johnsonauthor=M.+J.+Eckauthor=D.+G.+Tenenauthor=B.+Halmos&title=EGFR+mutation+and+resistance+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR mutation and resistance of non-small-cell lung cancer to gefitinib</span></div><div class="casAuthors">Kobayashi, Susumu; Boggon, Titus J.; Dayaram, Tajhal; Jaenne, Pasi A.; Kocher, Olivier; Meyerson, Matthew; Johnson, Bruce E.; Eck, Michael J.; Tenen, Daniel G.; Halmos, Balizs</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">786-792</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Mutations of the epidermal growth factor receptor (EGFR) gene were identified in specimens from patients with non-small-cell lung cancer who have a response to anilinoquinazoline EGFR inhibitors.  Despite the dramatic responses to such inhibitors, most patients ultimately have a relapse.  The mechanism of the drug resistance is unknown.  Here the authors report the case of a patient with EGFR-mutant, gefitinib-responsive, advanced non-small-cell lung cancer who had a relapse after 2 years of complete remission during treatment with gefitinib.  The DNA sequence of the EGFR gene in his tumor biopsy specimen at relapse revealed the presence of a second point mutation, resulting in threonine-to-methionine amino acid change at position 790 of EGFR.  Structural modeling and biochem. studies showed that this second mutation led to gefitinib resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8XXhT1hrbe7Vg90H21EOLACvtfcHk0ljqIDs4XpZlUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFCiurk%253D&md5=808223ad566e2a3748977727cc5a9846</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa044238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa044238%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DDayaram%26aufirst%3DT.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DKocher%26aufirst%3DO.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DTenen%26aufirst%3DD.%2BG.%26aulast%3DHalmos%26aufirst%3DB.%26atitle%3DEGFR%2520mutation%2520and%2520resistance%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D786%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. R.</span><span> </span><span class="NLM_article-title">A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=89-94&author=W.+H.+Linauthor=J.+S.+Songauthor=T.+Y.+Changauthor=C.+Y.+Changauthor=Y.+N.+Fuauthor=C.+L.+Yehauthor=S.+H.+Wuauthor=Y.+W.+Huangauthor=M.+Y.+Fangauthor=T.+W.+Lienauthor=H.+P.+Hsiehauthor=Y.+S.+Chaoauthor=S.+F.+Huangauthor=S.+F.+Tsaiauthor=L.+M.+Wangauthor=J.+T.+Hsuauthor=Y.+R.+Chen&title=A+cell-based+high-throughput+screen+for+epidermal+growth+factor+receptor+pathway+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DChang%26aufirst%3DT.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DFu%26aufirst%3DY.%2BN.%26aulast%3DYeh%26aufirst%3DC.%2BL.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DHuang%26aufirst%3DY.%2BW.%26aulast%3DFang%26aufirst%3DM.%2BY.%26aulast%3DLien%26aufirst%3DT.%2BW.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DHuang%26aufirst%3DS.%2BF.%26aulast%3DTsai%26aufirst%3DS.%2BF.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DHsu%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DY.%2BR.%26atitle%3DA%2520cell-based%2520high-throughput%2520screen%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520pathway%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D377%26spage%3D89%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Coumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C., W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leou, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittimalla, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span> </span><span class="NLM_article-title">Fast-forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification. <i>J</i></span> <span class="citation_source-journal">Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4980</span><span class="NLM_x">â</span> <span class="NLM_lpage">4988</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000198" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFyhs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4980-4988&author=M.+S.+Coumarauthor=C.+Y.+Chuauthor=C.%2C+W.+Linauthor=H.+Y.+Shiaoauthor=Y.+L.+Hoauthor=R.+Reddyauthor=W.+H.+Linauthor=C.+H.+Chenauthor=Y.+H.+Pengauthor=J.+S.+Leouauthor=T.+W.+Lienauthor=C.+T.+Huangauthor=M.+Y.+Fangauthor=S.+H.+Wuauthor=S.+K.+Chittimallaauthor=J.+S.+Songauthor=J.+T.+A.+Hsuauthor=S.+Y.+Wuauthor=C.+C.+Liaoauthor=Y.+S.+Chaoauthor=H.+P.+Hsieh&title=Fast-forwarding+Hit+to+Lead%3A+Aurora+and+Epidermal+Growth+Factor+Receptor+Kinase+Inhibitor+Lead+Identification.+J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Fast-Forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification</span></div><div class="casAuthors">Coumar, Mohane Selvaraj; Chu, Chang-Ying; Lin, Cheng-Wei; Shiao, Hui-Yi; Ho, Yun-Lung; Reddy, Randheer; Lin, Wen-Hsing; Chen, Chun-Hwa; Peng, Yi-Hui; Leou, Jiun-Shyang; Lien, Tzu-Wen; Huang, Chin-Ting; Fang, Ming-Yu; Wu, Szu-Huei; Wu, Jian-Sung; Chittimalla, Santhosh Kumar; Song, Jen-Shin; Hsu, John T.-A.; Wu, Su-Ying; Liao, Chun-Chen; Chao, Yu-Sheng; Hsieh, Hsing-Pang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4980-4988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Furanopyrimidines such as I [R = (S)-HOCH2CHPh; R1 = 3-(H2C:CCONH)C6H4] are prepd. as Aurora A kinase and epidermal growth factor receptor (EGFR) inhibitors by prepn. of a combinatorial library of approx. 350 furanopyridines and optimization of the inhibitors found from the library.  The initial hit compd. I (R = HOCH2CH2; R1 = Ph) was modified to better fit the back pocket to produce the potent Aurora A kinase inhibitor I (R = 4-PhNHCONHC6H4; R1 = Ph) with submicromolar antiproliferative activity in the HCT-116 human colon cancer cell line.  On the basis of docking studies with EGFR hit I [R = (S)-HOCH2CHPh; R1 = Ph], introduction of an acrylamide Michael acceptor group led to I [R = (S)-HOCH2CHPh; R1 = 3-(H2C:CCONH)C6H4], which inhibited both the wild and mutant EGFR kinases and also showed antiproliferative activity in the gefitinib-resistant HCC827 human lung cancer cells.  The X-ray cocrystal structures of I (R = HOCH2CH2, 4-PhNHCONHC6H4; R1 = Ph) bound to Aurora A kinase and the crystal structure of I [R = (S)-HOCH2CHPh; R1 = 3-(H2C:CCONH)C6H4] bound to EGFR confirmed their hypothesized binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCOPMtJ1xilrVg90H21EOLACvtfcHk0lg2FYoiSMSePg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFyhs7s%253D&md5=8064e99d8d31603c7186b5fa33e019a6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm1000198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000198%26sid%3Dliteratum%253Aachs%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DChu%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DC.%252C%2BW.%26aulast%3DShiao%26aufirst%3DH.%2BY.%26aulast%3DHo%26aufirst%3DY.%2BL.%26aulast%3DReddy%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DW.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DPeng%26aufirst%3DY.%2BH.%26aulast%3DLeou%26aufirst%3DJ.%2BS.%26aulast%3DLien%26aufirst%3DT.%2BW.%26aulast%3DHuang%26aufirst%3DC.%2BT.%26aulast%3DFang%26aufirst%3DM.%2BY.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DChittimalla%26aufirst%3DS.%2BK.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DHsu%26aufirst%3DJ.%2BT.%2BA.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DLiao%26aufirst%3DC.%2BC.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26atitle%3DFast-forwarding%2520Hit%2520to%2520Lead%253A%2520Aurora%2520and%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Kinase%2520Inhibitor%2520Lead%2520Identification.%2520J%26jtitle%3DMed.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4980%26epage%3D4988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(alpha-phenethylamino)quinazolines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1651</span><span class="NLM_x">â</span> <span class="NLM_lpage">1656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=1651-1656&author=A.+J.+Bridgesauthor=D.+R.+Codyauthor=H.+Zhouauthor=A.+McMichaelauthor=D.+W.+Fry&title=Enantioselective+inhibition+of+the+epidermal+growth+factor+receptor+tyrosine+kinase+by+4-%28alpha-phenethylamino%29quinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DEnantioselective%2520inhibition%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520by%25204-%2528alpha-phenethylamino%2529quinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1995%26volume%3D3%26spage%3D1651%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sercel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 16. 6,5,6-Tricyclic benzothieno[3, 2-<i>d</i>]pyrimidines and pyrimido[5,4-<i>b</i>]- and -[4,5-<i>b</i>]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5464</span><span class="NLM_x">â</span> <span class="NLM_lpage">5474</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9903949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5464-5474&author=H.+D.+Showalterauthor=A.+J.+Bridgesauthor=H.+Zhouauthor=A.+D.+Sercelauthor=A.+McMichaelauthor=D.+W.+Fry&title=Tyrosine+kinase+inhibitors.+16.+6%2C5%2C6-Tricyclic+benzothieno%5B3%2C+2-d%5Dpyrimidines+and+pyrimido%5B5%2C4-b%5D-+and+-%5B4%2C5-b%5Dindoles+as+potent+inhibitors+of+the+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm9903949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9903949%26sid%3Dliteratum%253Aachs%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSercel%26aufirst%3DA.%2BD.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252016.%25206%252C5%252C6-Tricyclic%2520benzothieno%255B3%252C%25202-d%255Dpyrimidines%2520and%2520pyrimido%255B5%252C4-b%255D-%2520and%2520-%255B4%252C5-b%255Dindoles%2520as%2520potent%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5464%26epage%3D5474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegrini, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosios, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McSheehy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span> </span><span class="NLM_article-title">AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4931</span><span class="NLM_x">â</span> <span class="NLM_lpage">4941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4931-4941&author=P.+Traxlerauthor=P.+R.+Allegriniauthor=R.+Brandtauthor=J.+Brueggenauthor=R.+Cozensauthor=D.+Fabbroauthor=K.+Grosiosauthor=H.+A.+Laneauthor=P.+McSheehyauthor=J.+Mestanauthor=T.+Meyerauthor=C.+Tangauthor=M.+Wartmannauthor=J.+Woodauthor=G.+Caravatti&title=AEE788%3A+a+dual+family+epidermal+growth+factor+receptor%2FErbB2+and+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DAllegrini%26aufirst%3DP.%2BR.%26aulast%3DBrandt%26aufirst%3DR.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGrosios%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DMcSheehy%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DCaravatti%26aufirst%3DG.%26atitle%3DAEE788%253A%2520a%2520dual%2520family%2520epidermal%2520growth%2520factor%2520receptor%252FErbB2%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4931%26epage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greis, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hook, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherwood, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trumpp-Kallmeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span> </span><span class="NLM_article-title">Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">12022</span><span class="NLM_x">â</span> <span class="NLM_lpage">12027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1073%2Fpnas.95.20.12022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=9751783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADyaK1cXmsV2ht7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12022-12027&author=D.+W.+Fryauthor=A.+J.+Bridgesauthor=W.+A.+Dennyauthor=A.+Dohertyauthor=K.+D.+Greisauthor=J.+L.+Hicksauthor=K.+E.+Hookauthor=P.+R.+Kellerauthor=W.+R.+Leopoldauthor=J.+A.+Looauthor=D.+J.+McNamaraauthor=J.+M.+Nelsonauthor=V.+Sherwoodauthor=J.+B.+Smaillauthor=S.+Trumpp-Kallmeyerauthor=E.+M.+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor</span></div><div class="casAuthors">Fry, David W.; Bridges, Alexander J.; Denny, William A.; Doherty, Annette; Greis, Kenneth D.; Hicks, James L.; Hook, Kenneth E.; Keller, Paul R.; Leopold, Wilbur R.; Loo, Joseph A.; McNamara, Dennis J.; Nelson, James M.; Sherwood, Veronika; Smaill, Jeff B.; Trumpp-Kallmeyer, Susanne; Dobrusin, Ellen M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12022-12027</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A class of high-affinity inhibitors is disclosed that selectively target and irreversibly inactivate the epidermal growth factor receptor tyrosine kinase through specific, covalent modification of a cysteine residue present in the ATP binding pocket.  A series of expts. employing MS, mol. modeling, site-directed mutagenesis, and 14C-labeling studies in viable cells unequivocally demonstrate that these compds. selectively bind to the catalytic domain of the epidermal growth factor receptor with a 1:1 stoichiometry and alkylate Cys-773.  While the compds. are essentially non-reactive in soln., they are subject to rapid nucleophilic attack by this particular amino acid when bound in the ATP pocket.  The mol. orientation and positioning of the acrylamide group in these inhibitors in relation to Cys-773 entirely support these results as detd. from docking expts. in a homol.-built mol. model of the ATP site.  Evidence is also presented to indicate that the compds. interact in an analogous fashion with erbB2 but have no activity against the other receptor tyrosine kinases or intracellular tyrosine kinases that were tested in this study.  Finally, a direct comparison between 6-acrylamido-4-anilinoquinazoline and an equally potent but reversible analog shows that the irreversible inhibitor has far superior in vivo antitumor activity in a human epidermoid carcinoma xenograft model with no overt toxicity at therapeutically active doses.  The activity profile for this compd. is prototypical of a generation of tyrosine kinase inhibitors with great promise for therapeutic significance in the treatment of proliferative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpibFpkhNyxDLVg90H21EOLACvtfcHk0liM4stjhFpeRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsV2ht7g%253D&md5=a89b0b8123511fb1bbb889c01a3f9df2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.20.12022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.20.12022%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DDoherty%26aufirst%3DA.%26aulast%3DGreis%26aufirst%3DK.%2BD.%26aulast%3DHicks%26aufirst%3DJ.%2BL.%26aulast%3DHook%26aufirst%3DK.%2BE.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DLoo%26aufirst%3DJ.%2BA.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DSherwood%26aufirst%3DV.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DTrumpp-Kallmeyer%26aufirst%3DS.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D1998%26volume%3D95%26spage%3D12022%26epage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">The development of HKI-272 and related compounds for the treatment of cancer</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">â</span> <span class="NLM_lpage">477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=465-477&author=A.+Wissnerauthor=T.+S.+Mansour&title=The+development+of+HKI-272+and+related+compounds+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DThe%2520development%2520of%2520HKI-272%2520and%2520related%2520compounds%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%2529%26date%3D2008%26volume%3D341%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tsou, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek-Klumpers, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">â</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1107-1131&author=H.+R.+Tsouauthor=E.+G.+Overbeek-Klumpersauthor=W.+A.+Hallettauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=R.+S.+Michalakauthor=R.+Nilakantanauthor=C.+Discafaniauthor=J.+Golasauthor=S.+K.+Rabindranauthor=R.+Shenauthor=X.+Shiauthor=Y.+F.+Wangauthor=J.+Upeslacisauthor=A.+Wissner&title=Optimization+of+6%2C7-disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+orally+active%2C+irreversible+inhibitors+of+human+epidermal+growth+factor+receptor-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.%2BR.%26aulast%3DOverbeek-Klumpers%26aufirst%3DE.%2BG.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMichalak%26aufirst%3DR.%2BS.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DUpeslacis%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DOptimization%2520of%25206%252C7-disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520orally%2520active%252C%2520irreversible%2520inhibitors%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520kinase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1107%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3958</span><span class="NLM_x">â</span> <span class="NLM_lpage">3965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm100607r&amp;key=10.1158%2F0008-5472.CAN-03-2868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm100607r&amp;key=15173008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100607r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3958-3965&author=S.+K.+Rabindranauthor=C.+M.+Discafaniauthor=E.+C.+Rosfjordauthor=M.+Baxterauthor=M.+B.+Floydauthor=J.+Golasauthor=W.+A.+Hallettauthor=B.+D.+Johnsonauthor=R.+Nilakantanauthor=E.+Overbeekauthor=M.+F.+Reichauthor=R.+Shenauthor=X.+Shiauthor=H.+R.+Tsouauthor=Y.+F.+Wangauthor=A.+Wissner&title=Antitumor+activity+of+HKI-272%2C+an+orally+active%2C+irreversible+inhibitor+of+the+HER-2+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase</span></div><div class="casAuthors">Rabindran, Sridhar K.; Discafani, Carolyn M.; Rosfjord, Edward C.; Baxter, Michelle; Floyd, M. Brawner; Golas, Jonathan; Hallett, William A.; Johnson, Bernard D.; Nilakantan, Ramaswamy; Overbeek, Elsebe; Reich, Marvin F.; Shen, Ru; Shi, Xiaoqing; Tsou, Hwei-Ru; Wang, Yu-Fen; Wissner, Allan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3958-3965</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HER-2 belongs to the ErbB family of receptor tyrosine kinases, which has been implicated in a variety of cancers.  Overexpression of HER-2 is seen in 25-30% of breast cancer patients and predicts a poor outcome in patients with primary disease.  Trastuzumab (Herceptin), a monoclonal antibody to HER-2, is specifically approved for HER-2-pos. breast cancer but is active only in a subset of these tumors.  Blocking HER-2 function by a small mol. kinase inhibitor, therefore, represents an attractive alternate strategy to inhibit the growth of HER-2-pos. tumors.  HKI-272 is a potent inhibitor of HER-2 and is highly active against HER-2-overexpressing human breast cancer cell lines in vitro.  It also inhibits the epidermal growth factor receptor (EGFR) kinase and the proliferation of EGFR-dependent cells.  HKI-272 reduces HER-2 receptor autophosphorylation in cells at doses consistent with inhibition of cell proliferation and functions as an irreversible binding inhibitor, most likely by targeting a cysteine residue in the ATP-binding pocket of the receptor.  In agreement with the predicted effects of HER-2 inactivation, HKI-272 treatment of cells results in inhibition of downstream signal transduction events and cell cycle regulatory pathways.  This leads to arrest at the G1-S (Gap 1/DNA synthesis)-phase transition of the cell division cycle, ultimately resulting in decreased cell proliferation.  In vivo, HKI-272 is active in HER-2- and EGFR-dependent tumor xenograft models when dosed orally on a once daily schedule.  On the basis of its favorable preclin. pharmacol. profile, HKI-272 has been selected as a candidate for addnl. development as an antitumor agent in breast and other HER-2-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2xeLXlAwWvbVg90H21EOLACvtfcHk0ljx6gb2EX_eOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKns7o%253D&md5=60accd0599b7c489e4c3753d4f39cab4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-2868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-2868%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DBaxter%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DTsou%26aufirst%3DH.%2BR.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DAntitumor%2520activity%2520of%2520HKI-272%252C%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520HER-2%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3958%26epage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H. R.</span><span> </span><span class="NLM_article-title">Synthesis and structureâactivity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020241c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=49-63&author=A.+Wissnerauthor=E.+Overbeekauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=E.+C.+Rosfjordauthor=C.+Discafaniauthor=R.+Davisauthor=X.+Shiauthor=S.+K.+Rabindranauthor=B.+C.+Gruberauthor=F.+Yeauthor=W.+A.+Hallettauthor=R.+Nilakantanauthor=R.+Shenauthor=Y.+F.+Wangauthor=L.+M.+Greenbergerauthor=H.+R.+Tsou&title=Synthesis+and+structure%E2%88%92activity+relationships+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles.+The+design+of+an+orally+active%2C+irreversible+inhibitor+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+the+human+epidermal+growth+factor+receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm020241c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020241c%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DTsou%26aufirst%3DH.%2BR.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles.%2520The%2520design%2520of%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yoshimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negoro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, M.</span><span> </span><span class="NLM_article-title">EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2006&pages=363-368&author=N.+Yoshimuraauthor=S.+Kudohauthor=T.+Kimuraauthor=S.+Mitsuokaauthor=K.+Matsuuraauthor=K.+Hirataauthor=K.+Matsuiauthor=S.+Negoroauthor=K.+Nakagawaauthor=M.+Fukuoka&title=EKB-569%2C+a+new+irreversible+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+with+clinical+activity+in+patients+with+non-small+cell+lung+cancer+with+acquired+resistance+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DN.%26aulast%3DKudoh%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DMitsuoka%26aufirst%3DS.%26aulast%3DMatsuura%26aufirst%3DK.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DK.%26aulast%3DNegoro%26aufirst%3DS.%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DFukuoka%26aufirst%3DM.%26atitle%3DEKB-569%252C%2520a%2520new%2520irreversible%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520with%2520clinical%2520activity%2520in%2520patients%2520with%2520non-small%2520cell%2520lung%2520cancer%2520with%2520acquired%2520resistance%2520to%2520gefitinib%26jtitle%3DLung%2520Cancer%26date%3D2006%26volume%3D51%26spage%3D363%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrogio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirieac, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padera, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelsbach, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span> </span><span class="NLM_article-title">BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4702</span><span class="NLM_x">â</span> <span class="NLM_lpage">4711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=4702-4711&author=D.+Liauthor=L.+Ambrogioauthor=T.+Shimamuraauthor=S.+Kuboauthor=M.+Takahashiauthor=L.+R.+Chirieacauthor=R.+F.+Paderaauthor=G.+I.+Shapiroauthor=A.+Baumauthor=F.+Himmelsbachauthor=W.+J.+Rettigauthor=M.+Meyersonauthor=F.+Solcaauthor=H.+Greulichauthor=K.+K.+Wong&title=BIBW2992%2C+an+irreversible+EGFR%2FHER2+inhibitor+highly+effective+in+preclinical+lung+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DAmbrogio%26aufirst%3DL.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DKubo%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DChirieac%26aufirst%3DL.%2BR.%26aulast%3DPadera%26aufirst%3DR.%2BF.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DHimmelsbach%26aufirst%3DF.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSolca%26aufirst%3DF.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DBIBW2992%252C%2520an%2520irreversible%2520EGFR%252FHER2%2520inhibitor%2520highly%2520effective%2520in%2520preclinical%2520lung%2520cancer%2520models%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D4702%26epage%3D4711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gewald, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BÃ¶ttcher, H.</span><span> </span><span class="NLM_article-title">Heterocyclen aus CH-aciden Nitrilen, VIII. 2-Amino-thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und Schwefel</span> <span class="citation_source-journal">Chem. Ber</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">â</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1966&pages=94-100&author=K.+Gewaldauthor=E.+Schinkeauthor=H.+B%C3%B6ttcher&title=Heterocyclen+aus+CH-aciden+Nitrilen%2C+VIII.+2-Amino-thiophene+aus+methylenaktiven+Nitrilen%2C+Carbonylverbindungen+und+Schwefel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGewald%26aufirst%3DK.%26aulast%3DSchinke%26aufirst%3DE.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DH.%26atitle%3DHeterocyclen%2520aus%2520CH-aciden%2520Nitrilen%252C%2520VIII.%25202-Amino-thiophene%2520aus%2520methylenaktiven%2520Nitrilen%252C%2520Carbonylverbindungen%2520und%2520Schwefel%26jtitle%3DChem.%2520Ber%26date%3D1966%26volume%3D99%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100607r&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm100607r%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100607r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995f3fd97b32a9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
